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The pleiotropic functions of the gastrointestinal tract 
Health of an organism, whether human or animal, is difficult to define, although it is the 
subject of extensive research activities all over the world. Many of these studies focus on 
restoring health, including cures for diseases. Other research is directed towards the devel-
opment of products and methods to prevent diseases, e.g. the development of diagnostics 
and vaccines. More recent studies are focussing on promoting and maintaining health e.g. 
with nutrition and change of lifestyle.  
Figure 1. Functionalities of the gastrointestinal tract (GIT). The GIT is depicted with its various 
functionalities. The gut is involved in digestion and absorption of food or feed nutrients. The gut is 
also involved in immune functions like tolerance of antigens in food and defending the organism 
against possible pathogens. There is also extensive signalling from the gut to other organs like the 
liver which receives absorbed nutrients and the brain which receives signals from the nervous sys-
tem. (Image adapted from Bischoff (Bischoff 2011)) 
Intestinal health significantly contributes to the overall health of an organism whether 
human (Bischoff 2011; J H Cummings et al. 2004) or animal (Kogut and Arsenault 2016). 
The gastro-intestinal tract (GIT) is considered to be healthy when it is able to efficiently 
digest and absorb components of feed or food, when the intestinal microbiota composition 
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and diversity is “in balance”, when pathogenic micro-organisms are absent or cannot colo-
nize and/or expand, and when the gut mucosal immune system is capable of efficiently 
neutralizing potential disease causing stressors (see Figure 1). In addition to this, the GIT 
has several signalling functions towards other parts of the body, which also contribute to 
the health of the organism. 
The GIT, which starts from the mouth, continues into the stomach and intestine and ends 
at the anus, transports, digests and absorbs food/feed components before the undigested 
waste is dispelled through the anus. During transport, food/feed components 
(carbohydrates, fat, proteins) are digested by enzymes, bile and by the fermenting action 
of microbes present in the lumen of the gut. Dietary components are broken up into nutri-
ents that are absorbed by the epithelial cells of the intestine and subsequently transported 
to different parts of the body via the bloodstream. The presence of specific nutritional 
components is signalled by the gut towards the brain via the gut-brain axis, and the brain 
then regulates hormonal levels for digestion in the gut, for example insulin levels in the 
blood are modulated when glucose is absorbed by the gut (Tsurugizawa et al. 2009; 
Berthoud 2008). 
The epithelial layer of the GIT is a single layer of cells that forms the luminal surface. 
Besides its role in digestion, the epithelial layer of the GIT has an important barrier func-
tion to defend the body against the outside world. It protects the body from the contents of 
the lumen. The gut-associated immune system, which is most abundant in the small intes-
tine, constantly monitors the content of the gut for toxic components, food/feed based 
antigens and antigens produced by commensal and (opportunistic) pathogenic organisms. 
The immune system is able to recognize several antigens that could be part of the food/
feed and to induce immunological tolerance (Pabst and Mowat 2012; Castro-Sánchez and 
Martín-Villa 2013). Immune tolerance also plays a role in dampening the immune re-
sponse to commensal bacteria that reside in the gut and perform several vital functions. 
The mucosal immune system is able to discriminate between commensal microbes and 
pathogens. Discrimination occurs by pattern recognition receptors on and within epithelial 
cells that can recognize specific pathogen-associated molecular patterns. In case antigens 
of (potential) pathogens are recognized, local and systemic immune responses are induced 
to defend the organism from disease development (Artis 2008).  
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Thus, the GIT exhibits a large variety of functions that are essential for the performance 
and health of the organism. Improved understanding of the mechanisms underlying the 
pleiotropic functionalities of the gut will allow the development of (nutritional) interven-
tions to modulate intestinal functionalities, thereby contributing to human and animal 
health.  
Morphology of the GIT tract 
Figure 2: Gut interface with the environment. The image is an illustration of a section of the 
small intestine showing the different cell types at the epithelial surface of the tissue. The epithelial 
layer is covered by a mucus layer that separates the cells from microbes in the lumen. A Peyer’s 
patch is also shown with several immune cells. Adapted from (Rossi, van Baarlen, and Wells 2011) 
There are several distinct sections of the GIT: the stomach; the small intestine; the large 
intestine; and the caecum. Each section has a different function for digestion and immune 
actions. In all the sections the luminal surface area is increased with projections of the 
epithelial layer that forms villi (projections) and crypts (invaginations). The small intes-
tine can be further divided into the duodenum, jejunum and the ileum. These sub sections 
have different morphologies but the small intestine in general has a high villus to crypt 
ratio and a higher concentration of mucosal immune cells than other sections of the gut. 
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The various sections of the intestine have common cellular structures that play a role in 
the functioning of the GIT as a whole. The different cell types present in the gut mucosa 
allow it to perform a multitude of processes. The different cell types are represented in a 
cartoon of the mucosal layer in Figure 2. Enterocytes are the major cell type of the intesti-
nal epithelium and contribute significantly to nutrient absorption. Goblet cells also form 
part of the single epithelial layer and secrete mucus, a thick layer of glycosylated proteins 
that acts as the first line of defence against the content of the gut lumen (Peterson and 
Artis 2014). Paneth cells and M-cells are epithelial cells specialized in immune functions. 
The mucosal layer of the intestinal tract contains a large number of different types of im-
mune cells that are part of the innate and/or the adaptive immune system (Mowat and 
Agace 2014). Scattered along the intestine are numerous lymphoid tissue structures, called 
gut associated lymphoid tissues with specialized immune structures; the Peyer’s patch(es) 
in the small intestine and the lymphoid follicles all over the intestine. These structures are 
involved in the regulation of the immune response of the gut.  
Microbiota 
A large number of microbial communities reside in the lumen of the gut. The number of 
microbial cells is comparable to the number of cells in an organism (Sender, Fuchs, and 
Milo 2016). These microbes have evolved with the host to form a mutually beneficial re-
lationship (O’Hara and Shanahan 2006; Scholtens et al. 2012). Bacteria are most abundant 
micro-organisms of the mammalian microbiota, 2-3 times the number of eukaryotes and 
archaea (Sender, Fuchs, and Milo 2016) and are the subject of most microbiota research. 
There is a large diversity (number and distribution of unique bacterial taxonomic groups) 
in the species of bacteria found in the gut. Yet a majority of the gut bacterial groups be-
long to a few dominant phyla, Bacteroidetes and Firmicutes are the largest contributors to 
gut microbes, followed by Actinobacteria, Proteobacteria and Verrucomicrobia (Lozupone 
et al. 2012). 
The number and concentration of the bacteria increases along the GIT with lower numbers 
in the small intestine than in the colon. The duodenum and jejunum are estimated to have 
about 107 bacterial cells. The ileum is estimated to have about 1011 bacteria, whereas the 
largest number of bacteria is observed in the colon, 1014 (Sender, Fuchs, and Milo 2016). 
15 
Chapter 1 
 
1 
The composition of gut microbiota is dynamic and changes with age as the morphology 
and physiology of the gut undergoes changes with the growth of the organism (Lozupone 
et al. 2012; Arrieta et al. 2014; Odamaki et al. 2016). Several studies have shown that the 
microbial populations are less steady and less diverse in early life and that they stabilize in 
adulthood (Scholtens et al. 2012; Ottman et al. 2012). Although it is known that there is 
an active cross-talk between microbes in the lumen of the gut and cells in the intestinal 
mucosa, not much is currently known about the microbial factors involved and the biolog-
ical processes they modulate in the gut system.  
Microbiota contribute to the breakdown of food/feed components such that they can be 
absorbed by the gut tissue into the bloodstream. The colon is a major site of fermentation 
of enzymatically indigestible feed/food components due to presence of the large bacterial 
population in this anaerobic environment. Several bacterial groups are known to ferment 
polysaccharides that the mammalian digestive system is unable to break down (Tremaroli 
and Backhed 2012; Macfarlane and Macfarlane 1997) and ferment undigested protein. 
The main products of this fermentation are Short Chain Fatty Acids (SCFA) (Haenen, 
Silva, et al. 2013; den Besten et al. 2013; Topping and Clifton 2001; Macfarlane and 
Macfarlane 1997). SCFA is readily absorbed by intestinal mucosal tissues and forms the 
major source of energy for this tissue, they are also known to contribute to intestinal 
health (den Besten et al. 2013). Microbiota also contributes to vitamin metabolism as bac-
terial enzymes are essential for the process, and bacteria have been observed to produce 
vitamin K (Sherwood L 1996). Additionally, immune functions of the gut mucosal tissues 
are modulated by commensal microbes in the lumen of the gut, for instance, by stimulat-
ing the production of antimicrobial proteins and increasing the production of mucosal 
immunoglobulins and intra-epithelial lymphocytes (Kabat, Srinivasan, and Maloy 2014; 
Arrieta and Finlay 2012; Ottman et al. 2012).  
Perturbation of gut homeostasis 
With the aid of specialized cells and by communicating with luminal microbiota and with 
other organs of the body, the gut maintains homeostasis, an equilibrium state essential for 
proper functioning of the gut (J H Cummings et al. 2004). This state of homeostasis is 
predicated on a balance between the host cells in the mucosa of the GIT, the microbiota 
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and the external environment. There are several different ways this homeostasis can be 
disturbed, for example by changes in the microbial composition of the gut (through the 
use of antibiotics) or stimulation of the immune system by dietary components, drugs, 
disease causing organisms or other changes in the environment. Many different studies 
have been published on changes in gut tissues and in resident microbiota after dietary in-
terventions. In many cases, the effect of changes in the diet is not always restricted to lo-
cal effects in the intestine but also induces changes at the systemic level e.g. changes in 
metabolite and cytokine levels in serum (Kar et al. 2016). Extreme changes in diets may 
lead to microbial dysbiosis, which is an acute change in the composition and diversity of 
the microbiota causing a change in microbial functionality that eventually harms the host. 
Severe changes in the microbiota due to administration of antibiotics, especially early in 
life, can have impacts on the host immune system (Olszak et al. 2012; Nylund et al. 2014; 
Schokker et al. 2014; Schokker et al. 2015). An infection with microbial pathogens is an-
other extreme change that activates the immune system while also reshaping the structure 
of the microbial community. Other environmental changes like a stressful environment, 
e.g. maternal separation, and changes in temperature are also known to cause changes in 
both intestinal cells and microbiota. Perturbations of homeostasis in the gut are manifested 
in changes in the microbial population, changes in signalling to other organs, changes in 
the expression of immunity parameters, and modified metabolic capacity.  
Several different environmental factors can affect the functionalities of gut mucosal tis-
sues either directly or through the microbiota, as depicted in Figure 3. For example, the 
administration of antibiotics is expected to affect functions of the gut by changing the 
microbial composition and diversity that results in a change in microbiome-host crosstalk 
(Willing, Russell, and Finlay 2011). As shown in Figure 3, changes in environmental fac-
tors may initially lead to changes in so-called internal phenotypes and ultimately in a 
change in the expression of external phenotypes, for example weight or production traits 
of livestock species. Internal phenotypes encompass profiles of several measurable molec-
ular/cellular components at different biological levels (Fontanesi 2016; Houle, 
Govindaraju, and Omholt 2010). A few examples of internal phenotypes are the transcrip-
tome: the transcripts (mRNA) that are expressed in a specific cell or tissue that are encod-
ed by the host genome, the proteome: all the host encoded proteins that are expressed in a 
cell/tissue or present in a particular sample (blood), the metabolome: all the metabolites 
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present in a specific cell or tissue or body fluid sample produced either by the organism or 
by its associated microbiome. 
While a disruption in the normal functioning of the gut can be observed and measured 
(especially in a pathological state), it is not yet known how to measure the homeostatic 
status of the gut. There are several measurable parameters that are commonly used in clin-
ical diagnosis as an indicator of a pathological state. In principle, this concept could also 
be used to measure the competence of an organisms to defend itself against developing 
disease (immune competence), which is only one aspect of health. Although these param-
eters have not been used in this context, it is likely that measurements of immune compe-
tence would include immunity parameters that are functional related to immunity-based 
external phenotypes. Normal levels of immunity parameters like Immunoglobin A levels 
and lymphocyte counts have been determined in healthy adults (J H Cummings et al. 
2004; Moss and Drayson 2015) and their role in the gut has been extensively studied. It is 
logical to assume that the levels of such immunity parameters result from biological pro-
cesses (internal phenotypes) of the mucosal tissue of the gut in interaction with several 
environmental factors, including dietary components. However, relationships between 
internal phenotypes of the gut mucosal tissue with local and/or systemic immunity param-
eters, have not been defined yet.  
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Figure 3: Effects of environmental factors on an organism mediated by the GIT. This schema 
shows how environmental factors can affect the gut system, either directly or through the microbio-
ta. These effects can be measured by studying changes in the internal phenotypes or in biomarkers 
that are indicative of changes in external phenotypes. (Depiction of the intestine taken from (Rossi, 
van Baarlen, and Wells 2011)) 
19 
Chapter 1 
 
1 
Functional plasticity of gut mucosal tissue  
Due to its various functionalities, the tissue of the GIT is able to respond to many different 
stressors in an appropriate way. For example, the gut responds to damage to the epithelial 
layer with cell proliferation (IJssennagger et al. 2012); when pathogens are recognised, 
immunity parameters are highly expressed (Rossi, van Baarlen, and Wells 2011); to pre-
vent the invasion of foreign substances the barrier function is improved (Wells et al. 
2017); when microbes are recognised too close to the epithelial layer the production of 
antimicrobials is increased (Donaldson, Lee, and Mazmanian 2016). All these changes in 
functionalities requires a high level of functional plasticity. This plasticity of the gut is a 
phenomenon that is poorly understood. Simultaneous evaluation of internal phenotypes of 
GIT mucosal tissues, exposed to different stressors that evoke different types of responses, 
could provide first insights into the way the gut displays its functional plasticity. Unfortu-
nately, most studies focus on the effect of single stressors and there is limited information 
available for multiple stressors in the same laboratory conditions.  
Measurement of internal phenotypes 
Several studies have measured the response of one or more internal phenotypes of the gut 
in response to an external challenge. There is a vast amount of data available from in vivo 
experiments on model organisms, like mice and pigs. In most in vivo experiments that 
study the gut, the organism is given a stimulus; a change in the environment that is ex-
pected to alter the normal functions of the intestine; and parts of the intestine are sectioned 
and analysed with different technologies to obtain either quantitative or qualitative data.  
With transcriptomic approaches, the transcriptome of the organism (collective RNA), in a 
particular tissue, at a specific time point. With this data, it is possible to define which 
genes are expressed in that tissue and which proteins are most likely to be found in that 
tissue. In some studies, the expression of only a few key genes are analysed using varia-
tions of polymerase chain reaction (a technology that can amplify a certain sequence of 
nucleotides) to understand processes known to be modulated by these genes. Instead of 
concentrating only on a few genes, genome wide transcriptomics gives an overview of the 
response of all the genes to the challenge. An efficient and cheap method of genome-wide 
gene expression measurements is the use of microarrays that provides a profile of the level 
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of expression of all the genes encoded by the genome of the host (Sanden, Lin, and 
Burzykowski 2008).  
The next level of biological measurement is to measure the translation of transcripts to 
proteins by methods, collectively called, proteomics. Even though the transcriptome gives 
an indication of the proteins that can be expected to be present in a tissue, measuring the 
actual protein contents is more accurate for functional characterization, as protein levels 
are more closely related to cellular functions than transcript levels. There are different 
ways of profiling the amount of all the proteins in a sample; several techniques utilizing 
mass spectrometry methods like liquid chromatography- mass spectrometry (LC-MS). 
Such MS based methods can identify a variety of proteins by comparing the mass spec-
trometry results to a database of known proteins. Protein microarrays use immunoassay 
techniques or functional proteins to bind to different proteins in the sample. These arrays 
are useful for identifying a specific group of biomarkers in the samples. 
Measuring metabolomics profiles of tissues and samples provides information on the me-
tabolites that the organism is able to produce by itself or with the help of its associated 
microbiome. Technologies used for this measurement (e.g. mass spectrometry, high per-
formance liquid-phase chromatography) can give quantitative values of known metabo-
lites when a targeted search is performed, by comparing the obtained biochemical signals 
to signals of known substances. The quantifiable metabolites are fewer than the metabo-
lites that can be produced by the host or the microbes. Hence it is sometimes preferable to 
perform an untargeted search where unknown metabolites are also recorded. 
The composition and diversity of intestinal microbiota can be measured either from the 
faeces, which reflects the microbial composition in the colon, or from the luminal content 
in sections of the intestine. Microarrays for bacteria are designed to detect bacteria with 
known 16S rDNA sequences and are tailored to the known composition in an organism, 
e.g. HITChip tailored for the human intestinal tract (Rajiliæ-Stojanoviæ et al. 2009) and 
PITChip tailored for the porcine intestinal tract (Pérez Gutiérrez et al. 2010). Another 
popular measurement is to sequence certain regions of the 16S rDNA of the all the bacte-
rial content and then identify the present bacteria by comparing measurements with se-
quences in databases (Ju and Zhang 2015). 
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Set-up of intervention experiments 
Animal experiments generally have a group of animals that are subject to the intervention 
or challenge. Usually, there are a comparable number of animals that are under the same 
conditions as the experimental animals except for the challenge under consideration. This 
group of animals is called the control or reference group. Data from the experimental ani-
mals is compared to the data from the control animals to obtain a differential value for that 
biological measurement. All the data described in the previous section can be subjected to 
this differential analysis to understand the effects of the challenges at the corresponding 
biological levels. This approach enables quantification of how an experimental condition 
affects the system or organism. For example, differential gene expression of certain genes 
indicates that the intervention affects the organism by regulation of the expression of 
those particular genes. Differential analysis requires the appropriate statistical analysis 
methods to take into account variability associated to small sample size, biological noise, 
intrinsic variability and additional external factors that could potentially bias or influence 
the comparison, the so-called blocking factors, such as age or sex.  
Analysis of individual data 
The application of high throughput –omics measurements provide an unprecedented 
wealth of data. The interpretation and analysis of these large datasets requires the use of 
computational tools to extract relevant biological knowledge. The majority of “-omics” 
data are/were generated to provide answers to research questions specific to the measured 
data type, for example, certain proteomic measurements are aimed at finding post-
translational modifications in proteins. But these different types of data can also be used 
to gauge the effects of the challenge on the system. However, effects of challenges do not 
only display changes at a single biological level, but could affect several, hence multiple 
levels need to be measured to understand the effects of the challenges. 
The most common data analysis method relies on fitting linear models to each data-point 
to account for the contribution of the blocking factors. This approach is widely used in 
gene expression analysis as it is implemented in the R package linear models for microar-
ray data (LIMMA) (Smyth 2005; Phipson et al. 2016), which has become a de facto stand-
ard. In the case of gene expression, linear modelling assumes that the changes in gene 
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expression, e.g. due to a drug, are linear to the gene expression in the control samples. 
Genes that fit this pattern of change are deemed to be relevant to the given challenge be-
fore an estimation of significance. Linear model fitting a technique that is quite flexible 
and can be extended to other types of biological data besides gene expression. However, 
since the responses of biological systems are rarely linear, several statistical methods are 
often used to augment the results of differential expression or abundance and to account 
for possible non linearities, the methods use generalized linear modelling, such as the one 
implemented in edgeR (McCarthy, Chen, and Smyth 2012).  
Most of these analyses only concentrate on measurements performed at one time point 
after the intervention. Studying more time points will give an improved understanding of 
the dynamics of the response. However, given the disruptive characteristics of most of the 
measurements, that often require the sacrifice of the host to collect samples, such time 
course analysis requires a large number of subjects and presents challenges of its own 
regarding the experimental design. Similarly, spatial location plays a critical role, since at 
each section of the intestine the stages of digestion differ. 
Although individual internal phenotypes of the gut have been studied extensively, it is not 
known if or how they contribute to the establishment of external phenotypes. There is 
theoretical knowledge on how these internal phenotypes are connected to each other, for 
example, the amount of a metabolite present in the tissue is dependent on the level of ex-
pression of the enzyme that catalyses the biochemical reaction that produces the metabo-
lite, and this protein level depends on the number of transcripts from the gene encoding 
this protein. So far there has not been data-driven confirmation of the existence of links 
between internal phenotypes. 
Databases and knowledgebases 
There are several databases where biological measurements can be/are stored for inde-
pendent confirmation of the results and further reuse. NCBI and EBI have several data-
bases for specific types of biological data, genomic sequences, protein sequences, genome 
wide association studies (GWAS) results etc. The most structured databases are those that 
store transcriptomics data, Gene Expression Omnibus (GEO) (Barrett et al. 2013) from 
NCBI and Array Express (Brazma et al. 2003) from EBI. But there are also repositories 
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that can handle more than one type of data like Zenodo (http://zenodo.org/) and Dataverse 
(Crosas 2011). All these databases have basic search functions to find a dataset based on a 
unique identifier, keywords in the experimental description of the data, specific techno-
logical platforms etc. Some of these databases also have integrated tools to perform basic 
data analysis functions, for example, GEO has an R user interface that allows simple dif-
ferential analysis. There are a few databases that integrate all the submitted data to allow 
users to query the results of basic analysis on the datasets rather than the raw data itself. 
One such database is the database of Genotypes and Phenotypes (dbGaP) (Tryka et al. 
2014) from NCBI where data from GWAS studies can be submitted. A search tool in this 
database, the Phenotype Genotype Integrator (Ramos et al. 2014), retrieves gene to pheno-
type associations based on a user-given threshold.  
A knowledge base is a specific type of database that contains information that can be used 
in analysis of different types of data. In gene set knowledge-bases genes are grouped to-
gether based on annotation of the genes. Gene Ontology (Ashburner et al. 2000) has sev-
eral genes classified under functional terms that could be biological processes, molecular 
functions or cellular locations. Other knowledge bases not only group genes but also add 
information on the interactions between these genes to form pathways that perform a par-
ticular function. Such knowledge-bases, like Reactome (Fabregat et al. 2016) and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and Goto 2000), use literature 
findings to build the pathways. This information is very useful in understanding the possi-
ble functionalities of significant genes obtained from a differential analysis. The 
GreenGenes (DeSantis et al. 2006) knowledge-base has information on mapping 16S 
rRNA sequences of bacteria to taxonomic units. As previously mentioned, this type of 
information is crucial in identifying the bacterial groups present in gut microbiota sam-
ples.  
Data integration methods 
In most studies, differential analysis of multiple measurements is performed separately, 
e.g. on several time points. For differential expression or abundance of the internal pheno-
types and the results of each of the time points are interpreted in the context of the results 
of the other measurements. In some cases, the time points themselves are used for differ-
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ential analysis, for example the gene expression at time point one is compared to the ex-
pression at time point two. These methods analyse changes caused by either the challenge 
or by the passage of time and do not give information on consistent changes in expression 
or abundance profiles. However, this type of information can be obtained by integrating 
different datasets (from different time points or different challenges) and analysing them 
together. Such approaches are frequently called horizontal or lateral integration to distin-
guish it from vertical integration (Tseng, Ghosh, and Feingold 2012; Xia et al. 2013). Ver-
tical integration is the case where different data types corresponding to the same time 
point and challenge are analysed together. So far there are not many methods available to 
perform this integration over time or challenges.  
When different types of data need to be analysed, several studies use individual analysis 
of each data type. For example, the effects of the use of novel protein sources in animal 
diets on the small intestinal tissue, on the microbiota of the small intestine and on cyto-
kines in the blood are analysed separately. The results of these individual analyses are 
then interpreted in the context of each other (Kar et al. 2016). But this method does not 
reveal interactions between the different internal phenotypes that are measured. Integra-
tion of the measurements of different biological levels is a preferred method to gain a ho-
listic view of the GIT system. Most computational methods currently available, can only 
handle one type of data as measured on one time point. Thus, there is a need for methods 
that can use existing single data analysis tools for integrative analysis. Many integrative 
tools are built to integrate specific types of data, e.g. the tool Conexic (Akavia et al. 2010) 
has been developed to find driver mutations in cancer with transcriptomic and genomic 
information. Other tools can work on any type of data, e.g. MixOmics (Dejean et al. 2011; 
González et al. 2012), Kernel Fusion (De Bie et al. 2007) and Similarity Fusion Network 
(B. Wang et al. 2014). The flexibility that such general tools provide, allows to use the 
variety of biological data that is necessary to provide an integrated picture of complex 
systems. For example, nutritional data could be integrated with transcriptomic data to pin 
point the parts of the diet that cause transcriptomic changes. Such tools use different ap-
proaches to integrate input data, but the first step usually involves pre-processing of each 
data on its own. Kernel Fusion uses kernel matrices of the input omics data and Similarity 
Fusion Network requires a similarity network from each of the data. The tool MixOmics 
uses sparse partial least squares regression to pre-select variables which is a good solution 
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to the dimensionality problem in biological measurements, where the number of variables 
(e.g. genes) is larger than the number of samples. 
Systems biology (of the gut) 
The dynamic functioning of the GIT and its plasticity results from interactions between 
several sub-systems like the digestive system, the immune system, endocrine system and 
the microbiome. In order to better understand the mechanisms behind the functional plas-
ticity, a holistic approach is required, so that the different sub-systems and their relation-
ships are analysed together.  
This holistic approach is one of the hallmarks of Systems Biology, a field of study where 
a living system is studied as several sub-systems together rather than one sub-system at a 
time (Kitano 2002). Systems Biology aims to understand biological systems as a sum of 
all its sub-systems especially by including the interactions between them. Given the com-
plexity of the GIT, its spatial heterogeneity and its functional plasticity, a Systems Biolo-
gy approach is required to gain an improved understanding on how intestinal homeostasis 
is maintained and using which underlying mechanisms. Synergies and interactions be-
tween the components of this system determine the response of the system to external 
stressors. Thus, it is essential to gain a systems perspective of the functioning and cross-
talk between these components across space and over time.  
Another hallmark of Systems Biology is the construction of models that are able to ac-
count for the response of the system. The models can be built bottom-up or top-down 
(Bruggeman et al. 2007). Bottom-up modelling approaches involve mechanistic models 
explaining the observed behaviour from the knowledge of the system’s components and 
their relationships. The large volume of available high-throughput data, enables top-down 
approaches, combining system-wide data with mathematical modelling to gain insights 
into the molecular networks under study. Some examples of existing models built using a 
top-down approach are a metabolic model of enterocytes (Sahoo and Thiele 2013), a mod-
el of metabolic interactions between gut microbes (Steinway et al. 2015) and a model of 
mucosal immune responses (Mei et al. 2015). These models use information from litera-
ture and experimental data. 
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Besides representing the system, models can be used to predict reactions of the system to 
environments it has not been exposed. The model only contains the parts of the system 
that are relevant to the question at hand. For example, statistical models can be built using 
a large amount of data of the varying parameters and the predictors, like different types of 
feed and the changes in weight of animals, and can make accurate predictions on weight 
without information on the mechanisms causing the change. Models in systems biology 
are built from different but complementary data. For example, genome scale metabolic 
models are based on biochemical interaction information, genomic data and can be further 
constrained by experimental results (Orth, Thiele, and Palsson 2010).  
Although there are models describing or predicting functionalities in the gut, there is no 
single model that can represent the entire gut. This is largely due to the complexity of the 
gut with the different cell types performing different functions, the lack of a complete 
understanding of the role of the microbiota and the complex dynamic changes in the gut 
when exposed to a changing environment. Thus, before a multiscale (cellular level and 
molecular level) model that can represent or predict all the functionalities of the gut to a 
variety of challenges (a virtual gut) can be built, several gaps in knowledge have to be 
filled with data acquisition and data analysis. The response of the different sub-systems of 
the gut to challenges must be catalogued, interactions between these sub-systems must be 
studied and mechanistic information on all these processes must be obtained.  
Research objectives and thesis outline 
The objective of the research, as described in this thesis, was to i) develop and apply com-
putational methods to get improved insight into time-dependent dynamics of a gut system, 
ii) to obtain information on key links between internal phenotypic or different biological 
levels, iii) to understand the functional plasticity of the gut mucosal tissue by studying 
effects of dietary / drug / immune system targeted interventions, and finally, iv) to develop 
a concept of a model that allows to make links between internal phenotypes and immunity 
parameters functionally related to external immune-based phenotypes.  
We aimed to uncover the effect of an early life perturbation and growth on animals and in 
Chapter 2 we analysed data from an antibiotic intervention on pigs which was adminis-
tered early in life and disrupted the homeostatic status of the microbiota. We perform a 
27 
Chapter 1 
 
1 
dynamic analysis in order to find if there were long lasting changes in the animals due to 
this early life perturbation and to find the drivers of these changes. We used a two-
dimensional method that can analyse data between experimental treatments and across 
time simultaneously. This analysis was applied on two internal phenotypes, transcriptom-
ics and microbiota, which were analysed along two dimensions and the results were inte-
grated to uncover the interactions between them. 
The second objective was to get improved insights into the interactions between internal 
phenotypic layers when stimulated by external factors. In Chapter 3, we observe the re-
sponse of another model animal, mice, to changes in the diet using five measurements of 
different internal phenotypes. This lateral data integration was done across different physi-
ological levels to find interactions between internal phenotypes in the gut and those in 
systemic levels. We used a flexible multi-omics integration method to link all the five 
measurements to each other. 
In Chapter 5 we attempted to identify mechanisms behind the functional plasticity of the 
gut using the same type of data from several different experiments. Here we used a high-
level data integration approach where we analysed each transcriptomic dataset separately 
and then combined the results. This horizontal data integration showcased the gut mucosal 
response towards different environmental challenges. The method developed in Chapter 
4 enables this analysis on a pathway level. By observing changes in the functionality of 
the gut mucosa under different experimental conditions involving dietary changes, drug 
administration and immune challenges, we aimed to identify mechanisms of functional 
plasticity of the gut.  
The fourth objective was to find associations between dietary changes and parameters that 
are functionally related to external immune-based phenotypes. In Chapter 6 we used the 
internal phenotype transcriptomics to link dietary changes to a few functional parameters 
that are related to the immune system. We used the high-level data integration technique 
similar to that used in Chapter 5 to analyse and integrate the transcriptomic data. The 
results obtained were then linked to functional parameters with information from a 
knowledge-base. 
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Chapter 7 discusses the result of Chapters 2-6 in a broader context. It describes rele-
vance of the work done in my thesis for improving scientific knowledge and its potential 
applications in the furthering insights into gut functionalities. I also discuss the limitations 
of this work and suggestions for general data management to improve the results of anal-
yses as performed in my thesis. There are several indications for future work based on the 
results of my work. 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2 
 
 
 
Network analysis of temporal functionalities of 
the gut induced by perturbations in new-born 
piglets.  
 
 
Nirupama Benis; Host Microbe Interactomics, Wageningen University. 
Dirkjan Schokker; Wageningen UR Livestock Research, Wageningen University. 
Maria Suarez-Diez; Systems and Synthetic biology, Wageningen University. 
Vitor AP Martins dos Santos; Systems and Synthetic biology, Wageningen University; Lifeglim-
mer GmbH, Berlin, Germany. 
Hauke Smidt; Laboratory of Microbiology, Wageningen University. 
Mari A Smits; Host Microbe Interactomics, Wageningen University; Wageningen UR Livestock 
Research, Wageningen University, Central Veterinary Institute, Wageningen University. 
 
 
Published in  
BMC Genomics 2015 16:556 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
Chapter 2 
 
2 
Abstract 
Background 
Evidence is accumulating that perturbation of early life microbial colonization of the gut 
induces long-lasting adverse health effects in individuals. Understanding the mechanisms 
behind these effects will facilitate modulation of intestinal health. The objective of this 
study was to identify biological processes involved in these long-lasting effects and the 
(molecular) factors that regulate them. We used an antibiotic and the same antibiotic in 
combination with stress on piglets as an early life perturbation. Then we used host gene 
expression data from the gut (jejunum) tissue and community-scale analysis of gut micro-
biota from the same location of the gut, at three different time-points to gauge the reaction 
to the perturbation. We analysed the data by a new combination of existing tools. First, we 
analysed the data in two dimensions, treatment and time, with quadratic regression analy-
sis. Then we applied network-based data integration approaches to find correlations be-
tween host gene expression and the resident microbial species.  
Results 
The use of a new combination of data analysis tools allowed us to identify significant long
-lasting differences in jejunal gene expression patterns resulting from the early life pertur-
bations. In addition, we were able to identify potential key gene regulators (hubs) for these 
long-lasting effects. Furthermore, data integration also showed that there are a handful of 
bacterial groups that were associated with temporal changes in gene expression.  
Conclusion 
The applied systems-biology approach allowed us to take the first steps in unravelling 
biological processes involved in long lasting effects in the gut due to early life perturba-
tions. The observed data are consistent with the hypothesis that these long lasting effects 
are due to differences in the programming of the gut immune system as induced by the 
temporary early life changes in the composition and/or diversity of microbiota in the gut.  
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1. Background 
Evidence is accumulating that perturbations of the early life colonization of the gastro-
intestinal (GI) tract by microbes induce long-lasting health effects in individuals (Foliaki 
et al. 2009; Hoskin-Parr et al. 2013. Though these effects have been studied and docu-
mented, the system components involved in the induction and maintenance of such long-
lasting effects have not yet been studied in detail. This is because the GI tract itself is a 
complex and dynamic system with variable interactions between the host tissue, resident 
microbiota and nutritional factors. The host tissue is comprised of different cells with dif-
ferent functions, varying from the digestion and uptake of nutrients to providing resistance 
towards toxic components in the diet. The mucosal layer of the GI tract separates the lu-
men of the digestive tract from the rest of the body and contains the largest repertoire of 
immune cells that display a pleiotropy of immune signalling and response functions. In 
addition, the mucosal layer also generates endocrine responses to the lumen of the gut and 
to the rest of the body. The lumen of the GI tract harbours a complex ecosystem of a huge 
number and a large variety of micro-organisms, collectively called “microbiota” (Relman 
2012.  
Gut microbiota play an important role in modulating diverse gastrointestinal functions, 
ranging from enzymatic digestion to modulation of immune responses (Lora V. Hooper 
2004; O’Hara and Shanahan 2006; Tremaroli and Backhed 2012; Arrieta and Finlay 2012; 
Kabat, Srinivasan, and Maloy 2014; Scholtens et al. 2012; Ottman et al. 2012. In turn, the 
host immune system has a regulatory effect on the composition and diversity of the micro-
biota (Willing, Gill, and Finlay 2010, by mechanisms known as immune exclusion 
(Mantis, Rol, and Corthesy 2011. Early life colonization of the gut with microbiota is an 
important driver for the development and ultimate functionality of the GI tract in mamma-
lians (Palmer et al. 2007; Inman et al. 2010; Kabat, Srinivasan, and Maloy 2014. Long-
lasting effects on the host due to disruption of early life colonisation of the gut have been 
demonstrated on the level of disease susceptibility, immune parameters (Olszak et al. 
2012 and the composition and diversity of microbiota (Nylund et al. 2014. Early life envi-
ronmental factors, such as caesarean delivery (C. E. Cho and Norman 2013, breastfeeding 
(Weng and Walker 2013; D. Kelly and Coutts 2000; Newburg and Walker 2007, exposure 
to stress (Jarillo-Luna et al. 2007; O’Mahony et al. 2009, and the use of antibiotics 
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(Schumann et al. 2005; Tanaka et al. 2009 influence the microbial colonisation of the gut 
and affect the development and programming of the mucosal and systemic immune sys-
tem (Nylund et al. 2014; Arrieta et al. 2014. Such early life factors may also result in vari-
ation of the abilities of the microbiota to ferment carbohydrates into short-chain fatty ac-
ids (I. Cho et al. 2012 and/or to ferment indigestible proteins in later stages of life. 
The effect of the use of antibiotics on the physiology of the host is believed to be due to 
the primary effect of antibiotics on the loss/change in bacterial (sub)-populations, espe-
cially in the GI tract (Willing, Russell, and Finlay 2011. The spectrum of the antibiotic 
and its mode of action determines the effects it has on the gut microbial community 
(Willing, Russell, and Finlay 2011. Some reports in this area also suggests that antibiotics 
have a direct effect on the immune system of the host (Willing, Russell, and Finlay 2011; 
Niewold 2007. For young piglets it has recently been demonstrated that an antibiotic treat-
ment at day 4 after birth causes changes in microbial populations and in tissue gene ex-
pression patterns in the small intestine (Schokker et al. 2014; Schokker et al. 2015. Stress 
is another factor that can influence the functionality of the GI tract by a temporary secre-
tion of hormones. Such short term hormonal secretions may cause several long lasting 
effects on the GI immune system (Jacobson and Sapolsky 1991; E A Mayer 2000; Braun 
et al. 2013 and on microbiota composition (Collins and Bercik 2009. This has led to stud-
ies focusing on the brain-gut-enteric microbiota axis (Konturek, Brzozowski, and 
Konturek 2011; Montiel-Castro et al. 2013; Emeran A Mayer, Savidge, and Shulman 
2014. The effect of stress on the GI tissue is most obvious in changes of morphology and 
functions of the gut (Söderholm and Perdue 2001; Bhatia and Tandon 2005; Taché et al. 
2001.  
The first objective of this study was to develop a workflow that can be used to analyse 
biological data in two dimensions simultaneously, over time and between treatments. The 
second objective was to apply this workflow on two types of gut-related data as measured 
in an experiment with pigs exposed to an early life perturbation, followed by effect meas-
urements at three different time-points later in life. Using these methods we endeavour to 
identify gut system components that contribute to induction and maintenance of long last-
ing effects of early life perturbations. We aim to find major host- and microbe-related 
components that propagate or regulate these long term effects. Such components may 
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form potential targets to modulate early life events that affect later life immunologic per-
formance. We used piglets as a model and the exposure to an antibiotic and/or stress on 
day four after birth as the perturbations. We measured whole genome gene expression 
profiles of intestinal tissues and provided community scale data on the composition and 
diversity of microbiota on three different time-points, taken during different stages of the 
life-span of pigs, neonate, adolescent and full grown adult. In order to take into account 
the extreme changes in the physiology and morphology of the animal, we simultaneously 
studied the effect of the treatment and the time. Once the gene expression and microbiota 
data were analysed separately, we integrated both to obtain information on their possible 
interactions. 
2. Materials and methods 
2.1. Experimental design 
The animal experiment consisted of one control group and two treatment groups, each 
consisting of 48 piglets derived from 16 different sows (TOPIGS20 (GY x NL)). Each 
litter contained 4 piglets of each treatment and control group. Litter-mates stayed with 
their sow until weaning at day 25. After weaning, the same number of piglets of each 
treatment and control group were housed together in pens. All pens were located in the 
same compartment. The first treatment group (Tr1) was given a dose of Tulathromycin 
(0.1 ml, 2.5mg/kg body weight) on the 4th day after birth and then left undisturbed until 
the time of tissue sampling after sacrifice. The same dose of the antibiotic was given to 
the second treatment group (Tr2) on the 4th day after birth but these piglets were also sub-
jected to stressful conditions on the same day. The stress was in the form of handling of 
the piglets, which is common practice in intensive pig husbandry systems (eg, weighing, 
nail clipping). The control group (Ctrl) was not disturbed for the entirety of the experi-
ment until the time of sacrifice for sampling.  
Sampling was done on three time-points, day 8 after they were born, day 55 and day 176. 
On each of these days, 16 piglets from each treatment group and derived from 16 different 
sows were sacrificed and samples were collected for microarray and microbiota analysis. 
Further details of the experiment have been described elsewhere (Schokker et al. 2014. 
The experiment was approved by the institutional animal experiment committee “Dier 
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Experimenten Commissie (DEC) Lelystad” (2011077.b), in accordance with the Dutch 
regulations on animal experiments. Supplementary Figure1 gives an overview of the ex-
perimental design. 
2.2. Sample preparation and data generation 
For transcriptome analysis, jejunal tissues scrapings were taken and RNA was extracted 
from the samples for microarray analysis as described in (Schokker et al. 2014. For micro-
biota analysis luminal contents were taken from the same location of the jejunum as the 
tissue scrapings and microbial DNA was extracted. The microbial composition was de-
tected by the Pig Intestinal Tract Chip (PITChip) (Pérez Gutiérrez et al. 2010 version 2.0. 
The PITChip is a phylogenetic microarray with 3,299 oligonucleotides based on 16S 
rRNA gene sequences of 781 porcine intestinal microbial phylotypes (Haenen, Zhang, et 
al. 2013; Pérez Gutiérrez 2010. The protocol for hybridization and generation of data was 
performed essentially as described before (Rajiliæ-Stojanoviæ et al. 2009; Schokker et al. 
2014. More details on sample preparation is given in previous descriptions of this experi-
ment (Schokker et al. 2014 and the data is available in GEO (Barrett et al. 2013 with the 
accession number GSE53170 (Schokker 2014. 
2.3. Gene expression analysis 
Microarray normalization and quality control: 
Background correction and quantile normalisation was performed on the microarray data 
(GSE53170) using the R package LIMMA (Smyth 2005 from Bioconductor (Gentleman 
et al. 2005. After quality control, six microarray samples were removed from the original 
72 samples and all further analysis were done on the remaining 66 microarray samples. 
Data points below the 5th percentile of intensities were removed, this resulted in 25,915 
genes from 66 microarray samples. Details of the applied analysis pipeline are in Supple-
mentary Figure 2.  
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Identification of differences in gene expression profiles  
To identify genes with significant expression profile differences over time between the 
experimental groups, we used maSigPro (Conesa et al. 2006 from Bioconductor. The time 
profile (expression over the three time-points) from each treatment is compared to that of the 
control. Quadratic regression is used to retrieve genes with time profiles significantly differ-
ent for the treatments versus the control group. The calculations were done with the default 
settings of the function maSigPro. With three time-points there are three regression coeffi-
cients calculated for each gene's expression profile. At least one of these coefficients has to 
be significant (with FDR corrected p-values less than 0.05) for the gene to be included in the 
result. The first coefficient (β1) denotes the difference in the first time point (day 8) between 
one treatment group and the control. The second one (β2) indicates the difference in slope 
between the first two timepoints. The third coefficient (β3) shows difference in curvature of 
the expression patterns and can thus capture long term differences between treatment and 
control expression patterns of the same gene. Each treatment is compared against the con-
trol group and this gives two lists, Tr1vsCtrl (Antibiotic vs Control) and Tr2vsCtrl 
(Antibiotic+Stress vs Control). For the rest of the analysis three lists of genes were used; 
genes unique to Tr1vsCtrl (OnlyTr1); gene unique to Tr2vsCtrl (OnlyTr2) and the over-
lapping genes (Tr1&Tr2). 
GO (Gene Ontology) enrichment analysis (Dopazo 2006, with focus on the sub-ontology 
Biological Process, was performed using the R package topGO (Alexa and Rahnenführer 
2009. The Fisher test was applied to obtain significantly enriched GO terms, only the terms 
with p-values below 0.01 were included.  
Functional interaction networks 
Functional interaction networks among groups of genes selected from the data, were built 
using the Cytoscape (Shannon et al. 2003 Reactome FI (Functional Interaction) application 
(Croft 2013; Milacic et al. 2012; G. Wu, Feng, and Stein 2010 and visualised with the or-
ganic layout. The network was built from information in the Reactome FI database such that 
nodes are genes and edges are interactions, either known or predicted. Modules in the net-
works were identified using community structure detection as described in (Newman 2006. 
Using inbuilt functions in the Reactome FI app, GO enrichment analysis was performed on 
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each of the identified modules. The final networks consisted of modules with more than 5 
nodes and with significantly enriched GO terms. The topological features of these final net-
works were determined using the NetworkAnalyzer (Assenov et al. 2008 tool in Cytoscape. 
Hubs were defined to be the nodes in the top 40% of the degree distribution, where the de-
gree is the number of connections of each node. These hubs were analysed using infor-
mation from www.genecards.or.  
2.4. Analysis of Microbiota 
Microbial populations from the jejunum were analysed using the PITChip.2 (Pérez 
Gutiérrez et al. 2010, which provides information on three levels of taxonomic resolution, 
level 1 is similar to the phylogenetic family, level 2 corresponds mostly to the genus level 
and level 3 is more the species level. Level 2 data provided population percentages for 
151 microbial genus groups. Initial exploratory analysis was done on the microbial data 
with the R package microbiome (http://microbiome.github.com) and the MySQL database 
as described by Rajilic-Stojanovic (Rajiliæ-Stojanoviæ et al. 2009. Microbial groups that 
do not differ between control and treatment piglets were filtered out with a threshold of 
0.01. A two-way ANOVA analysis of the temporal patterns with the package maSigPro 
was used to obtain only the groups that change with treatment or time, with a statistical 
significance threshold of 0.05. 
2.5.  Integration of Gene expression and Microbiota data 
The mixOmics R package (Lê Cao, González, and Déjean 2009; Dejean et al. 2011 was 
used to integrate gene expression and microbiota abundance data and to perform regres-
sion analysis of these two data types. The genes used were those selected using the meth-
od described in section 2.3, which leads to the identification of genes whose temporal 
expression profiles were significantly different between the control vs. the treatment 
group. The bacterial groups used for integration were also different either across time or 
between treatments. We set the microbial information as the independent variable and the 
gene expression data as the dependent variable. Interchanging the two set of parameters 
did not affect the results significantly. We only used the significant genes from the gene 
expression analysis as input for the data integration. Subsequently three networks were 
built using sparse Partial Least Squares for the each of the gene lists OnlyTr1, OnlyTr2 
39 
Chapter 2 
 
2 
and Tr1&Tr2. The first two networks were based on six variables (treatment and control 
in three time-points) and the third one on nine variables (two treatments and the control in 
three time-points).  
The resulting un-directed network connects the microbial groups and the genes that have 
absolute correlation values above 0.8. A positive high edge weight hints to a positive reg-
ulatory relationship while a low (negative) weight indicates a possible repression relation-
ship. Networks were visualised using Cytoscape 3.1.0. Enrichment analysis was done on 
the gene neighbours of the bacterial groups via topGO. Fisher's test was applied on the 
results and only terms with p-values lesser than 0.01 were further analysed. The function-
ality of the bacterial groups was determined with the help of experts in the field. 
3.  Results 
3.1.  Genes, gene networks and hubs  
For gene expression analysis, the temporal profiles of the samples from each treatment 
group were compared with those of the control group. We used quadratic regression analy-
sis to obtain two gene lists: one for Tr1vsCtrl (1,643 genes) and another one for Tr2vsCtrl 
(1,562 genes). These lists are in Supplementary File 1. The genes in these lists show sig-
nificant differences in their gene expression profiles over time between the control and 
treatment groups. Supplementary Figure 3 shows the temporal expression profiles of some 
genes, showcasing different possible behaviours under different conditions. For example, 
the expression profiles over time of CHIT1 differs for all three conditions while the pro-
files for some other genes, such as GRB2 and MAPK14, show most difference in only one 
treatment compared to the Ctrl. In other cases, such as ERBB4, MX2 and RELA, signifi-
cant differences in expression are restricted to a single time point. Based on the â3 coeffi-
cients (explained in the Materials and methods section 2.3), 60% of the OnlyTr1 and Only-
Tr2 gene-lists have genes with long lasting differences between the treatment and control. 
The Tr1&Tr2 list has 91% of the genes that have significant long term differences. The 
three gene lists; OnlyTr1, Tr1&Tr2 and OnlyTr2 consist of genes that have gene expres-
sion profiles over time that are significantly different in the treatment compared to the 
control group. These lists are used for the follow-up of the analyses. On these three lists, 
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functional analysis was done using GO enrichment analysis for biological processes with 
topGO. A summary of the results is presented in Figure 1. 
Figure 1: Summary of GO Enrichment analysis results from topGO. Biological processes (Gene 
Ontology terms) are given based on manual interpretation of the most significant enriched terms ob-
tained with topGO. The two circles represent the Tr1vsCtrl and Tr2vsCtrl comparisons. Numbers de-
note the number of input genes in topGO, these genes are have significantly different time profiles in 
the treatment vs the control groups. In the yellow, green and purple fields enriched processes are given 
for OnlyTr1, Tr1&Tr2, and OnlyTr2, respectively.  
In order to verify the results of the topGO analysis and to get insight into networks of genes 
potentially involved in the induction and maintenance of the long-lasting effects, a network 
based analysis was used. The Reactome Functional Interaction (FI) database was used to 
build three functional interaction networks, one for each list of genes. In any of the explored 
gene sets, about 30% of the genes were represented in the FI networks. More than 50% of 
the nodes had significant long-term differences from the control, with the Tr1&Tr2 FI net-
work having the biggest fraction (94%). Within each of the FI networks, we were able to 
identify several topological modules. We identified 9 modules with significant biological 
function in the OnlyTr1 network, 10 modules in the Tr1&Tr2 network, and 6 modules in 
the OnlyTr2 network. The modules are depicted by different colours in Figure 2. Subse-
quently GO enrichment analysis for Biological Processes was performed on the genes in 
each of the identified modules. The GO terms with the highest enrichment score for each 
module are shown in Figure 2. The results of GO enrichment by both methods for the 
same gene lists are notably different especially in the OnlyTr2 list. Information on the 
various topological parameters of the three networks can be found in the Supplementary File 
2. 
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Figure 2: Functional Interaction networks (A, B, C). Genes are represented as nodes in the net-
works, all these genes have time profiles that are significantly different in the treatment than in the 
control. The edges represent interactions between genes as determined by Reactome. Arrows repre-
sent directed interactions, bar-headed arrows indicate inhibition reactions. Dotted lines indicate 
predicted relationships. Network A was built from OnlyTr1 genes, network B from the common or 
overlapping genes (Tr1&Tr2) and network C from OnlyTr2 genes. Colours in the network repre-
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sent the network segmentation into modules. The text denotes the GO term that was most enriched 
for the genes in that module and the number in brackets denotes the number of genes associated 
with that particular GO term. Octagonal nodes are related to the GO term at the set p-value thresh-
old. The nodes with a larger diameter are hubs in the networks. The nodes of the Tr1&Tr2 network 
were rearranged for better visualisation of the modules; the network in the original structure is in 
Supplementary Figure 4. 
The results from topGO show that the OnlyTr1 and Tr1&Tr2 genes are mainly involved 
in innate and adaptive immune processes, whereas the OnlyTr2 list is dominated by genes 
involved in developmental processes. Compared to the topGO analysis, the enrichment 
analysis from Reactome FI provided more detailed functional information. It showed that 
the genes in all three lists are involved in immune processes with dominance of adaptive 
immune processes in OnlyTr1 and innate immune processes in OnlyTr2. The overlap-
ping gene list Tr1&Tr2 included immune signalling functions, interferon and interleukin 
genes, that are speculated to contribute to both types of immunity (Yu and Gaffen 2008; 
Langrish et al. 2004; Le Bon and Tough 2002.  
 
Table 1: Description of the 17 hubs in the three Functional Interaction networks. The number 
of connections of each gene in their respective network is given along with the gene symbol. The 
information about the genes is adapted from www.genecards.or. The hubs can be clustered into 
three broad groups, given in the last column, based on their functions. All these genes have signifi-
cantly different time profiles in the treatment compared to the control. 
   Gene 
Symbol 
Function Summary 
Only-
Tr1 
hubs 
GRB2 
17 
Important link between growth factor receptors on the 
cell surface and Ras signalling 
Cell cycle/ 
Proliferation 
STAT3 
15 
In response to cytokines and growth factors, STAT 
family members are phosphorylated and translocate to 
the nucleus to function as transcription factors. 
Immune 
CDC42 
12 
A GTP-ase involved in signalling for several process-
es, cell migration, morphology, endocytosis, cell cycle 
progression and cell proliferation. 
Cell cycle/ 
Proliferation 
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  CAV1 
11 
Encodes a scaffolding protein that an essential part 
of caveolar membranes. 
Immune 
FOS 
11 
The FOS family encodes for leucine zipper proteins. 
Regulates cell proliferation, differentiation, trans-
formation and apoptotic cell death. 
Cell cycle/ 
proliferation 
Tr1&
Tr2 
hubs 
MYC 
31 
Transcription factor that activates growth related 
genes 
Cell cycle/ 
Proliferation 
MAPK14 
24 
Important for the cascades of cellular responses 
evoked by extracellular stimuli leading to direct 
activation of transcription factors. 
  
RELA 
24 
Forms a complex with NFKB transcription factor 
and regulates the NFKB pathway. 
Immune 
UBE2D2 
24 
Ubiquitin conjugating enzyme that catalyses cova-
lent attachment of activated ubiquitin to other ubiq-
uitin ligases 
Ubiquitination 
ITCH 
23 
Ubiquitin-protein ligase which accepts ubiquitin 
from an ubiquitin-conjugating enzyme and then 
directly transfers the ubiquitin to targeted substrates. 
Ubiquitination 
IKBKG 
22 
Regulatory subunit of the IKK core complex which 
phosphorylates inhibitors of NFKB and ultimately 
the degradation of the inhibitor 
Immune 
SP1 
22 
Transcription factor (activator or repressor) that 
regulates many cellular processes 
Cell cycle/ 
Proliferation 
RHOA 
20 
Regulates signalling from plasma membrane recep-
tors to the assembly of focal adhesions and actin 
stress fibers. 
Cell cycle/ 
Proliferation 
RPS3 
20 
Component of the 40S ribosomal subunit, where 
translation is initiated 
  
FBXW7 
19 
Part of the ubiquitin ligase complex (SCF) which 
recognizes and binds to phosphorylated targets. 
Ubiquitination 
Only-
Tr2 
hubs 
UBA52 
20 
One of the four genes that code for ubiquitin, and 
ribosomal components which are part of the ribo-
some 60S subunit. 
Ubiquitination 
STAT1 
12 
In response to cytokines and growth factors, STAT 
family members are phosphorylated and translocate 
to the nucleus to function as transcription factors. 
Immune 
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The network analysis provided insight into genes with potential high level regulatory ac-
tivity, i.e. genes in the network with high number of connections/edges. A list of these 
potential high level regulators or hubs and a gist of their known biological functions is 
given in Table 1. The temporal expression patterns of three of these 17 genes are shown in 
Figure 3 (all 17 of them can be found in the Supplementary Figure 4). Except for the two 
hubs of the OnlyTr1 FI network, all the hubs have long term differences in expression 
between the treatment and control based on the β3 regression coefficient. The hubs in all 
the three networks can be roughly assigned to three functional categories: immune, cell 
cycle or proliferation, and genes involved in ubiquitination. There are two genes that are 
not part of these three clusters, MAPK14 and RPS3, where the latter is an important com-
ponent of the ribosome. MAP kinases act as an integration point for multiple biochemical 
signals, involved in a wide variety of cellular processes like proliferation, differentiation 
and development. They are activated by environmental stresses or cytokines.  
Figure 3: Gene expression patterns of important hubs. In Figure 3 each graph depicts the tem-
poral expression pattern of a single gene. These temporal changes are shown under three different 
conditions: Ctrl (red line), Tr1 (green line), and Tr2 (blue line). The x-axis indicates the time in 
days. The expression values (y-axis) are scaled such that the average expression of each gene is 0 
and the standard deviation is 1. 
All the hubs in the OnlyTr1 are either immune or cell cycle/proliferation related genes. 
This is reflected in the positioning of these genes in the network. They are found in the 
two modules related to immunity; T-cell co-stimulation and leukocyte migration (Figure 
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2). The genes in the ubiquitin cluster are from the Tr1&Tr2 and OnlyTr2 networks; they 
code for ubiquitin itself (UBA52) and also for proteins that perform the conjugation and 
ligation of ubiquitin to other proteins. These hubs in the Tr1&Tr2 network are in the 
module for protein ubiquitination; this module has the highest number of hubs. Other hubs 
in this network are from four modules as shown in Figure 2. In the OnlyTr2 network, 
there are two hubs, UBA52 and STAT1. 
3.2.  Microbiota temporal changes 
The relative contribution of the microbiota was filtered as described in Material & Meth-
ods and was left with 125 microbial groups which represent 99% of the population. The 
relative contribution values of these 125 groups were used in the regression analysis to 
identify groups that can be further related to gene expression levels. After a two-way 
ANOVA analysis in maSigPro, there were 46 microbial groups that showed significant 
differences over time or treatment compared to the control. Some bacterial groups like 
Brachyspira show different contributions in different conditions but some groups like 
Bacillus et rel show major differences only at one time point and one treatment. Supple-
mentary Figure 6 shows these temporal changes for all the 46 groups. 
3.3. Integration of microbiota and gene expression analysis 
By performing statistical integration of both the microbiota and host gene expression da-
tasets, (mixOmics R package), we tracked changes in jejunal gene expression which fol-
low the changes in microbial populations as determined on the same location in the gut. 
The changes will reflect the similarity or dissimilarity of a pair of data points across time. 
The resulting similarity matrix was used to connect the microbial groups and the expres-
sion of genes into a network. The first network, OnlyTr1, was built with 498 genes in 6 
conditions (Ctrl, Tr1 with 3 time-points each) and 46 level2 microbial groups in the same 
conditions. The second network (Tr1&Tr2) was built with 1,145 genes and the same 46 
microbial groups, and the conditions were the control and both Tr1 and Tr2 at the 3 time-
points, this gave rise to 9 conditions. The third one had again 6 conditions (Ctrl and Tr2 in 
3 time-points) with 417 genes and the same 46 bacterial groups. The networks represent 
the correlation between the microbiota and the gene expression data and are shown in 
Figure 4.  
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Figure 4: Correlation networks of changes in gene expression patterns and microbiota compo-
sition: Blue nodes represent genes and the pink ones represent bacterial groups; pink nodes with a 
cyan boundary are nodes common in the three networks. The edges represent positive (green) and 
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negative (red) correlation between a gene and a bacterial group. Networks A, B and C were built by 
correlating the gene lists OnlyTr1, Tr1&Tr2 and OnlyTr2 respectively with the 46 microbial 
groups resulting from the regression analysis. All the nodes (bacterial groups and genes) have a 
significantly different expression profile in time or treatment compared to the control. 
There are a total of 22 bacterial groups involved in the three networks, among these, 7 are 
found in all three networks (Table 2). Most of these bacterial groups share the same tem-
poral pattern of relative contribution (shown in Supplementary Figure 6) and are charac-
terized by an increase in abundance over time. Of the 22 bacterial groups in the three cor-
relation networks, only six are known to be possible pathobionts and their abundance, 
though increasing with time, remains low at all time-points and treatments. The other 16 
bacterial groups are known for being beneficial to the intestine by producing short chain 
fatty acids or reducing toxic substances (Table 2). Four of the bacterial groups show a 
decrease in abundance, and are found in the OnlyTr2 correlation network. Three bacterial 
groups had consistently large number of gene neighbours: Eubacterium et rel, Faecalibac-
terium et rel and Ruminococcus bromii. These three groups also share several gene neigh-
bours in all the three networks and are quite central in the network as indicated by net-
work parameters (Supplementary File 3).  
Table 2: Summary of the three correlation networks with information on bacterial groups. 
The bacterial groups that are part of the networks are listed along with the number of genes with 
which they are highly correlated. Several genes are shared between bacterial groups. Both the genes 
and the bacterial groups are significantly different either in time or treatment between the control. 
The first seven groups are common between the three networks. Some general information on these 
bacterial groups is also given in the last column. 
Bacterial Groups 
Number of cor-
related genes in 
Information Only 
Tr1 
Tr1& 
Tr2 
Only 
Tr2 
Eubacterium et rel 14 165 128 Anaerobic, Gram positive, broad range of species 
Ruminococcus bromii et rel 39 65 63 Anaerobic, Gram positive, keystone species in gut, 
digestion of resistant starch 
Faecalibacterium et rel 35 40 43 Obligate anaerobe, Gram negative, produces butyr-
ate, has anti-inflammatory properties 
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Campylobacter 1 35 62 Microaerophilic, Gram negative, known 
pathogen in humans 
Lawsonia intracellularis et rel 15 22 9 Gram positive, Porcine intracellular en-
teropathogen 
Butyrivibrio crossotus et rel 22 1 2 Anaerobic, Gram positive, butyrate pro-
ducer 
Bacteroides distasonis et rel 5 1 5 
Obligate anaerobe, Gram negative, reclas-
sified to Parabacteroides distasonis, pro-
duces acetate and succinate, possible path-
ogen 
Fusobacterium et rel   1 9 
Anaerobic, Gram negative, generally bu-
tyrate producers, possible pathogen, po-
tent lipopolysaccharide 
Eubacterium hallii et rel 3     Anaerobic, uses lactate and produces bu-
tyrate 
Roseburia intestinalis et rel 1     Anaerobic, Gram positive, butyrate pro-
ducer 
Coprococcus eutactus et rel 16   1 Anaerobic, Gram positive, mostly acetate 
producer 
Brachyspira     43 Anaerobic, Gram negative, some known 
pathogens 
Eubacterium biforme et rel     36 Anaerobic, involved in lipid metabolism 
Catenibacterium et rel     32 Obligate anaerobes, Gram positive, digest 
simple sugars 
Turneriella     18 Obligate anaerobes, Gram negative 
Bordetella et rel     15 Obligate anaerobes, Gram negative, 
known to cause respiratory diseases 
Erysipelothrix     11 Facultative anaerobes, porcine pathogens 
for skin diseases 
Lactobacillus acidophilus et rel     10 Microaerobic, Gram positive, ferments 
sugars into lactic acid, probiotic 
Desulfovibrio et rel     8 Aerotolerant, Gram negative, reduce toxic 
substances like sulphate 
Uncultured Prevotella     4 
Gram negative, pathogens in respiratory 
tract, breaks down proteins and carbohy-
drates 
Oxalobacter et rel     2 Anaerobic, oxalate reducing 
Thiocapsa et rel     2 Mostly anaerobic, oxidise sulphur, photo-
synthetic 
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Network topological features also revealed that in all three networks, 40% to 55% of the 
host genes were neighbours of a single bacterial group. The rest of the genes highly corre-
late with more than one bacterial group, and a maximum of 8 bacterial groups. About 60% 
of the genes are shared between at least two bacterial groups. The maximum radiality 
(indicative of how connected the nodes are to all the other nodes, with values ranging 
from 0 to 1) was 0.8 to 0.9. This is apparent from the visualization of the networks in Fig-
ure 4 which shows only a few nodes in the centre connected to most of the other nodes. In 
the three correlation networks, 60% – 80% of the edges have negative correlation values 
The GO terms that appeared enriched in the gene list of each of the correlation networks 
are mostly related to four broad functions, metabolic processes, transport of substances, 
translation, and some immune processes (shown in Supplementary File 3). Most of these 
genes are negatively correlated with the bacterial groups; this indicates general reduction 
of the expression levels of these genes across time. But these genes exhibit significant 
treatment effects, especially long term effects which are not reflected in the temporal pat-
terns of the bacterial groups with which they are highly correlated. 
In each correlation network, 20% of the genes are found in the FI networks from gene 
expression data alone. A separate topGO analysis shows that the genes in each of the cor-
relation networks are enriched for GO terms that are related to four broad categories of 
biological processes. These categories are, Metabolic Process, Transport, Translation and 
Immune Processes. In the OnlyTr1 and Tr1&Tr2 correlation networks, the genes associ-
ated with the most significant GO terms are mostly (70% and 80%) negatively correlated 
with the microbial groups. But in the OnlyTr2 correlation network, these genes are most-
ly (60%) positively correlated with the microbial groups. More than 50% of the genes in 
the three networks have significant long term differences from the control.  
4. Discussion 
In this paper we describe a workflow and a set of methods capable of analyzing and inte-
grating different types of data in two dimensions, treatment and time. These methods were 
then used for the identification of gut system components that contribute to the induction 
and maintenance of long-lasting effects in the GI tract as induced by perturbations at a 
young age. To this end we combined multiple, freely available tools and advanced statisti-
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cal analytical tools. We used temporal gene expression patterns, obtained using microar-
ray technology, to identify genes and biological processes that are affected over time by 
the early life perturbation with antibiotic and/or stress treatments. In addition, we used 
community-scale analysis of gut microbiota from the same location of the gut to identify 
changes in microbiota profiles over time due to the perturbations.  
With this approach we have taken the first steps in unravelling the genomic and microbial 
networks that contribute to long-lasting responses of early life perturbations in the gut. 
The results reveal that there are significant long-lasting differences in the system of the GI 
tract between the different perturbations groups, mainly at the gene expression level. The 
data presented are consistent with the hypothesis that observed long lasting effects on 
gene expression are most probably due to differences in the programming of the gut im-
mune system as induced by the temporary early life changes in the composition and/or 
diversity of microbiota in the gut. Furthermore, we were able to identify potential key 
regulator genes (hubs) for the long-lasting effects and we have identified microbial groups 
that are potentially associated with the observed changes in intestinal gene expression. 
In the following sections of this Discussion we explain the rationale behind choosing 
these methods for our particular biological question. In the sections “Biological relevance 
of the hubs”, “Crosstalk between host and microbe components” and “Understanding the 
long lasting changes in the host” we examine the biological relevance of the results. The 
other sections mainly deal with methodology aspects. 
Experimental approach 
Intestinal gene expression and microbiota profiles were generated on three different time-
points; day 8 (neonatal), 55 (young adult), and 176 (adult). Day 8 was chosen because it is 
known that immediately after perturbations, as used here, changes occur in the pattern of 
microbial colonizing of the gut as well as in the GI tract mucosal gene expression 
(Willing, Russell, and Finlay 2011; Niewold 2007; Collins and Bercik 2009. The second 
measurement at day 55 was chosen because the microbiota would have stabilised by then 
after weaning (around day 28). Weaning is an extremely turbulent process (Pluske, Le 
Dividich, and Verstegen 2003; Konstantinov et al. 2004; Lallès et al. 2007 that brings 
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about several temporary changes which are not the focus of our study. The last measure-
ment was on day 176 after birth which coincides with the time of slaughter of these pigs.  
Intestinal bacterial composition and gene expression patterns change over the lifetime of 
an animal due to changes in nutritional, environmental and physiological factors (Elahi et 
al. 2013; Belkaid and Hand 2014; Konstantinov et al. 2004. Obviously, these normal de-
velopmental changes could also be detected in this study; however we were particularly 
interested in deviations from the normal developmental patterns due to the early life per-
turbations. Previous work on subsets of these data (Schokker et al. 2014; Schokker et al. 
2015 showed that there are significant differences between the control and treatment 
groups at each time point. In the analysis described here, we incorporated the information 
across time and between treatments by the use of a quadratic regression analysis 
(maSigPro R package). In addition, we studied the behaviour of the microbiota over time 
and looked for correlations with gene expression patterns using the mixOmics R package, 
because it is known that the microbiota and gut mucosal tissue respond to each other in 
various ways (L. V. Hooper, Littman, and Macpherson 2012; Nicholson et al. 2012.  
Analysis of treatment effect on temporal gene expression 
For analysis of data derived from three time-points and two treatments, a regression analy-
sis is better suited than a pairwise comparison with linear models, PCOA or hierarchical 
clustering which was done in earlier work by Schokker et al (Schokker et al. 2014; 
Schokker et al. 2015. The resulting gene lists from Tr1vsCtrl and Tr2vsCtrl are separated 
into three lists to be able to look at the biological processes common to both the gene lists 
which is expected to be due to the effect of the antibiotic. With the resulting three gene 
lists, we performed GO enrichment analysis with two different methods: topGO and Reac-
tome. An important difference between the two methods is that Reactome is manually 
curated with experimentally verified information; whereas topGO only uses gene annota-
tion information that is, in many cases, automatically generated without further manual 
verification. As expected, the Reactome analysis resulted in richer information and en-
compassed most of the results from the topGO analysis. The network format of Reactome 
also allows for more informative visualization and further analysis using the topology. For 
these reasons we decided to concentrate our gene expression analysis on the enrichment 
results from Reactome where ever possible.  
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Network analysis  
In the FI networks OnlyTr1 and OnlyTr2, more than half of the nodes have a significant 
long-lasting expression pattern difference in the treatment versus control. This is signifi-
cant for most of the nodes in the Tr1&Tr2 FI network which is representative of the ac-
tion of antibiotic. This reveals that most of the long lasting effects are due to the antibiotic 
effect in the treatment. These genes with long lasting differences are spread over all the 
modules which indicates that all the biological processes in the network (Figure 2) are 
different over time. Several of these processes are essential cellular processes and some 
are immune related. This could lead to situations that the treated animals respond differ-
ently to external stimuli compared to control animals. In order to look further into these 
long lasting differences we analyse the hubs of the network. 
Analysis of hubs 
Investigating the hubs of networks gives insight into the entire network function (Barabasi 
and Oltvai 2004 and the nodes in our networks are also found to be important for several 
biological functions (Albert, Jeong, and Barabasi 2000; Jeong et al. 2001; Barabasi and 
Oltvai 2004 as mentioned in the Results. In most network analysis the degree itself 
(Ekman et al. 2006 or the degree distribution is used to choose the most connected hubs (I. 
W. Taylor et al. 2009. We chose the top 40% of the degree distribution as hubs, which is a 
more lenient threshold than usual because of the large differences in degree distribution 
within the three networks. Nevertheless, we still were able to identify multiple hubs per 
network and extract biological functions for these hubs (Table 1). Of the three categories 
that the functions of the hubs can be classified into, the cell cycle/proliferation category is 
more abundant than the other two.  
It is intriguing to note that most of the hubs of the three networks are known for being 
high level regulators for several biological processes, which supports the relevance of this 
network analysis. The hubs from the overlapping network, Tr1&Tr2 are involved in di-
verse biological processes and signalling/cascading events. The expression of all the hubs 
in the OnlyTr1 and the Tr1&Tr2 networks is significantly different over time in compar-
ison with their expression pattern in the control group. We speculate that the treatments 
directly or indirectly affect these hubs which then regulate genes to bring about the long 
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term effects of the treatments. The hubs in the OnlyTr2 network conspicuously do not 
have significant expression level differences over the time span of the experiment when 
compared to the control group. This suggests that the stress component of the treatment 
does not affect the animal in the long term as much as the antibiotic alone does. 
Biological relevance of the hubs 
Among the hubs, there are two STAT genes, STAT3 and STAT1, in the OnlyTr1 and On-
lyTr2 networks respectively. The STAT family of genes are well studied and have a role in 
signalling events but also act as transcription factors (Levy and Darnell 2002. The STAT1, 
STAT2, STAT3, STAT4 genes, found to have significantly different temporal expression 
patterns in the treatments versus the control, are especially related to immune reactions 
(Levy and Darnell 2002; Levy and Lee 2002; Poe et al. 2013. This is in agreement with 
the results of our functional analysis of the networks. STAT3 and STAT1 are known to be 
up-regulated in cases of bacterial infection (Levy and Darnell 2002; Lad et al. 2005; 
Kernbauer et al. 2012; Avalle et al. 2012. In addition, expression of STAT1 has been re-
ported to be reduced in the presence of antibiotics (Lad et al. 2005; Levy and Lee 2002; 
Fryknäs et al. 2007; Avalle et al. 2012. The latter is reflected in our data by the temporal 
expression patterns shown in Figure 3. Though the overall expression patterns of STAT1 
among the three groups are similar, antibiotic treatment and the concomitant change in 
microbial communities, has a clear effect on STAT1 expression, especially at the first two 
time-points. Expression of STAT1 on day 8 in Tr2 is, however, quite high compared to the 
Ctrl, this could indicate that the stress applied at day 4 counteracts the effect of the antibi-
otic. STAT3 is known to be important for survival of embryos (Ihle 2001; Levy and 
Darnell 2002; Levy and Lee 2002, it is important during the early stages of development 
but is not found to be essential in adult tissue (Levy and Lee 2002. This is reflected in the 
observed decreasing expression levels of STAT3 over the three time-points (Figure 3). The 
observed contrasting expression pattern of the STAT1 and STAT 3 hubs, may be related to 
the previous observations that STAT1 and STAT3 counteract each other (Qing and Stark 
2004; Avalle et al. 2012.  
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Data integration 
With regard to the microbiota composition and diversity, this study revealed a more prom-
inent effect of time than that of treatment. This is in accordance with previous observa-
tions that indicate that the diversity and composition of intestinal microbiota change con-
siderably over time (Konstantinov et al. 2006; Inoue et al. 2005. As expected, the treat-
ment effects are strongest at the first time point, taking into account the efficacy of the 
used antibiotic (Arrieta et al. 2014; “EMEA: Tulathromycin” 2004. As soon as the antibi-
otic wears off, the microbiota returns to the “normal” state. This is consistent with known 
literature about the resilience of microbial communities (Jernberg et al. 2010; 
Antonopoulos et al. 2009.  
Since the gene expression data as well as the microbiota data change with treatment and 
time, this presents an opportunity to correlate these different types of information and look 
into probable relationships and interactions in the jejunum between microbiota and gene 
expression of the cells in the mucosal layer. We assumed that the OnlyTr1 and Tr1&Tr2 
networks represent the effect of the antibiotic on the cross-talk between microbiota and 
mucosal cells. The OnlyTr2 correlation network could be interpreted as a representation 
of the cross-talk between the host and microbiota in response to stress, although we did 
not look at the effect of physical stress alone. The bacterial groups with the most gene 
connections are common to the three correlation networks. This indicates that the two 
treatments do not have drastic effects on the possible host microbiota interactions. The 
OnlyTr2 correlation network has more bacterial groups that correlate with genes which 
suggests that the physical stress factor alters the cross-talk more than the antibiotic alone 
does. The number of known pathobionts increases in the latter network which could be an 
indication of a tendency towards pathology in stressful conditions.  
Crosstalk between host and microbe components 
There are three bacterial groups that correlate with a high number of genes in all the three 
networks: Eubacterium; Ruminococcus bromii; and Faecalibacterium. Eubacterium is a 
genus with very diverse species. Ruminococcus bromii is a species that has been exten-
sively studied for its ability to breakdown resistant starch (Ze et al. 2012 to produce ace-
tate on which other bacterial groups can survive. Another beneficial bacterial group is 
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Faecalibacterium which is a relatively new genus with only one species documented so 
far, F. parusnitzii and it has been reported to be extremely beneficial to the host. Rumino-
coccus bromii; and Faecalibacterium are reported to be most abundant in the anaerobic 
environment of the colon (Abell et al. 2008; Zheng et al. 2009. Nevertheless, there is evi-
dence that the small intestine is populated with quite a few of such fermenters (Zoetendal 
et al. 2012. In our analysis the abundance of these bacterial groups in the jejunum corre-
lates to the expression level of a considerable number of genes. This suggests that they are 
major players in the cross-talk in the jejunum. Lawsonia intracellularis and species of 
Campylobacter are found to be correlated with several genes. These groups are known 
mammalian pathogens of the small intestine. It could be speculated that, in these healthy 
animals, they are involved in balancing between immune tolerance and immune respons-
es.  
Understanding the long lasting changes in the host 
The results of the regression analysis on gene expression alone show that there are differ-
ences between the three treatment groups for a long time after the perturbation. These 
differences are reflected in immune functions and cell proliferation related functions. It 
has been suggested that stress and antibiotics compromise the immune system, but in dif-
ferent ways (Söderholm and Perdue 2001; Konturek, Brzozowski, and Konturek 2011; 
Willing, Russell, and Finlay 2011. The action of antibiotics could change the delicately 
balanced signalling between microbiota and the intestinal cells. This change during early 
stages of development is expected to influence the development and programming of the 
immune system with consequences for the later life functioning of the immune system. It 
has been proposed that macrolides (the type of antibiotic given in this experiment) work 
by recruiting immune cells to carry the antibiotic to the afflicted tissue (X. Wang et al. 
2012; Benchaoui et al. 2004. This mode of action will bring about temporary changes in 
the immune system but cannot explain the observation as described here. Stress is known 
to cause structural changes in the intestinal tissue (Söderholm and Perdue 2001; Bhatia 
and Tandon 2005; Taché et al. 2001 and may affect the microbial populations (Collins and 
Bercik 2009.  
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The above described changes are not expected to last over a long period of time; intestinal 
cells have a large turnover (Creamer, Shorter, and Bamforth 1961; van der Flier and 
Clevers 2009 almost every 4 to 5 days. Yet we find changes that persist for 51 and even 
172 days after the perturbation of the gut system. This suggests that the programming and 
development of the immune system occurred differently between the different treatment 
groups. Since the microbial composition at day 8 significantly differed between the treat-
ments groups we believe that the difference in immune programming and development is 
due to differences in the early life crosstalk in the gut between microbes and host. This 
line of thinking is agreement with the conclusions in several other recent studies in this 
area (Hoskin-Parr et al. 2013; Cox et al. 2015. It is also in line with our own observation 
that the microbiota composition returns to the normal state briefly after the perturbation. 
Memory cells of the mucosal immune system could play an important role in the program-
ming of the mucosal immune system (Ahmed and Gray 1996; Schokker et al. 2015; 
Belkaid and Hand 2014. Furthermore even though stress was not expected to play a very 
prominent role in changing the system in the long term, we see that in some instances, it 
counteracts the effects of the antibiotic. The mechanism behind this is yet to be fully un-
derstood. 
Pigs are regarded as a useful model for research into modulation of the human gut, espe-
cially with regard to microbiota-host immune interactions (Heinritz, Mosenthin, and 
Weiss 2013. This experiment was designed to disturb the pattern of early colonization of 
the gut by microbiota with known effects later in life (Arrieta et al. 2014. The factors used 
for perturbation were, treatment with an antibiotic or an antibiotic with stress at day 4 
after birth. Both human neonates as well as piglets in intensive husbandry systems may be 
exposed to such factors. Therefore our results may be relevant for both humans and pig-
lets. 
Conclusions 
We used an early life intestinal perturbation in piglets and demonstrate long lasting ef-
fects, as measured on the intestinal gene expression level. We provide substantial evi-
dence that several biological processes of the gut mucosal tissue are in a different state 
between the experimental groups over a long period of time. However, the regression 
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analysis did not identify significant differences among the temporal patterns of the bacte-
rial species, and the treatments do not seem to affect long term changes in the microbiota. 
We conclude that the difference in immune programming and development is due to dif-
ferences in the early life crosstalk in the gut between microbes and host, resulting from the 
perturbations. Since we identified potential high-level regulators of long term changes in 
the gut, we are one step closer to identifying the underlying mechanisms. Although the 
treatments did not lead to phenotypical manifestations, like weight differences between 
the animals, the exposure of pigs to stressors like pathogen challenges could bring out 
immune variations between the groups. Studying these subtle differences may help to de-
velop strategies to modulate the process of immune development and programming. The 
results of this paper are supportive for the recent notion that antibiotics should be used 
more carefully in neonatal humans and animals.  
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Supplementary Figures and Files 
All the Supplementary files and figures can be found at:  
http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-015-1733-8#Declaration  
Supplementary Figure 1: Experimental Design. The figure shows the timeline of the 
experiment, and each line shows a different group of animals. The red line represents the 
control group, the blue line the Antibiotics alone (Tr1) and the green line the group given 
Antibiotics and Stress (Tr2). The pink block represents the intervention of the groups and 
the light blue boxes represent times of sampling. The boxes at the bottom represent the 
distribution of the groups among the sows, the pigs were housed in the same manner after 
weaning. 
Supplementary Figure 2: Microarray Analysis. Workflow of the microarray analysis 
with the specific details. 
Supplementary Figure 3: Types of Differences in Time Profiles. Each graph depicts 
the temporal expression pattern of a single gene. These temporal changes are shown under 
three different conditions: Ctrl (red line), Tr1 (green line), and Tr2 (blue line). The x-axis 
indicates the time in days, the y-axis has expression values scaled such that the average 
expression of each gene is 0 and the standard deviation is 1. 
Supplementary Figure 4: Expression of FI network hubs. Expression profiles of 17 
hubs of the three FI networks. Each graph depicts the temporal expression pattern of a 
single gene. These temporal changes are shown under three different conditions: Ctrl (red 
line), Tr1 (green line), and Tr2 (blue line). The x-axis indicates the time in days, the y-axis 
has expression values scaled such that the average expression of each gene is 0 and the 
standard deviation is 1. 
Supplementary Figure 5: Original Tr1&Tr2 FI network. Network formed with genes 
that have significantly different time profiles between both treatments vs the control 
group. 
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Supplementary Figure 6: Temporal changes in composition of bacterial groups used 
in the correlation networks. Each graph represents the compositional changes of select-
ed bacterial groups over time. The bacterial groups were chosen based on an ANOVA 
analysis. The time in days is on the x-axis, the log values of the contribution of the bacte-
rial groups is on the y-axis. Each of the 46 graphs have a different scale on the y-axis due 
to the extreme differences between contributions of each of the bacterial groups. 
Supplementary Figure 7: OnlyTr1 Reactome FI network 
Supplementary Figure 8: Tr1&Tr2 Reactome FI network 
Supplementary Figure 9: OnlyTr2 Reactome FI network 
Supplementary Figure 10: OnlyTr1 correlation network 
Supplementary Figure 11: Tr1&Tr2 correlation network 
Supplementary Figure 12: OnlyTr2 correlation network 
Supplementary File 1: List of significant genes in different conditions. 
Supplementary File 2: Information on the Reactome FI networks.  
Supplementary File 3: Information on the correlation networks. 
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Abstract 
The genotype and external phenotype of organisms are linked by so-called internal pheno-
types which are influenced by environmental conditions. In this study, we used five exist-
ing –omics datasets representing five different layers of internal phenotypes, which were 
simultaneously measured in dietarily perturbed mice. We performed ten pair-wise correla-
tion analyses verified with a null model built from randomized data. Subsequently, the 
inferred networks were merged and literature mined for co-occurrences of identified 
linked nodes.  
Densely connected internal phenotypes emerged. 45 nodes have links with all other data-
types and we denote them ‘connectivity hubs’. In literature, we found proof of 6% of the 
577 connections, suggesting a biological meaning for the observed correlations. The ob-
served connectivity’s between metabolite and cytokines hubs showed higher numbers of 
literature hits as compared to the number of literature hits on the connectivity’s between 
the microbiota and gene expression internal phenotypes. We conclude that multi-level 
integrated networks may help to generate hypotheses and to design experiments aiming to 
further close the gap between genotype and phenotype. We describe and/or hypothesize 
on the biological relevance of four identified multi-level connectivity hubs. 
Keywords: Data integration, Internal phenotype, Transcriptomics, Proteomics, Metabo-
lomics, Microbiota, Gastrointestinal tract, Systems Biology.  
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Introduction 
The information encoded in the genome (genotype) and the external quantitative traits or 
characteristics (phenotype) of an organism are linked to each other by several layers of so-
called, intermediate (Fontanesi 2016; Leuchter et al. 2014 or internal (Houle, 
Govindaraju, and Omholt 2010 phenotypes. Several of these internal phenotypic layers 
are shown in Figure 1 that visualizes the conceptual relationship between the external phe-
notype (P), the genotype (G), the environment (E), and the G&E interactions. The epige-
nome is tightly associated with the genome and represents the programming of gene ex-
pression which is not dependent on the DNA code itself. The transcriptome layer repre-
sents direct effects of the environment on the gene expression of the (epi-)genome. Trans-
lation of the transcriptome into proteins represents the next internal phenotype. The subse-
quent layer is represented by complex metabolite profiles. The organism-associated mi-
crobiota, especially those in the gut, can be regarded as a separate internal phenotypic 
layer, because it is not only dependent on the host genome but also heavily influenced by 
its environment, particularly by nutrition (Montiel-Castro et al. 2013; Schwartz et al. 
2012. Although for several traits the quantitative effects of the environment on the exter-
nal phenotypes are known (Cani et al. 2008; de Wit et al. 2011; Gentry et al. 2004, the 
specific effects of the environment on the internal phenotypes are largely unknown. Fur-
thermore, it is obvious to assume that the various layers of internal phenotypes are con-
nected to each other and that their joint profiles ultimately determine the external pheno-
type (Fontanesi 2016; Leuchter et al. 2014. Unfortunately, most of these assumptions are 
not based on solid evidence and at best represent oversimplifications of the dynamic na-
ture of processes involved in determining external phenotypes. It, furthermore, partly ex-
plains the knowledge gap that exists between the genotype and the external phenotype.  
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Figure 1: Relationship between the external phenotype (P), the genotype (G), the environment (E), 
and the G&E interactions. The internal phenotypic layers and the environmental factor with a darker 
outline are included in the present study.  
Therefore, the objective of this study was to develop methodologies to identify compo-
nents in the internal phenotypic layers that are connected to components in other internal 
phenotypic layers. To this end, we integrated multi-scale quantitative (-omics) data using 
a regression approach. The used data sets were derived from a single experiment with 
inbred mice which were exposed to five different dietary interventions as a means to per-
turb the different internal phenotypes. With a data-driven approach we were able to identi-
fy a large number of potential connections between the various intermediate phenotypes 
and for several we found proof of causal relationships in literature. The results of this 
study provide a basis to understand how various internal phenotypic layers are connected 
to each other. The identified connections may be crucial for the identification of causal 
relationships (Civelek and Lusis 2014 between various biological scales and to uncover 
mechanisms involved in determining external phenotypes. 
Materials and Methods 
Origin of data 
We used data from an experiment with six-week old inbred mice that were fed for four 
weeks with six different semi-synthetic diets (Kar et al. 2016. In brief: thirty-six 21-day-
old C57BL/6J mice (Harlan Laboratories, Horst, the Netherlands) were divided into 6 
groups and housed in pairs with ad libitum access to diet and water. After adaptation for 
one week to a standard diet, the mice were fed semi-synthetic diets containing 300 g/kg 
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(as fed basis) of one of the alternative protein sources for 28 days: soybean meal; casein; 
partially delactosed whey powder; spray dried plasma protein; wheat gluten meal and yel-
low meal worm. At the end of the experiment, mice were sacrificed to collect ileal tissue 
to acquire gene expression data, ileal digesta to study changes in microbiota, blood serum 
to profile cytokines and chemokines and blood and urine to profile amine metabolites. All 
procedures were approved by the animal experimentation board at Wageningen University 
& Research Center (accession number 2012062.c) and carried out according to the guide-
lines of the European Council Directive 86/609/EEC dated November, 1986. Multi-omics 
data were obtained with regards to: whole genome gene expression profiles of ileal tissue 
as measured with Affymetrix GeneChip mouse gene 1.1 ST microarrays (Affymetrix, 
Santa Clara, CA, USA); community scale microbiota composition of ileal digesta by tar-
geted-amplicon DNA sequencing of the bacterial 16S rDNA V3 region on an Illumina Mi
-Seq sequencer; 23 serum cytokine and chemokine concentrations (pg/ml) using a Bio-
Rad Mouse 23-plex kit (Bio-Rad, Hercules, CA, USA); and amine metabolic profiles of 
serum and urine using an ACQUITY UPLC system coupled online with a Xevo Tandem 
quadrupole mass spectrometer (Waters) operated using QuanLynx data acquisition soft-
ware (version 4.1; Waters) (Kar et al, in preparation). The data from the ileum reflects the 
local effects of the dietary interventions, the other three data assess the systemic effects.  
Pre-processing and selection of data 
An overview of the five types of data and their specifics are given in Table 1. Each dataset 
was pre-processed in a similar way using the R package limma (Smyth 2005 to find the 
differentially significant data-points. The data is first log transformed and then this data is 
fitted to a linear model using the function lmFit (Phipson et al. 2016 which will give back 
information on the differences between the genes in different arrays and subsequently 
different comparisons of control vs treatment. Then we used the function eBayes (Phipson 
et al. 2016 which applies an empirical Bayes method to compute p-values for a t-statistic 
under the assumption that only 1% of the genes are differentially regulated among all the 
genes in the arrays. This p-value is then subjected to a Benjamini-Hochberg (Benjamini 
and Hochberg 1995 multiple testing, also known as a False Discovery Rate (FDR).  
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Table 1: Pre-processing and specificities of each data-type. Details of the site of sampling and 
data dimensions before and after pre-processing are indicated. The first number indicates the num-
ber of variables in the data and the second number denotes the number of samples. 
 
This analysis was done by comparing the data of each dietary group against the data of the 
dietary group that received soy bean meal as protein source, which is the most common 
source of protein in animal diets. The FDR value of the data, is used to gauge significance 
and data-points that were significant in at least one of the five comparisons of the diets 
were included in the integration analysis. Except for the Cytokine and Metabolomics Se-
rum (using the amine measurement), all the data-types had some samples thrown out due 
to quality control. Two types of metabolomics measurements were done on the sampled 
urine; Amine and Acyl-carnitine, the amine dataset did not have sufficient statistically 
significant data-points so was discarded. We only work with the Acyl-carnitine measure-
ment in urine. 
Data integration, network generation and network assessment.  
All significantly different data-points were used in the integration which was initially per-
formed with two datasets at a time, so that from the 5 datasets 10 integrated networks 
were generated. The integration was performed using the function sPLS (sparse Partial 
Least Squares) in regression mode with ncomp = 5, from the R package mixOmics 
(Dejean et al. 2011; González et al. 2012; Lê Cao, González, and Déjean 2009. The re-
gression mode is used to model causal relationship between variables in both datasets by 
identifying combinations of variables between both datasets. Weight vectors used in the 
regression modelling are termed loading vectors. sPLS is used to perform simultaneous 
Properties Transcriptomics Microbiota Cytokine 
Metabolomics 
Serum 
Metabolomics 
Urine 
Sampling Ileum Ileum Serum Serum Urine 
Before pre-
processing 
16,410 * 33 148 * 33 23 * 36 41 * 36 16 * 28 
After pre-
processing 
52 * 33 22 * 33 13 * 36 26 * 36 16 * 28 
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variable selection in the two datasets to be integrated and employs LASSO (Least Abso-
lute Shrinkage and Selection Operator) penalization (Tibshirani 2011 on the loading vec-
tors. This approach requires one data set, X with nx elements, to be designated the predic-
tor and the other, Y with ny elements, the response. As an output, the approach produces a 
matrix Ma(X,Y) of size nx x ny representing the relevant correlations between both da-
tasets, so that: 
Where cor(Xi,Yj ) is Pearson’s correlation between elements i and j from datasets X and Y 
respectively. The correlation is computed across all available samples (here corresponding 
to dietary exposures). 
Since it is not trivial to determine the predictor and response with biological data, we 
swapped the two types of data to compute Mb(Y,X), a matrix of size ny x nx where the 
roles of X and Y have been interchanged. Both matrices, Ma and Mb where combined into 
a final matrix M(X,Y) size nx x ny using 
where t represents matrix transposition. Thus, non-null elements of the matrix M(X,Y) 
represent correlations between data types that have been deemed associated. This matrix 
can be seen as a weighted adjacency matrix representing a network where two nodes Xi 
and Yj are connected via an edge if a non-null weight can be assigned to the edge. This 
weight is represented by the matrix value mij. 
To further prune the network of (possibly) spurious interaction two additional thresholds 
(thl < 0; and thh > 0) were imposed to obtain an unweighted adjacency matrix A(X,Y) of 
size nx x ny 
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were |x| represents the absolute value. thl and thh where selected for each network so that 
only top 5% of the highest (positive) and lowest (negative) weights were kept for building 
the networks.  
Networks represented by these adjacency matrix were transformed into the edge-list for-
mat, a two column table of the connected nodes in a network were each row represents an 
edge and visualized in Cytoscape (Ono et al. 2015; Shannon et al. 2003.  
For each pair of integrated datasets, a null model of the association networks was con-
structed using a strategy based on random permutations of measured values (Saccenti et 
al. 2014. Measured data-points were randomly permuted over samples before data integra-
tion to obtain randomized datasets that still retained the same value distribution for each 
variable. The randomized datasets were then used for data integration following the afore 
mentioned approach thereby generating randomized associations networks. The process 
was iterated Nit = 1,000 times for each pair of datasets; for each iteration, k, the values of 
the dynamic cut-offs (thlk and thhk) (5% of the highest and lowest correlation) were record-
ed. For the ten pairwise combinations of datasets, the values obtained for thl and thh ob-
tained using the unpermuted dataset, were compared with the distribution of values of thlk 
and thhk with k = {1, …, Nit} to get networks from the random data to compare to the net-
works from the biological data. 
Network merging and topological analysis 
The ten networks arising from pair-wise data integration of the 5 data sets were merged in 
a combined network including all the nodes and edges of the 10 networks. This network is 
then restricted by only including nodes present in at least two of the separate networks. 
We used the igraph R package (Csardi and Nepusz 2006 to further analyze the network, 
which was treated as non-directed, since no particular directionality was assigned to the 
edges. We obtained values for the following topological properties of the merged network 
(Barabasi and Oltvai 2004; Csardi and Nepusz 2006: Degree: number of neighbors of a 
given node, that is the number of nodes connected to it. Clustering coefficient of a node is 
the ratio of the number of connections between the neighbors of a node and the total num-
ber of possible connections between said neighbors. Characteristic path length: median of 
the average distance between a node and all the rest. Network density: ratio between the 
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total number of existing edges and the total number of possible edges (given the number 
of nodes in the network). Connected components maximal subgraphs in a network such 
that each node is connected to all the rest by means of network paths. For node level met-
rics, such as degree or clustering coefficient average values were computed over all nodes. 
Cytoscape was used for network visualization.  
Literature mining 
To investigate the co-occurrence of the names of the connected nodes in the correlation 
network, we used the R package rentrez (Winter 2016. This package searches for selected 
keywords in PubMed abstracts while making use of the MeSH (Medical Subject Head-
ings) thesaurus to maximize results via the API from NCBI. The search was not restricted 
to a specific tissue type or organism. These results were examined, although not exhaust-
ively, to find literature evidence of established relationships between nodes connected 
through identified edges; these were then considered as true positive search results. 
The script used to generate all these results will be made available on request. All the 
above mentioned operations were performed using existing functions from R packages. 
Results 
Analysis of the individual datasets 
A dietary intervention was performed on mice where the protein content was changed and 
multi-omics data were obtained with regard to: whole genome gene expression profiles of 
ileal tissue (Transcriptomics), community scale microbiota composition of ileal digesta 
(Microbiota), 24 different cytokine levels in blood serum (Cytokine), and protein-
associated metabolic profiles of serum (Metabolomics Serum) and urine (Metabolomics 
Urine). These data were pre-processed and analyzed separately by fitting a linear model 
on the data-points and looking for differentially expressed readouts in each treatment ver-
sus the control. Each dataset had its own p-value (corrected for multiple testing with the 
Benjamini-Hochberg method) threshold, ranging from 0.001 to 0.1 for difference between 
the tested and reference diets. The highest number of statistically significant entities was 
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found in Transcriptomics. Furthermore, all the measured variables in Metabolomics Urine 
were found to be significantly different in at least one comparison.  
 
Pairwise data association and network generation 
We performed the integration by linking two data-types at a time and in such a way that 
after the pairwise analysis all the observed correlation data could be combined to build a 
multi- level interaction network. Therefore, each data-type was integrated with the other 
four types of data, resulting in ten correlation networks. The topological characteristics of 
all these ten networks are given in Table 2 and Figure 2, and the network graphs are avail-
able in Supplementary Figure S1 as an image. Supplementary File 1 has the networks in a 
format that can be uploaded into Cytoscape in order to further explore the connectivity’s 
of these networks by simply clicking on these nodes. Table 2 shows the positive and nega-
tive thresholds that were used separately for the correlation network. Connections between 
pairs of data points with correlation values between the threshold values, i.e. Low Thresh-
old (negative threshold) and High Threshold (positive threshold) as indicated in Table 2, 
were discarded and the corresponding edges removed from the final network. There were 
two disconnected sub-graphs in five of the networks while the other five have only a sin-
gle, fully connected graph. 
The largest network, in terms of nodes, is the Microbiota & Transcriptomics network. 
This seems logical as it represents the most comprehensive datasets and spacial interac-
tions between the two data-types are known to occur. Overall, networks involving Tran-
scriptomics data had higher number of nodes than other networks. The smallest network 
with 18 nodes and 22 edges was the Metabolomics Urine & Cytokine network. 
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Table 2: The 10 individual correlation networks. Each row represents one of the 10 correlation 
networks. Low Threshold and High Threshold represent the thresholds used for the correlation val-
ues. The 3rd and 4th columns have the number of nodes in the network that belong to the first and 
second data, respectively. The last column displays the number of connected graphs in the network.  
 
 
 
Network Names  
(data A & data B) 
Low 
Threshold 
High 
Threshold 
# of nodes 
(A) 
# of nodes 
(B) 
Connected 
graphs 
Metabolomics Serum & 
Metabolomics Urine 
-0.51 0.6 14 12 2 
Metabolomics Serum & 
Microbiota 
-0.38 0.3 21 14 1 
Metabolomics Serum & 
Transcriptomics 
-0.31 0.35 26 33 2 
Metabolomics Serum & 
Cytokine 
-0.33 0.5 18 13 2 
Metabolomics Urine & 
Microbiota 
-0.28 0.42 16 12 1 
Metabolomics Urine & 
Transcriptomics 
-0.55 0.54 14 29 1 
Metabolomics Urine & 
Cytokine 
-0.32 0.55 10 8 2 
Microbiota & Tran-
scriptomics 
-0.28 0.27 19 48 1 
Microbiota & Cytokine -0.38 0.35 11 11 1 
Transcriptomics & Cy-
tokine 
-0.27 0.34 31 13 2 
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Figure 2: Multilevel integration. This schematic image shows the number of connections between 
each internal phenotypic level with the other levels in a merged network. The colours of the parallel-
ograms denote the internal phenotypic level to which the data-types belong. Green is Metabolomics 
(light green – Metabolite from Serum and dark green – Metabolite from Urine), blue is Cytokines, 
red is Transcriptomics and pink is Microbiota. Each line connects two levels and the vertical num-
ber above the line indicates the number of edges in the correlation network between those two phe-
notypic levels. The number of connected nodes in each level is given in circles above and below the 
connecting lines. 
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Technical validation of pairwise integration networks by random permutation 
We performed the same method of integration on the five different data-types after ran-
domly permuting the measured data, this process was iterated a 1000 times. In this way, 
the networks obtained from random permutations are considered a null model with no 
biological information, and used to assess the significance of the results obtained with the 
non-permuted data. Figure 3 shows the spread of correlation values for the integration of 
Metabolomics Serum and Transcriptomics. The thresholds for network reconstruction 
were selected so that only the 5% highest and lowest correlations were kept. The separa-
tion between the values obtained for the integrated data and the randomly permutated da-
tasets indicates the high significance of the edges in the integration networks. In this way, 
selection of the 5% highest and lowest correlations and significant limits the number of 
spurious correlations that could be due to chance alone while retaining maximum infor-
mation in the networks.  
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Figure 3: Distribution of network correlations and random network cut-offs of the 
Metabolomics Urine and Transcriptomics networks. The x-axis depicts the range of 
correlation values and the y- axis shows its frequency. The grey bars denote the distribu-
tion of the thresholds of the 1,000 random correlation networks with frequency on the left 
y-axis. The red bars are distributions of the correlation values of the inferred network with 
frequency on the right y-axis. 
Similar results were obtained for most of the integration networks (Supplementary Figure 
S2). In three of the networks, there is an overlap between the correlation values from the 
inferred network and the values arising from the randomly generated networks. The over-
laps are in the networks Metabolomics Urine & Microbiota, Metabolomics Urine & Cyto-
kine and Transcriptomics & Cytokine network. The highest overlap appears in the first 
two and mostly affects edges with negative correlations. 
Merged Network 
All the 10 integration networks (Supplementary File 1) were merged and only nodes 
linked with nodes of at least two other data-types were kept (see Table 3). The gene ex-
pression data has the highest number of nodes in the merged network. However, nodes 
with the highest degree (number of connecting edges) arise from the microbiota data, with 
S24-7 having 57 neighbors and Bifidobacterium having 47 neighbors. The merged net-
work encompasses 45 nodes that are connected to all the other types of data. For that rea-
son we denote them ‘Connectivity hubs’ and they are included in Table 3 and Supplemen-
tary Table 1.  
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Table 3. Characteristics of the merged network. Characteristics of the merged correlation net-
work. The number of nodes from each data-type are given in rows three to seven. Between brackets 
the number of connectivity hubs is indicated.  
 
Functional validation of merged network by text mining 
A PubMed literature search for co-occurrence of linked nodes gave results for 6% of the 
links corresponding to 37 edges. We further investigated reported causality effects be-
tween the nodes in question. Most of the retrieved results are related to metabolites and 
Network Statistics  
Total number of nodes 112 (45) 
Total number of edges 577 
Number of Metabolomics Urine nodes 15 (8) 
Number of Metabolomics Serum nodes 24 (11) 
Number of Cytokine nodes 13 (7) 
Number of Transcriptomics nodes 43 (12) 
Number of Microbiota nodes 17 (7) 
Degree range 2 to 57 
Average number of neighbours 10.35 
Clustering coefficient 0.20 
Network Diameter 4 
Network radius 3 
Characteristic path length 2.31 
Network density 0.09 
Connected components 1 
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cytokines measurements whereas a few results confirming causal relationships were found 
involving gene nodes. We were able to find literature confirmation pertaining to associa-
tions for six out of the ten pair-wise connections between phenotypes, as summarized in 
Table 4 and Supplementary Table 2. Among the nodes with literature results, four are 
from Microbiota, two from Transcriptomics, 15 from Metabolomics Serum, three from 
Metabolomics Urine and six from Cytokines. The node with the highest number of hits in 
literature is Tnfa which co-occurs 8,563 times with nine metabolites from the Metabolom-
ics Serum data and one bacterial group (Bifidobacterium). 
Table 4: Overview of text mining results. The first column shows the types of data that are con-
nected by the edges that were found in the PubMed literature search.  
 
Of the 30 data-points from all the types of data that have literature results, 15 are connec-
tivity hubs. One such connectivity hub is Glutathione (GSH) which has 21 direct neigh-
bors from four data-types as shown in Figure 4. This hub is especially interesting because 
six of the connected nodes (Carnitine, Tnfa, Il-1b, Il17c, Bifidobacterium and Dapk2) 
have textual co-occurrences found by the text mining algorithm. The terms GSH and Tnfa 
were found 2,231 times in the abstracts of Pubmed indexed articles. Full text inspection 
shows that some of the connections are causal relationships as one of the connected nodes 
activates or inhibits the other. 
 
Data Connections PubMed Ids Distinct edges 
Cytokines & Metabolomics Serum 9,554 16 
Metabolomics Serum & Metabolomics Urine 906 6 
Microbiota & Metabolomics Serum 254 7 
Microbiota & Cytokines 250 5 
Transcriptomics & Microbiota 83 3 
Metabolomics Serum & Transcriptomics 59 2 
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 Figure 4: Glutathione sub-network. This figure shows the 21 connections of the node Glutathi-
one in the merged network. The different colours of nodes indicate the data-type of internal pheno-
typic level of that node, pink is Microbiota, red is Transcriptomics, blue is Cytokines, and green is 
Metabolites (light green – Metabolites from Serum and dark green – Metabolites from Urine). Oval 
nodes are connectivity hubs. Dotted lines show un-validated edges and continuous, thicker edges 
show connections also present in the results retrieved from scientific literature. Edge colour, yellow 
and purple, indicates positive and negative correlations, respectively.  
Discussion 
In this study we developed and used a set of computational methods to identify compo-
nents in internal phenotypic layers that are connected to components in other internal phe-
notypic layers of an organism. We successfully integrated multi-scale quantitative (-
omics) data, derived from a single experiment with inbred mice and which were exposed 
to five different diets. Since the data originated from an animal experiment that was not 
designed for the detection of genetically and/or dietarily induced differences in external 
phenotypes, we only focused on the connectivity between 5 intermediate phenotypic lev-
els. Some studies have reported pairwise data integration of two (Benis et al. 2015; Lu et 
al. 2014; Rajasundaram et al. 2014 or three data sets (Adourian et al. 2008. But this is, to 
the best of our knowledge, the first time that an integration of such heterogeneous data-
types from different tissues, arising from a single experiment, has been reported. The ap-
79 
Chapter 3 
 
3 
proach as described here could, in principle, be applied on any number and type of da-
tasets, as long as they are from the same experiment, from samples at the same time-point 
and have comparable dimensions of differentially regulated data. 
Internal phenotypic data and pairwise data integration 
Each used data-type represents a different internal phenotype and a different layer of the 
system that (co-) drives the manifestation of external phenotypes. We subjected each data-
type to a separate analysis in order to correlate only those changes induced by the dietary 
intervention. Nodes with significantly different values could easily be identified in each of 
the sampled tissues and fluids (ileum, blood and urine) thereby representing the local and 
systemic effects of the interventions and the need of a multi-scale approach. 
In order to investigate connections between the five data-types we used sPLS, an integra-
tion method that can be applied to several types of data, two at a time. This method can 
also handle the dimensionality problem of biological datasets where the number of varia-
bles is usually higher than the number of samples. sPLS has been previously used for inte-
gration of microbiota with gene expression data (Benis et al. 2015; Steegenga et al. 2016, 
and measurements on cell wall polysaccharides of fibers with phenotypic characteriza-
tions of fibers in cotton balls (Rajasundaram et al. 2014.  
We performed pairwise integration of the datasets, resulting in ten networks with varying 
spreads of correlation values. Deciding on a threshold to distinguish genuine from spuri-
ous correlations is a major bottleneck for the definition of correlation networks. While a 
0.8 threshold (absolute value) has been suggested for gene expression data (Schäfer and 
Strimmer 2005, other authors suggested smaller values (0.6) in metabolomics data sets 
(Camacho, De La Fuente, and Mendes 2005. The correlation values greatly depend on the 
biological dataset under study and its dimensionality. There are several methods to choose 
a threshold based on the data: use assigned p-values as threshold; use network characteris-
tics of the correlations; or use a percentage of the correlation distribution. When evaluated 
by Borate et al (Borate et al. 2009 they concluded that threshold selection methods based 
on network properties such as the clustering coefficient are best for gene co-expression 
networks. This would not work here because the generated networks always induce con-
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nections between data points of different type and as a result they have a zero clustering 
coefficient for every node. While integrating two types of metabolomics datasets with 
gene expression of the tissues in which they were measured Adourian et al (Adourian et 
al. 2008 assigned p-values to the correlation values and then set a threshold. In this study, 
we used the top 5% of the correlation values because this dynamic threshold (separate for 
the positive and negative values) eliminates bias towards the size of the datasets. 
We further validated the observed correlations by comparing them with a null model ob-
tained by randomly permuting the data along the samples (Eguíluz et al. 2005; Saccenti et 
al. 2014. In two of the networks, Metabolomics Urine & Microbiota and Metabolomics 
Urine & Cytokine (the smallest network), the significance of the negative correlation val-
ues could not be established as we observed a considerable overlap between the negative 
correlation values of this network and the negative thresholds of the random networks. 
This calls for caution when biologically interpreting these networks. For five of the net-
works we observed a very clear separation of the random thresholds and the start of the 
correlation values in the network (Supplementary Figure S2). The other networks showed 
slight overlaps between the random threshold distribution and the network correlation 
distribution. This extra validation step reassured us that the observed correlations are root-
ed in biological phenomena. To our knowledge this technical validation step is not com-
mon in current studies of this type. 
The edges of the inferred networks, indicate significant computationally-determined cor-
relations between values of connected nodes. Our approach does not require a mechanistic 
model on how the associations are established and in each network these associations may 
be caused through entirely different mechanisms. In some cases the associations would be 
due to causal relationships between the connected nodes, such as increased expression 
levels of a cytokine gene linked to increased cytokine levels. However, in many cases, the 
associations could be indirect, mediated by elements that have not been measured in the 
experimental set up. In a formal mathematical model, they are considered hidden varia-
bles. Such would be the case of, for example, the changes in the metabolite levels of urine. 
These changes might have been caused by the colonic microbiota, in turn affected by the 
ileal microbiota. Since we only used the ileal microbiota data, we observe correlations 
81 
Chapter 3 
 
3 
between the ileal microbial populations and the urine metabolite levels which could be in 
reality, indirect relationships mediated by the colonic microbiota. 
Network of connected internal phenotypes 
The pair-wise integration method allowed us to merge the ten individual networks into a 
single network. Correlations within a dataset were deliberately excluded from this study 
because we only wanted to focus on connections between different internal phenotypes, 
where little work has been done. Thus in the ten networks, all detected connections are 
between two different data types and every node has a zero clustering coefficient. Howev-
er, in the merged network, a non-zero clustering coefficient emerges as a result of nodes 
connecting to multiple data types (Table 2). This emphasizes the biological relevance of 
this method because the ten networks were built without any information on cross-linking. 
Thus, we identified individual nodes that directly or indirectly participate in processes of 
the other four individual networks. Because they seem to connect different internal pheno-
types, we denoted them ‘Connectivity Hubs’. Starting the procedure as developed and 
applied here with networks with non-zero clustering coefficients (correlating within a da-
taset) would, however, not alter the connections between internal phenotypes. 
Functional validations of phenotype connections 
Results of the text-mining were used to validate some of the identified links. This revealed 
insights into the mechanistic relationships between the variables predicted to be linked to 
each other. 37 of the 577 (6%) computational inferred links have already been described 
in literature as detected by our text-mining approach, which was not exhaustive because it 
focused only on text in journal abstracts. This indicates that our method identifies current-
ly known biological interactions. The rest of the predicted links have not been discovered 
and investigated yet, have not been mentioned in abstracts, or do not exist in the biologi-
cal system. Furthermore, by inspecting some of the retrieved abstracts and corresponding 
articles, we were even able to find causal relationships between some of the computational 
identified nodes where one of the nodes was used as an experimental perturbation and the 
other node was measured as a response parameter. Several indirect associations were also 
validated through reports on experiments where nodes, found to be connected in this 
study, were measured in response to another perturbation. During text-mining, in order to 
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retrieve as many results as possible, search terms were matched against the MeSH thesau-
rus, irrespective of the organism, and all the synonyms were included in the search. The 
downside to this approach is the inclusion of several false textual associations. The most 
striking case is that of the identified association between Glutathione and Il17c. In the 
literature results, the reported association is between Glutathione and Il17a and not Il17c. 
Through the thesaurus, Il17c was mapped to Il17 and subsequently to Il17a thereby giving 
rise to that falsely identified association in literature. 
In order to increase the precision and recall of text mining searches, and overcome prob-
lems associated to the use of a thesaurus, one needs to move from mining text, to mining 
the knowledge embedded in the text and the use of data hidden in public databases. Such 
an approach requires the use of knowledge management tools and representations that can 
be automatically accessed (Antezana, Kuiper, and Mironov 2009. Semantic web technolo-
gies represent a new class of tools that include natural language processing, ontologies, 
machine learning algorithms and much more to facilitate integration knowledge from het-
erogeneous sources. The expansion of the use of semantic technologies in the life sciences 
domain will allow associating concepts such that inferences on causality, regulation, or-
ganism or tissue can be made using high-throughput methods and automated reasoning. 
Among the interactions retrieved from the automated literature search, a high prevalence 
of associations involving cytokines and/or metabolites was observed. In fact, such type of 
interactions represent 97% of the retrieved results. This probably highlights the extraordi-
nary amount of work that has been done in these types of data in the past. On the opposite 
extreme, only 8% of the retrieved interactions involved associations between the expres-
sion of genes, reflecting the fact that most of the available gene expression data originates 
from genome-wide techniques. In such type of experiments, papers, especially abstracts, 
usually report on systems behaviors and pathways and less frequently on the individual 
behavior or role of individual genes and connected response nodes.  
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Validated connectivity hubs 
Even though we only performed integrations of two datasets at a time, we find data-points 
(metabolites, cytokines, genes or microbial groups) that correlate with different types of 
data. We identified 45 connectivity hubs in the merged network that seem to have associa-
tions with all four types of data. More than 30% of them are involved in links that were 
retrieved in literature. To further support the biological relevance of identified multi-level 
connectivity’s we discuss the implications of two of the 15 biologically validated connec-
tivity hubs as examples. The two connectivity hubs were chosen because of the large 
amount of literature results for these hubs. The first hub, Tnfa has the highest number of 
literature results among all the nodes in the network and the other hub, Glutathione, has 
literature validations to the most number of data-types.  
Tnfa is a connectivity hub in the merged network, with links to several neighbors belong-
ing to the four other types of data. The position of this cytokine in our merged network 
shows that it plays a role in processes of the other internal phenotypes. The literature vali-
dated links are between Tnfa and two other types of data (Metabolomics Serum, Microbi-
ota). Many of the validated links represent causal relationships. With regards to immune 
responses and as a drug target, Tnfa has been studied in great detail (Cicha and Urschel 
2015. The un-validated edges show that Tnfa could be a regulator of other internal pheno-
types as well, than currently known. 
The metabolite Glutathione (GSH) was measured in the serum and in the merged network 
is a connectivity hub proving that it is vital part of the system that connects several inter-
nal phenotypes. Among the 15 connectivity hubs with functionally validated links, GSH is 
the only one that has validated links to all other data-types based on our literature mining. 
These results support our claim of GSH being a connectivity hub, a biological component 
influencing several internal phenotypes. Several PubMed results for GSH are from in-vivo 
studies where GSH was administered to alleviate symptoms of a disease. Our literature 
results show that GSH has been studied in relation to all different types of data. Of the six 
validated links in our merged network, five represent proven causal relationships (see Fig-
ure 4 and discussion of the functional validation). These neighboring nodes in the merged 
network are mostly related to immune and homeostatic mechanisms. GSH is a tripeptide, 
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ubiquitously distributed in living cells and plays an important role in the intracellular de-
fense mechanism against oxidative stress (Couto, Wood, and Barber 2016; Diaz-Vivancos 
et al. 2015. It is known that GSH metabolism is very important for the antioxidant and 
detoxifying action of the intestine. It is also essential for the maintenance of the luminal 
thiol-disulfide ratio involved in regulation mechanisms of the protein activity of epithelial 
cells (Iantomasi et al. 1997 which could be important since the intervention is changes in 
protein. Our results also demonstrate the manifold and central role of GSH when it comes 
to proteins, peptides and amino acids in nutrition. These observations indicate that the 
presented merged network represents, at least in part, associations of biological phenome-
na.  
Potential relevance of selected connectivity hubs 
There are 30 connectivity hubs in the merged network that do not co-occur with their con-
nected nodes in our literature search. However, the prominence of these nodes in our 
merged network indicates that they could represent potential relevant interactions with 
components of the other internal phenotypes. In order to demonstrate how the results of 
this study may be used to hypothesize on functional relationships between different mo-
lecular components, we here describe the potential biological relevance of two highly 
linked connectivity hubs, Tmem72 and S24-7. Both hubs are not yet described in litera-
ture abstracts in conjunction with other data-types.  
The high number of connectivity hubs in the Transcriptomics layer suggest that the ex-
pression of several intestinal genes is involved in many more interactions than currently 
known. None of the observed Transcriptomics connectivity hubs popped-up in our litera-
ture mining results. The most highly connected Transcriptomics node, Tmem72 
(Transmembrane Protein 72), has only been studied in the kidney so far (Habuka et al. 
2014 and not much information is available on it. But in the merged network this node has 
27 links to other data-types (can be visualized in Supplementary File 1), mostly to metab-
olites from both the metabolomics datasets. Based on this, we hypothesize that Tmem72 is 
not specific to the kidney and that it has some sort of communication function in intestinal 
mucosa as well. The fact that Tmem72 is a transmembrane protein is supportive for this. 
Given its observed links with different microbiota, metabolites and cytokines, it might be 
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involved in diverse interactions with other internal phenotypes. Based on such a hypothe-
sis, targeted experimental designs may be developed in order to investigate the hypothe-
sized “communication” function of Tmem72 in intestinal mucosal tissue. 
The most highly linked node of the merged network is the bacterial family classification, 
S24-7, suggesting an important role for this species in gut functionality. In some of the 
inferred individual correlation networks we already found it to be linked to a high number 
of nodes. Unfortunately, this node is not represented in literature abstracts together with 
the here observed neighbors. However, there is compelling literature that shows this mi-
crobial classification to be a significant part of the gut microbial community structure 
(Harris et al. 2014; Jakobsson et al. 2015. This family classification does not have a good 
functional definition, yet several studies show that it could be an important player in the 
functionality of the gut (Evans et al. 2014; Harris et al. 2014; Rooks et al. 2014. The latter 
claims are in line with the high number of neighbors that S24-7 has in our merged net-
work. The current technical inability to cultivate S24-7 is most certainly due to the ab-
sence of knowledge on S24-7 interactions. However, a recent in-silico study (Ormerod et 
al. 2016 shows that S24-7 species have the ability to survive on different types of carbo-
hydrate sources, similar to the genus Bifidobacteria. In the merged network, the connec-
tivity hubs S24-7 and Bifidobacteria, share the highest number of neighbors (directly 
linked nodes). Among them are 16 genes, and neither S24-7 nor Bifidobacteria have liter-
ature results with any of these genes. An enrichment analysis on these shared network 
gene neighbors shows that they are involved in functions related to linoleic and linolenic 
acid metabolism (data not shown). It is known that these fatty acids are produced by 
Bifidobacteria (Teran et al. 2015 and that they are involved in the maintenance of the epi-
dermal barrier function (Muñoz-Garcia et al. 2014. The observation that in our network 
these genes are shared between S24-7 and Bifidobacteria underscores the here hypothe-
sized importance of S24-7 and indicates that these two bacterial groups are indeed closely 
related in function as hypothesized before (Ormerod et al. 2016. 
From the results described in this paper, we conclude that we successfully developed 
methodologies to identify components in internal phenotypic layers that are connected to 
components in other internal phenotypic layers. By integrating multi-scale quantitative (-
omics) data using a regression approach, we were able to provide provisional insight into 
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potential ways internal phenotypic layers are connected to each other, including those 
between local and systemic layers. By a technical and functional validations, we under-
scored the relevance of our findings. Based on data generated by this type of integrated 
approaches, hypothesis driven and targeted research may be developed to identify causal 
relationships between various biological scales in order to diminish our knowledge gap 
between genotype and external phenotype. In addition, by expanding comparable ap-
proaches by incorporating data on genetic diversity and/or variation in external pheno-
types, this knowledge gap may be even further closed down. The analysis pipeline that we 
developed is very general and can easily be applied to any other type or number of data 
sets. 
Availability of data and materials 
Transcriptomics data has been uploaded into GEO with the accession number GSE84442. 
The microbiota data, the two metabolomics datasets and the cytokine data are available on 
request. 
The R scripts using functions from existing R packages are also available on request. 
Supplementary files: 
All supplementary files are also available at http://semantics.systemsbiology.nl/index.php/
data-sets-used-in-pubblications/ 
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Supplementary Figure S1. 10 correlation networks. The images show the 10 networks 
from pairwise integration of 5 datasets. The colours indicate different types of data, pink 
is Microbiota, red is Transcriptomics, blue is Cytokines, and green is Metabolites (light 
green – Metabolite Serum and dark green – Metabolite Urine). 
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Supplementary Figure S2: Distribution of network correlations and random net-
work cut-offs of all 10 networks. The x-axis of all these graphs has the range of correla-
tion values, the y- axis the frequency of the correlation values. The grey bars denote the 
distribution of the cut-offs of the thousand random correlation networks. The red bars are 
distributions of the correlation values of the real networks. The y-axis on the left has the 
frequency of the random network cut-offs and the y-axis on the right has the frequency of 
the real network correlations. 
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Supplementary File 1 
This file is a zipped file that contains the 10 individual networks and the merged network 
that can be loaded into Cytoscape.  
Supplementary Table 1: Connectivity hubs. This table has the names and details of 45 
nodes from the merged network that have connections to the other four types of data. 
Their degree in the network is also shown in the third column.  
Supplementary Table 2: Literature connections. This table shows the 37 literature con-
nections that are found in the co-occurrence search of the merged network edges.  
All the supplementary data is available at  http://semantics.systemsbiology.nl/index.php/
data-sets-used-in-pubblications/ 
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Abstract  
Biological pathways are increasingly available in the BioPAX format which uses an RDF 
model for data storage. One can retrieve the information in this data model in the scripting 
language R using the package rBiopaxParser, which converts the BioPAX format to one 
readable in R. It also has a function to build a regulatory network from the pathway infor-
mation. Here we describe an extension of this function. The new function allows to build 
graphs of entire pathways, including regulated as well as non-regulated elements, and 
therefore provides a maximum of information. This function is available as part of the 
rBiopaxParser distribution from Bioconductor. 
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BioPAX, RDF, R, rBiopaxParser, Reactome 
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Introduction 
Biological pathways represent signalling and/or metabolic events involving protein and 
non-protein molecules. They are increasingly used in gene and protein expression studies 
to provide an aggregate score for gene sets encoding for defined biological events (Mitrea 
et al. 2013. Several pathway databases, either curated or not, have adopted the BioPAX 
[RRID:SCR_009881] (Biological Pathway Exchange) language as a standard for pathway 
representation using the RDF (Resource Description Framework) data model (Demir et al. 
2010. 
The structure of BioPAX is founded upon groupings, called classes, for physical entities 
and interactions with hierarchical networks of their sub-classes. Interactions between 
physical entities are represented such that conjoint interactions may form a specific path-
way with defined, but different types of interactions between the involved physical enti-
ties. The BioPAX format is being actively developed, with BioPAX level 2 format focus-
ing on metabolic pathways and BioPAX level 3 introducing full support for signaling 
pathways. 
SPARQL (Simple Protocol And RDF Query Language) is a query language able to re-
trieve and manipulate data stored in RDF. Pathway information is often combined with 
statistical data analysis using tools such as R (Kramer, Bayerlová, and Beißbarth 2014. 
The rBiopaxParser [RRID:SCR_002744] 4 is an R package to retrieve data stored in a 
BioPAX RDF format. It comes with several options that are useful to probe the data and 
extract specific information from it, for example participants of a pathway, stoichiometric 
conditions to be fulfilled for an interaction, etc. 
One such option is the pathway2RegulatoryGraph (P2RG) function that converts a path-
way into a graphical structure. This is extremely useful for visual representation and sub-
sequent graph-based network analysis. The P2RG function returns the parts of a pathway 
that are regulated (activated or inhibited) by proteins or protein complexes which is im-
portant to understand the role of regulated proteins in pathways. Here we present an adap-
tation of P2RG, denoted pathway2Graph (P2G) which can be used to build a graph of the 
entire pathway, including the regulated as well as the non-regulated elements. This new 
function expands P2RG and can be used to investigate all different types of processes and 
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connections of pathways instead of only studying the regulated elements of pathways. 
P2RG retrieves regulatory interactions, such as inhibitions and activations, the new P2G 
additionally retrieves protein modifications, such as translocations or complex formation, 
like the ones shown in Figure 1.  
Figure 1. Hypothetical pathway. This cartoon of a pathway shows examples of nodes and edges 
that could be encountered in a BioPAX database. The nodes are proteins, complexes or other physi-
cal entities and the edges are interactions between the nodes, that represent either interactions 
among proteins or protein modifications. The solid edges are those detected by the P2RG function 
and the solid and dashed edges are detected by the P2G function. 
P2G is specifically aimed at retrieving results from Reactome BioPAX level 3. In this 
paper we describe detailed information on this function which, we believe, will help rBi-
opaxParser users to better understand the graphs generated from pathway information. We 
have verified P2G results by directly querying the original BioPAX data using SPARQL. 
Methods and Results 
The classes of PhysicalEntity and Interaction that are used in Reactome v51 to represent 
information on pathways are shown in Figure 2. This graph was generated using the tool 
RDF2Graph 5 on the Reactome Level 3 RDF file. The nodes in Figure 2 represent classes 
and the edges show the possible relationships, called predicates, these classes could have 
in the database. As depicted in Figure 2 the node Pathway could have one or more Path-
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waySteps that consist of different types of Interaction sub-classes. All the Interaction 
nodes shown in Figure 2 describe interactions between PhysicalEntities, hence are con-
nected to them by particular types of predicates as indicated in the edge labels. The Inter-
action classes are interconnected because they can be dependent on each other. The Con-
trol interaction and its sub-classes (Catalysis and Modulation) represent signaling events. 
They regulate BiochemicalReaction and Degradation interactions which mostly represent 
metabolic reactions. 
 Figure 2. Interplay of classes in Reactome BioPAX. This figure shows a network of the Interac-
tion and PhysicalEntity classes that are a part of a pathway in Reactome v51 BioPAX level 3. Nodes 
are classes and the directed edges are links between them in the database. The green nodes are the 
Pathway and PathwayStep classes, the blue nodes are Interaction classes and orange nodes are Phys-
icalEntity classes. 
To create a regulatory graph, the P2RG function starts with the Control, Catalysis and 
Modulation interactions that are either activating or inhibiting other interactions. This 
method provides a graph with plenty of information on the regulatory components of the 
pathway. The nodes of this graph are physical entities like Proteins or SmallMolecules 
and the directed edges are either activation or inhibition events. An example of such a 
reconstruction is shown in Figure 1, where P2RG is able to retrieve the black nodes and 
the continuous edges. However, interactions can be missed if they are not regulated by the 
Control interactions and could result in the loss of valuable information in the graphical 
representation of the pathway. 
The new function P2G can start with any type of interaction in order to obtain a graph 
with all possible physical entities involved in the pathway. Similar to the result of the 
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P2RG function, the P2G function gives a graph with nodes that are physical entities, but 
the edges are not strictly activation or inhibition events. The directed edges could repre-
sent several types of events like translocation of a protein or cleavage of DNA, these are 
shown as dis-continuous edges in the cartoon in Figure 1. The P2G function recognizes 
the continuous and the dis-continuous edges and thus retrieves the black as well as the red 
nodes shown in Figure 1. In some cases there is more than one documented connection 
between the same physical entities. In this case only the first connection is used as an edge 
in the final pathway graph. 
Comparison of two methods: P2G vs P2RG 
The Reactome database (v51) categorizes pathways into 27 branches. Here we worked 
with pathways that have more than one interaction, which resulted in 1,666 pathways. 
Using P2RG, graphs for 1,548 pathways were retrieved. By using the new P2G function, 
we were able to retrieve information on all 1,666 pathways. The highest number of path-
ways were obtained, using either method, in the “Disease” category (P2RG: 3,396 path-
ways, P2G: 4,888 pathways). In 85% of the cases, pathways retrieved using P2G consist-
ed of more physical entities (nodes) than those retrieved using P2RG. 19% of the P2G 
retrieved pathways have at least twice the number of nodes, and 60% have at least twice 
the number of interactions between nodes (edges) as compared to the P2RG version, Fig-
ure 3 is an example of this difference. Total numbers of nodes and edges in major Reac-
tome categories are given in Table 1. Missing information causes the appearance of dis-
connected graphs when reconstructing pathways. By using the new P2G function, the per-
centage of disconnected pathways is reduced by 9%. Additionally, P2G also has the op-
tion of only retrieving the largest connected component, for example with this option, in 
Figure 3.A only the top left part of the graph will be retrieved and the disconnected graphs 
discarded. The pathways have directed edges because most of the interactions have direc-
tion. Edges without a direction are represented as bidirectional edges in the output of P2G. 
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Table 1. Numbers of nodes and edges. The number of nodes and edges of ten different pathways 
(Reactome Categories) are indicated as obtained after application of P2RG and P2G on the same set 
of BioPAX RDF information. 
 
As an example, we discuss here the ‘Apoptosis induced DNA fragmentation’ pathway, 
which is a pathway in the “Programmed Cell Death’ category (Figure 3). When the infor-
mation in the BioPAX file is reconstructed with the P2RG function, the pathway has sev-
en nodes (Figure 3.B); with the P2G function the same pathway has 16 more nodes 
(Figure 3.A). Detailed information on these nodes, as retrieved with P2G and P2RG, is 
given in Table 2 and demonstrates the additional information retrieved by P2G. The node 
‘Complex4169’, which is found in the cytosol, translocates to the nucleus where it is 
called ‘Complex4238’. However, this information is only available from the P2G function 
because the node ‘Complex4169’ does not regulate any other interaction or node. The 
presence of extra nodes in the P2G retrieved graph (Figure 3) also visualize that 
‘Complex4240’ breaks up into its’ individual components after being cleaved by Caspase-
3 (‘Complex4238). This extra information is very useful for researchers analyzing the 
Reactome Categories P2RG  
Nodes 
P2RG  
Edges 
P2G  
Nodes 
P2G  
Edges 
Binding and Uptake of Ligands  
by Scavenger Receptors 
0 0 68 56 
Cell-Cell communication 13 14 142 142 
Disease 3,396 5,878 4,888 12,159 
Gene Expression 652 900 1,110 2,450 
Immune System 1,431 2,233 2,419 5,045 
Membrane Trafficking 86 121 181 382 
Metabolism 3,082 5,922 3,479 11,289 
Signaling Pathways 2,069 3,274 3,430 7,131 
Steroid hormones 72 147 81 333 
Transcription 281 420 623 1,324 
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phenomen represented by the pathway. In case P2G retrieved pathway graphs are used for 
analysis (e.g, differential gene expression analysis) the presence of these extra nodes may 
improve biological interpretation of experimental data. 
Figure 3. Graphs of the pathway ‘Apoptosis induced DNA fragmentation’. Both graphs were 
extracted from the same BioPAX file. A) Graph recovered using the new P2G function; B) Graph 
recovered using P2RG function. In both panels blue nodes are proteins or protein complexes, white 
nodes are non-protein entities. Black encircled nodes are found in both graphs and red encircled 
nodes are only detected with the new P2G function. Names of the nodes are in Table 2. 
 
Table 2: Node names and locations of the “Apoptosis induced DNA fragmentation” pathway. 
The first column has the names of the nodes in the pathways depicted in Figure 3. The second col-
umn has the actual name of the node and the third column the cellular location of the node. All this 
information is represented as given in Reactome version 51. The nodes shown with a black outline 
in Figure 3 are shown here in bold font. 
Node Name Location 
Protein8776 DFFB Cytosol 
Protein8777 DFFA Cytosol 
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Complex4232 DFFA : DFFB  Cytosol 
Complex4233 Importin alpha : Importin beta  Cytosol 
Complex4234 DFF : associated with Importin al-
pha : Importin beta  
Cytosol 
Complex4235 DFF : associated with Importin al-
pha : Importin beta  
Nucleoplasm 
Complex4169 Active CASP3  Cytosol 
Complex4238 Active CASP3  Nucleoplasm 
Complex4236 DFFA : DFFB  Nucleoplasm 
Complex4239 Caspase cleaved DFFA  Nucleoplasm 
Complex4240 Caspase cleaved DFFA : DFFB  Nucleoplasm 
Protein8779 DFFB  Nucleoplasm 
Protein8784 DFFA fragment  Nucleoplasm 
Protein8785 DFFA fragment  Nucleoplasm 
Protein8783 DFFA fragment  Nucleoplasm 
Complex4241 DFFB homodimer  Nucleoplasm 
PhysicalEntity567 DFFB homodimer/homooligomer  Nucleoplasm 
Complex2061 Histone H1 bound chromatin DNA  Nucleoplasm 
Complex4242 DFFB associated with chromatin  Nucleoplasm 
Protein8786 HMGB1/HMGB2  Nucleoplasm 
PhysicalEntity109 DNA  Nucleoplasm 
Complex4243 HMGB1/HMGB2 – bound chromatin  Nucleoplasm 
Complex4244 DFF cleaved DNA  Nucleoplasm 
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Conclusion 
P2G is a useful addition to the rBiopaxParser package because it retrieves all the compo-
nents of a pathway from the database and provides complete graphical information for 
both signaling as well as metabolic pathways. The P2G function (pathway2Graph) is cur-
rently available in the rBiopaxParser package in the Bioconductor 3.4 release.  
Data availability 
The input data for this package is the BioPAX format of any pathway database. We used 
the Reactome database which is freely available for download in different formats from 
the website www.reactome.org. A subset of this database is given as Supplementary file 1. 
Software availability 
The function pathway2Graph is available in the latest version of the R package rBiopax-
Parser and can be installed from Bioconductor. 
Archived source code as at the time of publication: http://dx.doi.org/10.5281/
zenodo.61618 6  
Software license: GPL-2  
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Supplementary material 
Subset of Reactome database.  
This .owl file contains information on four pathways from the Reactome v51 BioPAX 
level 3 database. This format can be loaded into the R environment using the rBiopaxPar-
ser package and used to test the P2G function and obtain graphs which were used as the 
basis for Figure 2. More information on loading and processing this file format can be 
found in the package documentation. 
Supplementary material can be accessed at https://f1000research.com/articles/5-2414/v2 
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Abstract: 
The mammalian intestine is a complex biological system that plays an important role in 
the processing of a high diversity of nutritional and environmental stimuli. These stimuli 
may alter the functioning of the intestine and elicit different responses from the intestinal 
mucosal tissue to maintain gut homeostasis. This variety of responses requires a high 
functional plasticity for the intestinal mucosal tissue. In order to improve our understand-
ing of the underlying mechanisms of this plasticity, we performed a high-level data inte-
gration of 14 whole-genome transcriptomics datasets from samples of intestinal mouse 
mucosae. The data integration was not performed at the level of individual gene expres-
sion but on pathway expression. The gene expression datasets were obtained from open 
access databases and derived from 14 independent experiments that satisfied all our selec-
tion criteria. We used a customized version of the pathway analysis tool CePa (Centrality 
based Pathway Analysis), along with pathway information extracted from the Reactome 
database. The results of pairwise comparisons were combined to obtain an integrated pic-
ture of gut mucosal responses in mice, orally challenged with biological, chemical or die-
tary agents which are expected to perturb intestinal homeostasis.  
The results of this high-level integrated pathway analysis show that the mucosal tissue 
uses a common set of pathways to respond to the three classes of stimuli. Based on these 
results we designed and executed an in vitro experiment on intestinal organoids to verify 
that the pathway modulation is the result of local changes. We conclude that the function-
al plasticity of intestinal mucosal tissue can be explained, at least partially, by variation in 
the pathway sets that are regulated by different challenges and by the induction of intra-
pathway specific gene expression patterns.  
 
Keywords: 
Gastrointestinal tract, gene expression, functional plasticity, pathway analysis 
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Introduction 
The mammalian gastro-intestinal tract is crucial for the digestion and absorption of nutri-
ents, while maintaining a peaceful co-existence with the microbial symbionts and avoiding 
infection from enteric pathogens. The intestinal epithelium plays an important role in or-
chestrating innate defences (Wells et al. 2017; Peterson and Artis 2014 and signalling to 
the numerous cells of the immune system located underneath the epithelial layer (Wells, 
Loonen, and Karczewski 2010; Akira and Takeda 2004; Sharma, Young, and Neu 2010. 
The chemical and physical defences of the intestinal mucosa, such as antimicrobial pep-
tides, REG3 proteins, mucins and secreted mucus, often referred to as the “gut barrier,” 
provide the first line of defence the against colonisation and invasion by intestinal bacteria 
(Lodish et al. 2000; Henderson et al. 2011; Peterson and Artis 2014; Wells et al. 2017; 
Rossi, van Baarlen, and Wells 2011. Besides these innate defence mechanisms, a number 
of tolerance mechanisms exist to maintain homeostasis and prevent chronic inflammatory 
responses to antigens from food/feed or commensal microbes (O’Hara and Shanahan 
2006. Chronic perturbations in homeostasis can lead to hyperpermeability of the gut barri-
er, contributing to the pathogenesis of several gastrointestinal disorders, including IBD, 
celiac disease, IBS, and food allergy (Bischoff et al. 2014.  
The intestinal mucosa is exposed to a variety of different components: diverse types of 
nutrients (including proteins, fats, carbohydrates, minerals, vitamins); commensal micro-
biota (bacteria, viruses); (opportunistic) pathogens and orally taken drugs such as antibiot-
ics. After passage through the stomach, food is digested by pancreatic and small intestinal 
enzymes. Microbiota in the small intestine also metabolise nutrients generated by the di-
gestive process and produce certain vitamins absorbed by the host. Changes in the diet 
composition, e.g. high fat diets, can drastically change the community structure of the 
intestinal microbiota (Serino et al. 2012, but also the mucosal gene expression of the host 
(de Wit et al. 2011. Dietary fibres which are not digested in the small intestine are fer-
mented by a consortia of microbiota in the colon, resulting in the production of short-
chain fatty acids and other metabolites which impact the intestinal physiology and immun-
ity (Van den Abbeele et al. 2011; C. J. Kelly et al. 2015; Burger-van Paassen et al. 2009; 
P. M. Smith et al. 2013; Segain et al. 2000. Gastrointestinal physiology is also known to 
be sensitive to the administration of certain drugs (Willing, Russell, and Finlay 2011; 
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Niewold 2007; Schokker et al. 2014; Schokker et al. 2015, emotional stress (Emeran A 
Mayer, Savidge, and Shulman 2014; Collins and Bercik 2009, and many other environ-
mental factors.  
The gut functionalities as described above, cannot be explained by the activity of single 
genes alone, they are often attributed to groups of genes (Mootha et al. 2003 based on 
their annotation. Such gene-sets (Ashburner et al. 2000 or pathways (Kanehisa and Goto 
2000; Croft et al. 2014; Fabregat et al. 2016 can be regarded as representations of func-
tional building blocks that, in different combinations, may be used to respond to challeng-
es such as infections or toxins, and restore homeostasis once the threat has subsided. We 
hypothesized that each type of challenge requires a different combination of pathways, 
each at a specific expression level, to restore homeostasis. 
An adequate response of the intestinal mucosa to the exposure to diverse components, 
requires a high-level of functional plasticity that is expected to be much higher than the 
liver and kidney which are specialised for a particular function. This theory is supported 
by data present in the human protein atlas (Uhlén et al. 2015; Fagerberg et al. 2014, which 
provides an overview of gene expression profiles in different tissues. Genes mainly ex-
pressed in specialized tissues like the heart, liver and kidney are related to a narrow range 
of functions. The heart tissue specifically expresses genes related to contraction and re-
generation functions (Lindskog et al. 2015. Genes with higher expression in the kidney 
than other measured organs are involved in transport and absorption functions (Habuka et 
al. 2014 and genes with higher expression in the liver compared to other organs are in-
volved in immune and metabolic processes and growth (Kampf et al. 2014. The number of 
genes, specifically expressed in gut mucosal tissues is higher than that in heart, liver, kid-
ney and they are involved in a wider variety of functions, nutrient breakdown, transport 
and metabolism, enteroendocrine system, host protection and maintenance of tissue mor-
phology (Gremel et al. 2015.  
Responses of intestinal mucosal tissues to individual stimuli or perturbations have been 
documented widely in literature in terms of gene expression data (Kar et al. 2016; 
Reikvam et al. 2011; Schokker et al. 2014. However, little is known yet with regard to the 
differences and commonalities in the functional genomic information used by the mucosal 
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tissue to display its extreme functional plasticity. A major driver in the understanding of 
this plasticity is the current trend to develop (dietary) interventions to stimulate intestinal 
health. Therefore, it might be useful to investigate the functional plasticity of mucosal 
tissues at the genomic level in terms of pathways. Such an approach may help to identify 
key sets of biosynthetic and signalling pathways involved in the various mucosal respons-
es and to identify the commonalities and differences in the use of pathways between the 
various responses.  
The objective of this study was to identify pathways expressed in intestinal mucosal tissue 
that are regulated by different types of challenges (e.g. dietary, infectious/immune, and 
drugs) in order to identify commonalities and differences in the use of pathways to display 
the challenge-specific tissue responses. The ultimate aim is to understand the functional 
plasticity of the mucosal tissue in more detail. To perform this study, we used publicly 
available gene expression datasets generated from mouse intestinal tissues exposed to 
orally administered challenges.  
Materials and Methods 
Datasets 
With the R tool GEOmetadb (Zhu et al. 2008 we searched Gene Expression Omnibus 
(GEO) (Edgar, Domrachev, and Lash 2002; Barrett et al. 2013 for publicly available da-
tasets generated from intestinal samples of mice. Among the 450 experiments available 
(as of 07-07-2015) we only selected 14 experiments (17 GEO datasets) on wild-type mice 
where the tissue of any section of the intestine was sampled after weaning. These experi-
ments all used single channel microarrays with at least 3 biological replicates and were 
published on GEO between 2006 and 2014. Except for 3 of the datasets that were meas-
ured using Illumina microarrays, all the others were performed on different versions of 
Affymetrix. Most of the experimental data were obtained from inbred C57BL6J mice, but 
there were two experiments that used BALB/c mice, one that used the 129S1/svlmj mouse 
strain and another that used IQI mice. 
There were 2 experiments where the fat content of the diet was increased by reducing the 
carbohydrate portion of the diet (de Wit et al. 2011; Desmarchelier et al. 2012. The former 
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experiment gave 3 different levels of fat (20%, 30% and 45% of total energy in the diet) to 
the mice and measured the response in 3 sections of the small intestine. The latter used fat 
for 60% of the energy from the diet and measured 2 sections of the small intestine. One 
experiment tested 5 different fibres which were substituted for part of the corn starch in 
the diet and the transcriptomics data was generated from the colon (Lange et al. 2015. The 
rest of the dietary interventions were additives or supplements to the mouse diet. In one 
experiment, dietary heme was added to a high fat diet and the response was measured in 
the colon (IJssennagger et al. 2012. In another experiment quercetin was added to the 
standard diet and the response was measured in 2 parts of the small intestine (jejunum and 
ileum), as well as in the colon (Mutch et al. 2006. Another experiment added a synthetic 
PPARα agonist to the diet and a microarray analysis was performed on the small intestine 
(Bünger et al. 2007. One experiment tested a probiotic on 2 strains of mice and 2 sections 
of the intestine (small and large intestine) (Mariman et al. 2015. There are 3 experiments 
where a drug was administered to the animals. In one of these experiments a herbal drug 
was tested on wild-type and specific pathogen free mice, and the response measured in the 
small intestine and colon (Munakata et al. 2012. The other 2 drug experiments involved 
administration of antibiotics. One study utilised a mix of several antibiotics to strongly 
deplete the abundance of gut bacteria, and investigated gene expression in the colon 
(Reikvam et al. 2012. In the other experiment with antibiotics a low dose of penicillin was 
administered daily to the animals from an early age and also changed the diet to measure 
the response in the small intestine (Cox et al. 2015. The Immune challenge experiments 
involved infectious challenge with Salmonella typhimurium (Liu et al. 2010 or the parasite 
Giardia Duodenalis (Tako et al. 2013. Additionally, the effect of flagellin from Salmonel-
la enterica serovar Typhi (Carvalho et al. 2012 on severity of DSS-induced colitis was 
investigated (Ahmad et al. 2014. In the experiment involving G. Duodenalis the small 
intestine was sampled, whereas the colon was sampled for the other immune challenges. 
More details on the experimental conditions and the control conditions can also be found 
in Supplementary Table 1. 
Data pre-processing 
Using GEOQuery (Davis and Meltzer 2007, we downloaded normalised datasets of prese-
lected experiments from GEO. In each experiment the normalization was performed with 
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one of the following methods, GCRMA, RMA, MAS5 or quantile normalization. Our 
high-level integration approach does not require uniform normalization, so in each case 
we preferred the method chosen by the authors of the original study. The probes were 
mapped to mouse Entrez identifiers using the annotation files from the platform that was 
used for microarray analysis. After a quality check using Principle Component Analysis 
plots, these mice gene identifiers were then mapped to their human homologs using the 
NCBI HomoloGene database [RRID:SCR_002924].  
Pathway Database 
The analysis of all the datasets was done using pathways from the Reactome database 
[RRID:SCR_003485], a freely accessible and a manually curated database available in 
different formats. Pathways from Reactome were downloaded in the BioPAX 
[RRID:SCR_009881] (Biological Pathway Exchange) (Demir et al. 2010 format (version 
51) from the official website. These pathways were then converted to a pathway catalogue 
object in R that can be used by the pathway analysis algorithm. This was accomplished by 
using the pathway2Graph function from the R package rBiopaxParser 
[RRID:SCR_002744] (Benis et al. 2016; Kramer et al. 2013.  
Pathway analysis 
We used a modified version of the algorithm CePa (Centrality based Pathway analysis) 
which uses pathways as networks where the nodes in a pathway could be small molecules 
(compounds), macro-molecules (proteins or RNA) or complexes (more than one protein). 
The topological information of the pathway is used to assign weights to each node using 
centralities. The user can choose between one of 4 centrality measures, in-degree (number 
of edges that are directed towards the node), out-degree (number of edges that are directed 
outwards from the node), in-reach (longest path that brings information to the node) and 
out-reach (longest path that directs out of the node), with another option of giving equal 
weight to all nodes. This centrality information is used along with the expression data to 
give a list of significantly enriched pathways for given conditions.  
The gene expression data is mapped to the nodes of the pathways, when the node is a pro-
tein the expression value of the corresponding gene is used as such. When the node is a 
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complex, the largest component from a Principle Component Analysis of the expression 
values of all the corresponding proteins is assigned as the node expression value. Subse-
quently, these expression values are inputted in a t-statistic to obtain a differential ex-
pression value for each node, which can be positive or negative based on the up- or down
-regulation of that protein. This differential node value is multiplied with the centrality 
based weight of the node to obtain a final node value. This calculation is performed for 
each of the nodes in the pathway and all these values are averaged to obtain a pathway 
level score. The pathway level score is then tested for significance by substituting ran-
dom expression values in the same pathway calculations. This p-value calculation was 
modified from the original CePa function which randomizes the samples of the tested 
conditions. As we work with a minimum of 3 samples per condition, we modified this 
calculation to be able to handle smaller sample sizes. Because the hierarchical nature of 
the pathway database implies dependence between the pathways, we decided not to per-
form a multiple testing correction. 
We weighted the nodes with the in-reach and out-reach centrality calculations, because 
they assign higher weights to the nodes down-stream and up-stream of the pathway re-
spectively. In this way, we can capture signalling pathways, where the effectors are more 
likely to be down-stream of the pathway. However, we did not rule out the metabolic 
pathways where the enzymes are generally up-stream in a pathway. The threshold of the 
p-values was set at 0.01 to compensate for the lack of multiple testing correction. 
Intestinal organoid cultures 
3-D organoids grown from murine small intestine as described before in (T. Sato et al. 
2009; T. Sato et al. 2011; Dekkers et al. 2013. Briefly, a 2cm duodenal section was 
opened longitudinally and washed in ice-cold phosphate-buffered saline solution (PBS). 
After scraping excess villi, the tissue was transferred to PBS containing 2.5 mM EDTA 
and incubated for 30 minutes. Following incubation, the sections were washed with PBS 
and remaining residue was passed on a 70 μm cell strainer, pelleted at 300 x g for 5 
minutes, and suspended in matrigel basement membrane (Growth factor reduced, Corn-
ing) at a density of 50-100 crypts per 50 μl. After inversed polymerization at 37 ⁰C for > 
10 minutes, 600 μl basal culture medium (DMEM/F12) was added, enriched with mouse 
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EGF, Hepes 1M (Invitrogen), N-acetylcysteine (Sigma), B-27 (Thermo-Fisher), Noggin, 
and R-spondin. The culture was passaged 1:4 every 7 days by mechanical disruption, and 
re-suspended in fresh matrigel. All experiments were performed after 2 passages of the 
organoid cultures. 
Stimulation of organoids and reverse transcriptase-quantitative PCR. 
3-D organoids were stimulated with TNFα (10 ng/ml), a PPARα agonist (WY14643 0.1% 
v/v), and flagellin (200 ng/ml) for 6 hours before total RNA was extracted with the Qi-
agen mini-kit according to manufacturer’s instructions along with a 15 minutes DNAse 
step. Purity and integrity measurements were performed on a DS-11 spectrophotometer 
(DeNovix) and 1 μg total RNA was reverse transcribed into cDNA using a QScript kit 
(Quantabio). Quantification of gene expression (RT-qPCR) was performed using a Rotor-
gene Q2 plex RT-cycler (Qiagen) on primers specified in Table 1 with the rotor-gene 
SYBR green PCR kit. These genes were selected based on their representative contribu-
tion to the pathway ‘Regulation of Complement Cascade’. Relative expression levels were 
calculated following methods described in (Schmittgen and Livak 2008 using individual 
amplification values, with 18S and β-Actin as endogenous control genes for normaliza-
tion.  
Table 1. Primers used for RT-qPCR. The information on the primers used to quantify 10 genes is 
given in each row along with the publication from which this sequence was obtained. 
Gene Forward Reverse AT 
(⁰C) 
Amplicon 
(bp) 
Ref 
C2 CTCATCCGCGTTTA
CTCCAT 
TGTTCTGTTCGATG
CTCAGG 
60 178 (Li et al. 
2016) 
C3 AGAGGTCATCAAGT
CAGGC 
GATGTAGCTGGTGT
TGGGCT 
60 167 (Li et al. 
2016) 
C5 AGGGTACTTT-
GCCTGCTGAA 
TGTGAAGGTGCTCT
TGGATG 
60 173 (Li et al. 
2016) 
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Results 
Intestinal gene expression datasets 
Based on the stimuli in the 14 experiments, we classified the interventions into three 
broad stimulation categories: Diet; Drug; and Immune Challenge. Seven of the experi-
ments had dietary interventions with changes either in the composition of the diet or with 
additives (non-immune and non-drug) in the diet and were placed in the Diet category. In 
the ‘Drug’ category there were 3 experiments, one with a Japanese herbal drug and two 
with antibiotics. The Immune Challenge category consisted of 4 experiments performed 
with infectious or inflammatory stimuli. Information on the age of the animals during the 
intervention/challenge period and sampling time is indicated in Figure 1. These 14 experi-
ments comprised of 37 experimental conditions, where a condition is defined as a unique 
combination of an inbred mouse strain, a stimulus and intestinal tissue sectioned at a spe-
cific time point, as depicted in Figure 1.  
 
Cfh CGTGAATGTGGTG-
CAGATGGG 
AGAATTTCCACACAT
CGTGGCT 
60 248 (Li et al. 
2016) 
Cfi TTCCAC-
TGGGTGTTCGTGAC 
TAAAGGCACAC-
TCCGCCAAA 
60 126 (Li et al. 
2016) 
Cd46 CCAGGGCCAGA-
TAAGTTTTC 
TATTTCGCCAGCTCC
TGATA 
60 153 (Li et al. 
2016) 
Cd55 CTCTGTT-
GCTGCTGTCCC 
CGAATAA-
TATGCCGGTTG 
60 477 (Nie et al. 
2015) 
Cd59 TAAGTGAG-
TTCCTGGCAACC 
AGGGCCTGTGAA-
GATTATGA 
60 152 (Li et al. 
2016) 
Cr2 CCTGCTCCTCTCTG-
TAAACT 
GATCTGACTGCTTCC
ACTCA 
60 162 (Li et al. 
2016) 
C8g CTGGCTCCTT-
GTGGCTGT 
CGAAACTCTGGTAG-
TCGGTCTC 
60 257 Author 
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Figure 1. Experimental datasets: The 37 conditions from 14 experiments (with 17 GEO accession 
numbers) used in this study are detailed in a timeline of the age of the mice in the experiment. Mice 
of varying ages can be selected for the same experimental group if they weigh the same, this varia-
tion in ages is shown with empty and filled stars and triangles. The stars and triangles denote the 
start and end of the interventions respectively. Challenges have been divided in three categories 
(colour coded): Diet, Drug and Immune challenge. The names given for each dataset are abbreviated 
to show the challenge category in the first part of the name, the tissue sampled at the end (SI: small 
intestine; C: colon) and the text in the middle indicates the nature of challenge. Additional detailed 
115 
Chapter 5 
 
5 
explanations for the abbreviated condition names and the control conditions are given in Supple-
mentary Table 1. 
Pathway database 
We employed the freely available and manually curated pathway database Reactome ver-
sion 51. All pathways are made up of several interactions between different entities in-
cluding proteins, complexes, and DNA. In the Reactome database, pathways are arranged 
in a hierarchy, larger ‘root’ pathways consist of more and more specific pathways, ending 
in several ‘leaf’ pathways. This hierarchy is depicted in a simplified cartoon in the inset of 
Figure 2. The main image in Figure 2 shows a network of all the root pathways in Reac-
tome version 51. These 27 root pathways contain 1,639 pathways within their hierarchy, 
of which 950 are leaf pathways. All individual pathways can belong to more than 1 root 
pathway. These shared pathways are shown as edges in Figure 2. Disease and Metabolism 
are root pathways that have the largest number of leaf pathways. There are several other 
roots with smaller numbers of member pathways as shown in Figure 2. 
Figure 2. Network of Reactome root pathway. The nodes in this network represent the 27 root 
pathways as present in Reactome v51 and the edges indicate the ‘leaf’ pathways shared by connect-
ed root pathways. The thickness of the edges indicates the number of leaf pathways shared by the 
nodes. The nodes are labelled with the names of the root pathways and the number of enclosed leaf 
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pathways is given between brackets. The inset shows a simplified example of root and leaf path-
ways, where the cartoon has one root pathway with 3 leaf pathways. 
 
Significant pathway results for all the datasets 
Pathway analyses were performed on the gathered datasets using the modified version of 
the CePa algorithm in order to identify pathways that are specifically regulated by the 
challenges. Each analysis was performed on single comparisons, where a comparison is 
made between a stimulated condition versus the control in that experiment. In the 
collection of datasets used in this study, we compared 37 stimulated conditions against 
their respective controls. Most of the conditions (25) belong to the Diet category, 5 are 
from the Drug category, and the remaining 7 from the Immune Challenge category 
(Figure 1). Leaf pathways enriched in differentially expressed were considered 
significantly regulated and were compared between challenge categories. Over all 37 
conditions, 1,351 pathways were significantly enriched and 710 are leaf pathways 
belonging to 21 root pathways. The majority of these leaf pathways (84%) were signifi-
cant in both centrality measures whereas about 11% were significant only in the ‘in reach’ 
centrality and 5% significant in only the ‘out-reach’ centrality. An overview of these 
significant leaf pathways, irrespective of the centralities, is shown in the heatmap in 
Figure 3. The number of signifcantly regulated pathways for each condition is highly 
variable, with the maximum being 377 from the experiment with Heme 
(Diet.Add.Heme.C) and the minimum being 37 in the experiment where 20% of the 
energy in the diet came from fat (Diet.Fat.20.P.SI). The average number of signifcantly 
regulated pathways is highest in the conditions belonging to the Diet category with 132 
pathways, second highest is Immune Challenge with 101 pathways followed by Drug with 
87 pathways on average. Many of these results were concentrated in 3 root pathways, 
‘Disease’, ‘Metabolism’ and ‘Signalling Pathways’ (see Figure 3) which have the highest 
number of leaf pathways in the database. The root ‘Steroid Hormones’ is signifcantly 
regulated in only 7 of the 37 conditions.  
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Figure 3. Significant leaf pathways arranged in their respective root pathways. Each row repre-
sents the results of the pathway analysis of one experimental condition versus its respective control. 
Each square in the heatmap represents the number of significant pathways in one root whose name 
is indicated at the bottom of each column. Darker squares indicate a higher number of pathways in a 
category. Conditions are colour coded according to the type of challenges as done in Figure 1. 
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Comparison of the three categories 
The results of all the experimental conditions within a category were compared to the re-
sults of the other challenge categories. There was a large overlap in the results between 
the three classes (Figure 4). In addition, there were several pathways unique to each chal-
lenge category, the largest number of pathways were identified in the Diet category, 
which had the largest number of experimental conditions. The pathways ‘PKA activation’ 
and ‘DARPP-32 events’ are two examples of pathways which were only significant in 
experiments in the Diet category. These pathways are from the roots Signalling Pathways, 
with PKA activation also belonging to the roots Disease and Immune System. Another 
example of a pathway unique to Diet is ‘Glutathione synthesis and recycling’ which is 
significant in 7 of the 25 dietary conditions.  
The number of pathways unique to Drug and Immune Challenge was less than in the Diet 
category. The root pathway Neuronal System has only some significant pathways that are 
unique to the Drug category. Two recurring pathways in experiments within the Drug 
category were ‘Glutamate neurotransmitter release cycle’ and ‘Acetylcholine neurotrans-
mitter cycle’, which share several interactions. The Immune System pathway ‘IRF3-
mediated induction of type1 IFN’ and ‘Synthesis of dolichyl-phosphate mannose’ from 
the Disease and Metabolism of Proteins pathway were unique to the Immune Challenge 
category.  
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Figure 4: Number of differentially expressed leaf pathways in the three challenge categories. 
The three circles are indicative of the significant leaf pathways in the datasets belonging to one of 
the three challenge categories Diet, Drug, or Immune Challenge. The 212 common pathways of all 
the three classes are indicated in the centre. 
There is a large number (212) of leaf pathways that are shared among all challenge cate-
gories (Figure 4). These 212 leaf pathways belong to 24 of the 27 root pathways. These 24 
shared or common root pathways are statistically significant in at least 3 of the 37 condi-
tions, but the number of experimental conditions in which the pathway is significant var-
ies. The distribution of the 212 leaf pathways among the 24 root pathways is shown in 
Table 2. The roots with the largest number of results are Metabolism, Disease, and Signal-
ling pathways, but the proportion of common leaf pathways is similar to the proportion of 
all the leaf pathways in the roots with which we started.  
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Table 2. The 24 root pathways common to the three challenge categories. The names of the root 
pathways are given in the first column. The second column shows the number of leaf pathways in a 
particular root and this number is shown as a percentage of all the leaf pathways in the root pathway 
in the database.  
Root pathways Common Leaf 
pathways 
Ratio of common 
leaf pathways in the 
root pathway 
Metabolism 54 22% 
Disease 53 24% 
Signalling Pathways 47 32% 
Immune System 29 33% 
Cell Cycle 20 30% 
Gene Expression 13 18% 
Hemostasis 11 44% 
Programmed Cell Death 7 26% 
Transcription 6 29% 
Metabolism of proteins 4 8% 
Chromatin organization 3 60% 
Circadian Clock 3 100% 
Developmental Biology 2 5% 
DNA Replication 2 18% 
Extracellular matrix organization 2 18% 
Membrane Trafficking 2 18% 
Transmembrane transport of small molecules 2 6% 
Binding and Uptake of Ligands by Scavenger Recep-
tors 
1 20% 
Cell-Cell communication 1 13% 
Cellular responses to stress 1 9% 
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Use of common pathways under specific conditions 
When the differential expression values (or node values) of individual experimental con-
ditions in these pathways are superimposed on the nodes, we observed that under different 
challenges the same pathway had different expression patterns (number of genes ex-
pressed and levels of gene expression). In Figures 5 to 7 we show graphical representa-
tions of three pathways, ‘Regulation of Complement Cascade’ (Figure 5): the pathway 
with highest differences between gene expression of nodes in the three challenge catego-
ries, ‘Digestion of Dietary Lipid’ (Figure 6): a common pathway that has similar node 
expression profiles over all the experimental conditions where it is significant, and 
‘Laminin Interactions’ (Figure 7): a common pathway representing a mechanism that is 
important for proliferation, migration and differentiation of the intestinal epithelium 
(Khalfaoui et al. 2013. The 3 pathways are arranged based on the cellular location infor-
mation provided in the Reactome database. Each figure panel shows the same pathway; 
however, it is superimposed with the pathway gene expression measurements for 3 differ-
ent conditions, one from each challenge category. Here we consider a pathway to be up-
regulated when most of its nodes have a positive differential value, and down-regulated 
when most of the nodes have negative differential value. By simplifying the response to 
up- or down-regulation we observed that 95% of the pathways were up-regulated com-
pared to the controls in all the experiments. When we investigated the responses of the 
pathways across all experimental conditions within each challenge category, we observed 
that 85% (181 pathways) of the common pathways were up-regulated in the same direc-
tion in the three categories. About 15% of the pathways common to the three challenge 
categories were regulated in different directions, either up- or down-regulated depending 
on the challenge category.  
DNA Repair 1 4% 
Muscle contraction 1 50% 
Organelle biogenesis and maintenance 1 9% 
Post-Elongation Processing of the Transcript 1 25% 
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‘Regulation of Complement Cascade’ is an Innate Immune pathway for expression of 
complement factors and proteins that protect host cell membranes from microbial activa-
tion of the complement cascade. The ‘Regulation of Complement Cascade’ pathway is 
further linked to the pathways ‘Terminal Pathway of Complement’ and ‘Alternative Com-
plement Activation’ in the Reactome database. This pathway is significantly regulated in 
17 conditions (11 Diet, 3 Drug and 3 ImmuneChallenge conditions) and has the most di-
vergent differential expression values between the 3 categories. The responses of 
‘Regulation of Complement Cascade’ pathway for all 17 significant experimental condi-
tions are shown in Supplementary Figure 1. 
In most of the Diet conditions (see Supplementary Figure 1) the pathway is up-regulated 
except for the Diet.Add.Ppar.Agonist.SI and Diet.Add.Probio.BALBc.C conditions, the 
graphical pathway representation is dominated by down-regulated (green nodes in Figure 
5 and Supplementary Figure 1) genes. When Penicillin is administered 
(Drug.Penicillin.SI), the genes in the pathway are down-regulated, whereas in the other 
Drug conditions involving the herbal drug (Drug.HerbalDrug.SI, 
Drug.HerbalDrug.SPF.C), the pathway genes are up-regulated. All the significant Im-
muneChallenge conditions have highly up-regulated the pathway, with large differential 
values for the pathway genes (red nodes in Figure 5 and Supplementary Figure 1). 
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Figure 5. Expression profile of nodes within the complement cascade pathway. Expression 
values in each condition were superimposed on the graphical representation of the pathway, where 
panel A represents the condition Diet.Fat.45.P.SI, panel B Drug.Penicillin.SI, and panel C 
IC.STyph.4day.SL1344.C. The nodes represent expressed gene products or small molecules in dif-
ferent states that are involved in the pathway. The round nodes are proteins or complexes which are 
coloured according to their differential values and the square nodes are non-protein nodes like me-
tabolites or ATP. Darker reds indicate a more positive differential gene expression and darker 
greens indicate a more negative differential gene expression. The edges represent interactions be-
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tween the nodes as given in the Reactome database. The legend indicates the range of colours allo-
cated to nodes based on their differential values from t-statistic calculations. 
 ‘Digestion of Dietary Lipid’ is a Metabolic pathway that is significant in 15 conditions 
(13 – Diet, 1 – Drug and 1 – ImmuneChallenge). This pathway is known to be active in 
the stomach and in the small intestine that uses lipases to digest dietary lipids for absorp-
tion by enterocytes. Figure 6 shows that the genes of this pathway are expressed in a simi-
lar way all over the 3 challenge categories (details of all significant experimental condi-
tions are shown in Supplementary Figure 2). 
There are 11 Diet.Fat conditions where ‘Digestion of Dietary Lipid’ pathway is signifi-
cant, these conditions modulate the gene expression profile of the pathway genes in a very 
similar way. Only a few genes of the pathway are regulated differently in the Diet.Fat 
conditions, but overall the pathway is up-regulated in these conditions. However, in the 
Diet.Fiber conditions (Diet.Fiber.AX.C (Figure 6) and Diet.Fiber.RS.C), the pathway 
genes are down-regulated. When an antibiotic was administered to deplete intestinal bac-
teria (Drug.Antibiotics.C), the pathway behaves quite similarly to the Diet.Fat conditions. 
The significant ImmuneChallenge condition, IC.GDuodenalis.SI shows a tendency to-
wards up-regulation of the pathway genes. 
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Figure 6. Digestion of dietary lipids. Expression values in each condition were superimposed on 
the graphical representation of the pathway, where panel A represents the condition Di-
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et.Fiber.AX.C, panel B represents Drug.Antibiotics.C, and panel C represents IC.GDuodenalis.SI. 
The nodes represent expressed gene products or small molecules in different states that are involved 
in the pathway. The round nodes are proteins or complexes which are coloured according to their 
differential values and the square nodes are non-protein nodes like metabolites or ATP. Darker reds 
indicate a more positive differential gene expression and darker greens indicate a more negative 
differential gene expression. The edges represent interactions between the nodes as given in the 
Reactome database. The legend indicates the range of colours allocated to nodes based on their 
differential values from t-statistic calculations. 
‘Laminin Interactions’ is a biologically relevant pathway representing interactions of a 
family of laminin binding proteins, (including integrins and non-integrins) on intestinal 
epithelial cells with laminin, a major intestinal basement membrane glycoprotein. These 
interactions regulate cell proliferation and adhesion, two crucial functions for intestinal 
epithelial homeostasis. ‘Laminin Interactions’ is a leaf pathway from the root ‘Extra-
cellular Matrix Organization’ and is also a common pathway in all the three challenge 
categories. The genes in the pathway react very differently to the different types of expo-
sures (Figure 7). It is significantly regulated in 18 experimental conditions, 16 of which 
are from the category Diet and 1 experimental condition from both the Drug and Im-
muneChallenge categories (shown in Supplementary Figure 3).  
Most of the Diet conditions up-regulate the ‘Laminin Interactions’ pathway genes. The 
exceptions being the Diet.Fat.60.D.SI and Diet.Add.Heme.C which down-regulate the 
pathway genes (see Supplementary Figure 3), the latter has a stronger suppressing effect 
on pathway expression than the former condition. The single Drug condition in which 
this pathway is significantly regulated is Drug.Antibiotics.C where the pathway genes are 
overall down-regulated (see Figure 7). The ImmuneChallenge condition 
IC.STyph.4day.SB1117.C, strongly up-regulated some genes in the ‘Laminin Interac-
tions’ pathway but also strongly down-regulated some others (see Figure 7). 
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Figure 7. Laminin Interactions. Expression values in each condition were superimposed on the 
graphical representation of the pathway, where panel A represents the condition Diet.Fat.30.M.SI, 
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panel B represents Drug.Antibiotics.C, and panel C represents IC.STyph.4day.SB1117.C. The nodes 
represent expressed gene products or small molecules in different states that are involved in the path-
way. The round nodes are proteins or complexes which are coloured according to their differential 
values and the square nodes are non-protein nodes like metabolites or ATP. Darker reds indicate a 
more positive differential gene expression and darker greens indicate a more negative differential 
gene expression. The edges represent interactions between the nodes as given in the Reactome data-
base. The legend indicates the range of colours allocated to nodes based on their differential values 
from t-statistic calculations. 
 
Stimulation of organoids and reverse transcriptase-quantitative PCR of gene expres-
sion in the ‘Regulation of Complement Cascade’ pathway. 
To investigate which signalling pathways might regulate genes of the Regulation of Com-
plement Cascade’ pathway and verify the results obtained with some of the conditions in 
vivo we performed experiments on intestinal organoids derived from mice. Organoids gen-
erated from dissociated intestinal crypt cells contain all the differentiated types of epitheli-
al cells found in the intestinal location from which they were isolated (Fatehullah, Tan, 
and Barker 2016. These untransformed cells have a global transcriptome profile that more 
closely resembles that of the tissue of origin and overcome some of the limitations associ-
ated with aneuploidy cancer cell lines.  
As stimuli, we used TNFα, an inflammatory cytokine induced by infection or activation of 
inflammatory pathways, flagellin an agonist of TLR5 used as one of the challenge condi-
tions in the Immune category and a pharmacological agonist of PPARα which was used as 
one of the challenge conditions in the Diet category. Untreated 3-D organoids were used 
as control to obtain relative gene expression values of the 10 chosen genes when stimulat-
ed by the three treatments. All data were analysed using Prism statistical software (v5.0, 
Graphpad, San Diego, US), measured for normality using the Kolmogorov-Smirnov test, 
and shown in Box and Whisker plots in Supplementary Figure 4. A t-statistic test was per-
formed on the RT-qPCR results of the 10 genes using the same methods used on the nodes 
in the gene set pathway analysis of CePa, see Table 3. The results of the validation experi-
ment are shown in Supplementary Figure 4 as box and whisker plots. 
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These genes were chosen to represent the activity of the pathway ‘Regulation of Comple-
ment Cascade’, five of them (C3, C5, CD46, CD55, and CD59) were chosen to observe 
the activity of the complement system and the host defence against the complements. The 
other five (C8GH, CFI, CFH, CR1, and C2) were chosen because they are part of nodes 
that change the most in the 17 experimental conditions where the ‘Regulation of Comple-
ment Cascade’ pathway is significant. The expression of the 10 homologous mice genes is 
not changed much when stimulated by the virulence factor flagellin but respond signifi-
cantly to the inflammatory cytokine TNFα and moderately to the PPARα agonist. Overall 
the genes that change most in the pathway analysis show more differential changes com-
pared to the ones chosen from a biological perspective. 
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Discussion 
The results of this study showcase examples of the functional plasticity of the gut mucosal 
tissue at the level of pathway biosynthesis and signalling. By integrating the results of 
experiments in which intestinal homeostasis was perturbed by completely different chal-
lenges, we were able to investigate the plasticity of the gastrointestinal tissue in terms of 
pathway use. To the best of our knowledge, this type of study, focusing on one tissue and 
different types of challenges, has not yet been performed on this scale. By grouping the 
different challenge conditions in categories according to whether they were drugs, dietary 
ingredients or inflammatory agents, we grouped the responses of the mucosal tissue to 
facilitate broader comparisons. We observed that some pathways are regulated by experi-
mental conditions in all categories. In addition, we observed large differences in the ex-
pression profiles of pathway genes between different exposure conditions, in some cases, 
irrespective of the challenge category. By focussing on the commonly regulated pathways, 
we show that the gut mucosa employs similar pathway systems, however, in different 
combinations and with different intra-pathway gene expression profiles, to respond to 
different exposures. Experimental validation of one of these pathways shows that these 
responses are due to local responses of the tissue to the administered challenge. 
High-level data integration 
The most important criteria for dataset selection was the age of the mice when sampled, 
because the mucosal immune system and intestinal microbiota of mammals is known to 
change dramatically around weaning (Cera et al. 1988. This holds true for mice (X. Gu, 
Li, and She 2002; D. Kelly, Smyth, and McCracken 1991, therefore we only included 
datasets where the mice were sampled 2 or more weeks after weaning. The inclusion crite-
ria provided datasets that are comparable, but they still differed in many aspects such as 
the use of microarray platforms, in sampling of the tissue and in the control conditions. 
Therefore, we used a high-level data integration method that started with the identification 
of differently expressed pathways as detected within an individual experiment and/or ex-
perimental condition. 
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Pathway level analysis 
We reasoned that genome-wide gene expression data is more easily interpreted, in terms 
of biological processes, when the analysis is performed on a functional level with path-
ways or gene-sets as functional units or buildings blocks of biological processes, rather 
than on individual genes (Emmert-Streib and Glazko 2011. We used the pathway database 
Reactome because it is manually curated and regularly updated. Both signalling and meta-
bolic pathways are represented in the same format with separate nodes for proteins (we 
use gene expression values here) and metabolites. The nodes are also annotated with de-
tails of the cellular location.  
It has been theorized that using the topology of the pathways will enhance the results of 
the enrichment analysis Therefore we chose the CePa algorithm that considers pathways 
topology although we modified the algorithm to accommodate smaller sample sizes. 
Based on the biological information behind the pathways, we decided to use two centrality 
calculations, ‘In-reach’ and ‘Out-reach’ to capture regulation of pathways down-stream 
(important for signalling pathways) and up-stream (for metabolic pathways) respectively. 
Most of the results were significant in both the centrality calculations irrespective of the 
type of pathway. This apparent indifference in topology is also observed by Bayerlova et 
al. (Bayerlová et al. 2015 in a different pathway database using a variety of algorithms. 
Several pathways are regulated by all three challenge categories 
The results of the integrated pathway analysis show that there is a notable overlap in the 
pathway response between the 3 challenge categories. The Diet category has the highest 
number of leaf pathway results, and also the highest number of experimental conditions. 
Surprisingly, most of the results from Drug and Immune Challenges were also shared by 
the Diet class. This is not expected since the drug and immune challenges are regarded as 
more severe perturbations of homeostasis than a change in the diet. However, the results 
demonstrate that there is a group of common pathways (building blocks) that are always 
regulated when homeostasis is perturbed. These common pathways contribute to a major 
extent to the capability of the intestinal mucosa to display a high-level of functional plas-
ticity. That is the reason we focussed our subsequent research on these common pathways.  
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Most of the transcriptomics data used in this study came from intestinal scrapings which 
greatly enriches for different types of epithelial cells involved in innate immunity and 
cross talk with the immune cells in the lamina propria (Wells et al. 2011. The different 
functions of these epithelial cells contribute to the functional plasticity of the epithelium. 
The results of this study revealed another layer of plasticity which is based on the specific 
use of a common set of pathways. These common pathways are significantly differentially 
expressed compared to controls in at least one experimental condition in each category. 
Simplifying the regulatory output of a whole pathway is difficult due to issues like up-
regulation of the expression of stimulatory or inhibitory molecules. For the sake of sim-
plicity, in this paper we assume that if the majority of the nodes are up-regulated, then the 
pathway as a whole is up-regulated and vice versa.  
Examples of pathways that respond differently to the classes of exposure 
Three of the 212 common pathways which respond differently to the challenge categories 
are discussed further below. The first pathway, ‘Regulation of Complement Cascade’, was 
chosen because it showed the largest difference in node expression profile between the 
three challenge categories (based on t-values of the nodes) and because the bulk of soluble 
complement proteins are produced by the liver with some being produced by only a few 
cell types, suggesting they may have specific functions. Hence, we also investigated 
whether stimuli for specific signalling pathways that might be associated with the chal-
lenges induced complement pathway genes in intestinal organoid models. The second 
pathway, ‘Digestion of Dietary Lipids’, was chosen because it is part of the majority of 
pathways that display an almost similar intra-pathway gene expression profile between the 
three challenge categories. The third pathway, ‘Laminin Interactions’, was chosen because 
it is part of the ‘Extra Cellular Matrix Organization’ root pathway, which regulates diverse 
functions, including proliferation, migration and differentiation and also morphogenesis of 
the intestine (Khalfaoui et al. 2013.  
Regulation of Complement Cascade 
The complement system consists of several inactive pre-proteins produced in the liver that 
circulate in the blood. It is part of the innate immune system and activation of the comple-
ment cascade plays a key role in the opsonisation of microorganisms to increase phagocy-
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tosis by macrophages and neutrophils at the sites of infection (Ricklin et al. 2010. Activa-
tion of the complement cascade also promotes the development of the pore forming mem-
brane attack complex on microorganisms. The triggers for activation of this cascade are 
the formation of the C1 complex pathogen-binding antibodies (classical pathway), sponta-
neous hydrolysis of C3 and deposition of C3b on the surface of microorganisms or bind-
ing of mannose-binding lectin and activation of serine proteases acting on complement 
factors (Merle et al. 2015. A family of regulatory proteins act as regulators of complement 
activation to protect host cells from homologous complement attack. This prevents the 
membrane attack complex formed during complement activation, from lysing nearby host 
cells.  
It is expected that the regulation of complement cascade pathway is modulated in the 
Drug category by administration of antibiotics and ImmuneChallenge conditions. The fact 
that the ‘Regulation of Complement Cascade’ pathway was modulated by several condi-
tions (five Diet.Fat, two Diet.Fibre and five Diet.Additive conditions) in the Diet category 
that are not considered to be extreme perturbations, was surprising and interesting. How-
ever, there has been research linking elements of the complement system to lipid metabo-
lism by acylation-stimulating protein/complement C3adesArg (ASP/C3adesArg) which 
has been shown to stimulate triglyceride (TG) synthesis in both mature adipocytes and pre
-adipocytes (Munkonda et al. 2012; Mamane et al. 2009; Paglialunga et al. 2007 .  
The Diet and ImmuneChallenge conditions up-regulate the ‘Regulation of Complement 
Cascade’ pathway and the experimental conditions in the Drug category mostly down-
regulated the pathway. The regulation of the pathway is the strongest in the ImmuneChal-
lenge conditions, however our results indicate that several Diet conditions induce similar 
regulation of the pathway, although expression is lower than with two conditions 
(IC.STyph.4day.SL1344.C, IC.STyph.4day.SB1117.C) in the Immune Challenge catego-
ry. The expression of the regulators of complement cascade that protect host cells from 
potentially damaging effects of complement in response to infectious agents seems logi-
cal. Mucosal damage due to infection might lead to vascular damage and leakage of plas-
ma into the lamina propria. Here activation of the complement cascade would necessitate 
up-regulation of the host regulators of complement cascade (CD46, CD55) to protect its 
own cell membranes. Additionally, the production of blood complement components by 
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epithelial cells would contribute to the local pool. This could be an important mechanism 
in the periphery of the intestine which might have poor access to circulating complement 
components from the blood. The Diet category of challenges which strongly upregulated 
this pathway were from high fat diets (Figure 5), which are known to cause low-grade 
inflammation and a leaky gut (Bischoff et al. 2014; Chassaing and Gewirtz 2014. Interest-
ingly depletion of the microbiota with penicillin, reduced pathway expression suggesting 
that the microbiota contribute to “tonic” stimulation of the complement related pathways 
via stimulation of innate immunity.  
To investigate this hypothesis and identify the signalling pathways associated with altered 
expression of this pathway we stimulated small intestinal mouse organoids with TNFα, 
flagellin, an agonist of PPARα, or culture medium as a control and compared the relative 
transcript abundance of several complement pathway genes by reverse transcription poly-
merase chain reaction (RT-PCR). The RT-PCR measurements were made on mice homo-
logs of the human genes in the pathway, and these mice genes are denoted in italics with 
only the first letter of the gene symbol capitalized. Stimulation with TNFα a cytokine se-
creted by activation of NF-κB in tissue and immune cells simulates inflammation of the 
intestine. The PPARα agonist simulates high-fat dietary conditions and the flagellin an 
agonist of TLR5, was used to investigate the role of TLR signalling. Transcription of 
complement factors C2, C3 and regulatory proteins Cfi, Cd46 and Cd55 were significantly 
up-regulated by TNFα whereas expression of C5, C8 and Cfh was not significantly 
changed and Cd59 was significantly down-regulated. The agonist of PPARα significantly 
up-regulated transcription of regulatory proteins Cd55, Cr2, Cd46, and Cfi and signifi-
cantly down-regulated expression of Cd59. Surprisingly flagellin (which was shown to 
activate TLR5 in reporter cells) did not significantly alter expression of any of these 
genes. These results suggest that activation of inflammatory pathways in intestinal organ-
oids via TNFα-receptor mediated pathway upregulates expression of host membrane pro-
teins (CD46 and CD55) involved in protection of membranes against complement activa-
tion as well as factor I (CFI) which regulates complement activation by cleaving cell-
bound or fluid phase C3b. Upregulation of C2 required for generation of the C3 convert-
ase upon complement activation and C3 which is crucial component for activation and the 
first stages of complement cascade were also upregulated by TNFα.  
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This finding suggests that activators of NF-kB pathway (e.g. IL-1β, and agonists of NLRs 
and TLRs) would also induce expression of the complement related genes. However, ad-
dition of flagellin to organoids did not induce significant changes in expression of these 
genes. The reasons for this are unclear but may be due to lack of expression of membrane 
TLRs in organoid cells or strong negative regulation of TLR signalling pathways. It has 
been proposed that TLR signalling is tightly controlled in epithelial cells to avoid chronic 
inflammatory responses to bacterial MAMPs from the intestinal lumen (Sham et al. 2013; 
Biswas et al. 2011. Interestingly, activation of the PPARα pathway also increased expres-
sion of protective factors Cd55, Cd46, Cfi and Cr2 which allows the complement system 
to play a role in B cell activation and maturation. This links PPARα to regulation of com-
plement cascade in the gut and the effects of high fat diets on this pathway in vivo.  
The variations in the expression of the genes measured in the validation experiment reflect 
the plasticity in the response of the ‘Regulation of Complement Cascade’ pathway that is 
observed in the high-level data integration results.  
Digestion of Dietary Lipids 
The “Digestion of Dietary Lipids’ pathway describes the digestion of dietary lipids by 
pancreatic and gastric lipases which are known to increase with increase in fat consump-
tion (Deschodt-Lanckman et al. 1971; Corring 1980. This pathway is regulated in the up-
wards direction under all the experimental conditions where it is significant (featured in 
Supplementary Figure 2). All the Diet conditions (11 experimental conditions) with an 
increase in fat content show up-regulation of this pathway which is consistent with exist-
ing literature. However, up-regulation is also seen in four other experimental conditions, 
two of which are substitutions of fibres in the diet. Dietary fibres have been documented 
to change lipid levels (Ulmius, Johansson, and Önning 2009; Brown et al. 1999 depending 
on the type of fibre, but the fibres used in the original study (Arabinoxylan from wheat 
and Resistant Starch from tapioca) have no documented effects on lipid levels. Antibiotics 
that severely affect the intestinal microbiota have been observed to reduce lipid absorption 
in mammals (H. Sato et al. 2016; Rotenberg and Andersen 1982. Bacterial pathogens of 
the genus Giardia have an interesting relationship with dietary lipids which can kill them 
in in vitro conditions (Rayan, Stenzel, and McDonnell 2005; Das et al. 1988; Yichoy et al. 
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2011 but only reduces the severity of the infection in in vivo conditions (Suh, Belosevic, 
and Clandinin 2004; Yichoy et al. 2011. In our analysis, we see that even though these 15 
experimental conditions have very different effects on lipid levels in the organism, they 
modulate the ‘Digestion of Dietary Lipids’ pathway in the same direction. 
The “Laminin Interactions’ pathway as indicator for gut health 
Our analysis enables unbiased analysis of the response of pathways to experimental condi-
tions. Therefore, besides analysing significant pathways it is possible to investigate mi-
nutely at the behaviour of specific pathways to understand their regulation by any of the 
37 different experimental conditions. One biologically relevant pathway for the tissue is 
the ‘Laminin Interactions’ pathway. It is a leaf pathway that is part of the root pathway 
Extracellular Matrix Organization which is important for intestinal health (Frantz, 
Stewart, and Weaver 2010. This class of pathways encompass biological processes related 
to the extracellular matrix, which is made up of several types of fibrous proteins that are 
linked to provide structural support to the cells. The biological process of maintaining the 
extracellular matrix is crucial to the barrier function of the gut and intestinal regeneration 
(Blikslager et al. 2007; Göke, Zuk, and Podolsky 1996. There are 11 leaf pathways in this 
root, and two of them were part of the common significantly regulated pathways: the 
‘Integrin Cell Surface Interactions’ pathway and the ‘Laminin Interactions’ pathway. The 
latter is a pathway that describes the interactions of the laminin family of proteins with 
each other and other fibrous proteins. Laminins have been extensively studied 
(Domogatskaya, Rodin, and Tryggvason 2012 and have been implicated in, among other 
things, wound repair (Iorio, Troughton, and Hamill 2015 and cell adhesion. These are 
functions that are of eminent importance to the gut in keeping harmful substances from 
breaching the epithelium.  
Our analysis shows that this pathway is up-regulated in most of the 18 conditions in which 
it is significant. The Diet conditions modulate the pathway in mostly the same way except 
for the experiment when 60% fat is added to the diet. In the latter experiment two parts of 
the small intestine were sampled, the proximal and distal halves. The ‘Laminin Interac-
tions’ pathway is modulated in opposite directions in each of these sections, and this dif-
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ference between the two tissue sections has also been described by the researchers who 
conducted this experiment (Desmarchelier et al. 2012.  
In the Drug condition where several antibiotics were administered, almost all the nodes of 
the ‘Laminin Interactions’ pathway are down-regulated. This treatment depletes the intes-
tinal microbe population the presence of which stimulates epithelial proliferation and the 
involvement of the Laminin pathways in epithelial remodelling (Hörmann et al. 2014. 
This down-regulation of the ‘Laminin Interactions’ pathway in the Drug.Antibiotics.C 
condition is consistent with the reports from an experiment with similar conditions 
(Reikvam et al. 2011 where there was reduced epithelial turnover. ‘Laminin Interactions’ 
shows strong signals in the ImmuneChallenge condition IC.STyph.4day.SB1117.C, some 
nodes are highly up-regulated and some highly down-regulated. The paper on this im-
mune challenge (Liu et al. 2010 shows that there is an up-regulation of genes involved in 
‘cell growth and proliferation’. This modulation of the ‘Laminin Interactions’ pathway 
shows that laminins are reactive to different types of conditions and play an important role 
in the functional plasticity of the gut. 
Conclusions  
In this study we performed a high-level data integration of a number of datasets represent-
ing whole genome gene expression patterns of intestinal mucosa’s that have been exposed 
to different types of stimulations. The results highlight the functional plasticity of the gut 
is high and point towards different layers of plasticity. Firstly, the same pathways can be 
used in different combinations to generate extremely different physiological responses. 
Secondly, genes within pathways are not uniformly regulated which contributes further to 
the plasticity. The large number of the so-called common pathways that are regulated by 
the different classes of stimulations are proof of plasticity on the functional level. Further-
more, these pathways also show intra-pathway variations in response to the different stim-
ulations which reveals another layer of plasticity in the pathways themselves. The latter 
calls for caution when analysing expression data as pathway enrichment cannot be equat-
ed to a uniform functional response. We conclude that the functional plasticity of intesti-
nal mucosal tissue can be explained, at least partially, by variation in the pathway sets that 
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are regulated by different stimuli and by the induction of intra-pathway specific gene 
expression patterns. 
Acknowledgements 
The authors would like to acknowledge the fruitful discussions with Prof. Vitor Martins 
dos Santos in guiding the direction of the analysis. This work has been financially sup-
ported by the Systems Biology Investment Programme of Wageningen University, KB-
17-003.02-022. 
Supplementary files 
Supplementary Table 1. Description of the 37 conditions. This table describes the 
abbreviated names of experimental conditions as used in the paper and the control condi-
tions in each of the experiments.  
 
Names Description of Experi-
mental conditions 
Description of the control 
condition 
Diet.Fat.20.P.SI 20% of the energy in the diet 
comes from fat, proximal 
section of the small intestine 
10% of the energy in the diet 
comes from fat, proximal 
section of the small intestine 
Diet.Fat.30.P.SI 30% of the energy in the diet 
comes from fat, proximal 
section of the small intestine 
Diet.Fat.45.P.SI 45% of the energy in the diet 
comes from fat, proximal 
section of the small intestine 
Diet.Fat.20.M.SI 20% of the energy in the diet 
comes from fat, middle sec-
tion of the small intestine 
10% of the energy in the diet 
comes from fat, middle sec-
tion of the small intestine 
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Diet.Fat.30.M.SI 30% of the energy in the diet 
comes from fat, middle sec-
tion of the small intestine 
  
Diet.Fat.45.M.SI 45% of the energy in the diet 
comes from fat, middle sec-
tion of the small intestine 
Diet.Fat.20.D.SI 20% of the energy in the diet 
comes from fat, distal section 
of the small intestine 
10% of the energy in 
the diet comes from fat, 
distal section of the 
small intestine 
Diet.Fat.30.D.SI 30% of the energy in the diet 
comes from fat, distal section 
of the small intestine 
Diet.Fat.45.D.SI 45% of the energy in the diet 
comes from fat, distal section 
of the small intestine 
Diet.Fat.60.D.SI 60% of the energy in the diet 
comes from fat, distal section 
of the small intestine 
11% of the energy in 
the diet comes from fat, 
distal section of the 
small intestine 
Diet.Fat.60.P.SI 60% of the energy in the diet 
comes from fat, proximal sec-
tion of the small intestine 
Diet.Fiber.AX.C Control diet with 10% of corn 
starch substituted with Arabi-
noxylan, sampled at the colon 
Standard semi-synthetic 
low fat diet with corn 
starch as carbohydrate 
source, sampled at the 
colon 
Diet.Fiber.FOS.C Control diet with 10% of corn 
starch substituted with Oli-
gofructose, sampled at the 
colon 
Diet.Fiber.GG.C Control diet with 10% of corn 
starch substituted with Guar 
gum, sampled at the colon 
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Diet.Fiber.IN.C Control diet with 10% of 
corn starch substituted 
with Inulin, sampled at the 
colon 
  
Diet.Fiber.RS.C Control diet with 20% of 
corn starch substituted 
with Resistant starch sam-
pled at the colon 
Diet.Add.Heme.C  Control diet supplemented 
with 0.5 µmol/g heme, 
sampled at the colon 
Westernized control diet 
(40% fat (mainly palm oil) 
low calcium (30 µmol/g)), 
sampled at the colon 
Diet.Add.Quercetin.C RM3 (E) 801710 Soya-free 
powdered diet + 7mg quer-
cetin, sampled in the colon 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled in the colon 
Diet.Add.Quercetin.I.SI RM3 (E) 801710 Soya-free 
powdered diet + 7mg quer-
cetin, sampled in the ileum 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled in the ileum 
Diet.Add.Quercetin.J.SI RM3 (E) 801710 Soya-free 
powdered diet + 7mg quer-
cetin, sampled in the jeju-
num 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled in the jejunum 
Diet.Add.PparAgonist.SI Standard laboratory chow 
(RMH-B), sampled at the 
small intestine 
Standard laboratory chow 
(RMH-B), sampled at the 
small intestine 
Diet.Add.Probio.BALBc.C SSNIFF R/M-H feed pellet 
diet or 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain BALBc 
mice, sampled at the colon 
SSNIFF R/M-H feed pellet 
diet given oral gavage with 
PBS, strain BALBc mice, 
sampled at the colon 
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Diet.Add.Probio.BALBc.SI SSNIFF R/M-H feed pellet 
diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain BALBc 
mice, sampled at the small 
intestine 
SSNIFF R/M-H feed pel-
let diet, oral gavage with 
PBS, strain BALBc mice, 
sampled at the small in-
testine 
Diet.Add.Probio.C57BL6.C SSNIFF R/M-H feed pellet 
diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain C57BL6 
mice, sampled at the colon 
SSNIFF R/M-H feed pel-
let diet, oral gavage with 
PBS, strain C57BL6 
mice, sampled at the co-
lon 
Diet.Add.Probio.C57BL6.SI SSNIFF R/M-H feed pellet 
diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain C57BL6 
mice, sampled at the small 
intestine 
SSNIFF R/M-H feed pel-
let diet, oral gavage with 
PBS, strain C57BL6 
mice, sampled at the 
small intestine 
Drug.HerbalDrug.C Orally treated with JTX 
solution (1.0g/kg body 
weight), strain BALBc, 
sampled at the colon 
Treated with water (1.0g/
kg body weight), strain 
BALBc, sampled at the 
colon 
Drug.HerbalDrug.SPF.C Orally treated with JTX 
solution (1.0g/kg body 
weight), strain IQI, sampled 
at the colon 
Treated with water (1.0g/
kg body weight), strain 
BALBc, sampled at the 
colon 
Drug.HerbalDrug.SI Orally treated with JTX 
solution (1.0g/kg body 
weight), strain BALBc, 
sampled at the small intes-
tine 
Orally treated with JTX 
solution (1.0g/kg body 
weight), strain BALBc, 
sampled at the colon 
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Drug.Antibiotics.C Oral gavage of mixture of antibiot-
ics and in drinking water, sampled 
in the colon 
Drinking water, sam-
pled in the colon 
Drug.Penicillin.SI Low dose penicillin was added to 
the drinking water, sampled at the 
small intestine 
Normal chow and 
drinking water, sam-
pled at the small 
intestine 
IC.STyph.4day.SB1117.C Streptomycin treatment followed 
by oral gavage of 1 × 10^7 CFU of 
S. Typhimurium (100 μl suspen-
sion in HBSS), S.Typhimurium 
strain SB1117, after 4 days sam-
pled in the colon 
Oral gavage of 
HBSS, sampled in 
the colon at day 4 
IC.STyph.4day.SL1344.C Streptomycin treatment followed 
by oral gavage of 1 × 10^7 CFU of 
S. Typhimurium (100 μl suspen-
sion in HBSS), S.Typhimurium 
strain SL1344, after 4 days sam-
pled in the colon 
IC.STyph.8hr.SB1117.C Streptomycin treatment followed 
by oral gavage of 1 × 10^7 CFU of 
S. Typhimurium (100 μl suspen-
sion in HBSS), S.Typhimurium 
strain SB1117, after 8 hours sam-
pled in the colon 
Oral gavage of 
HBSS, sampled in 
the colon at 8 hours 
IC.STyph.8hr.SL1344.C Streptomycin treatment followed 
by oral gavage of 1 × 10^7 CFU of 
S. Typhimurium (100 μl suspen-
sion in HBSS), S.Typhimurium 
strain SB1117, after 8 hours sam-
pled in the colon 
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IC.GDuodenalis.SI Oral gavage of 1 × 10^6 
parasites in 0.1 ml phos-
phate-buffered saline 
(PBS), sampled in the small 
intestine 
Sampled in the small intes-
tine 
IC.Flagellin.C Flagellin (FliC) from WT 
Salmonella enterica serovar 
typhimurium (SL3201, 
fljB−) was given 10 μg per 
mouse in 0.2 ml PBS) intra-
peritoneally, sampled in the 
colon 
0.2 ml PBS was given in-
traperitoneally, sampled at 
the colon 
IC.Colitis.C Dextran Sodium Sulfate 
(DSS: 4% w/v) in drinking 
water, sampled at the colon 
Normal drinking water, 
sampled at the colon 
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Supplementary Figure 1: Pathway ‘Regulation of Complement Cascade’ in 17 condi-
tions. This figure contains the pathway as a graph, the nodes are proteins, complexes or 
other physical entities and the edges are interactions between them. Circular nodes repre-
sent proteins or protein complexes, square nodes represent small molecules like metabo-
lites or ATP. The nodes are coloured based on the differential expression values calculat-
ed by the algorithm CePa, darker reds indicate a higher up-regulation of the node and 
darker greens indicate a higher down-regulation. Each section of the figure has the same 
pathway overlaid with expression data from the experimental condition with which it is 
labelled, a subset of this figure is in Figure 5. 
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Supplementary Figure 2: Pathway ‘Digestion of Dietary Lipids’ in 15 conditions. 
This figure contains the pathway as a graph, the nodes are proteins, complexes or other 
physical entities and the edges are interactions between them. Circular nodes represent 
proteins or protein complexes, square nodes represent small molecules like metabolites or 
ATP. The nodes are coloured based on the differential expression values calculated by the 
algorithm CePa, darker reds indicate a higher up-regulation of the node and darker greens 
indicate a higher down-regulation. Each section of the figure has the same pathway over-
laid with expression data from the experimental condition with which it is labelled, a sub-
set of this figure is in Figure 6. 
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Supplementary Figure 3: Pathway ‘Laminin Interactions’ in 18 conditions. This fig-
ure contains the pathway as a graph, the nodes are proteins, complexes or other physical 
entities and the edges are interactions between them. Circular nodes represent proteins or 
protein complexes, square nodes represent small molecules like metabolites or ATP. The 
nodes are coloured based on the differential expression values calculated by the algorithm 
CePa, darker reds indicate a higher up-regulation of the node and darker greens indicate a 
higher down-regulation. Each section of the figure has the same pathway overlaid with 
expression data from the experimental condition with which it is labelled, a subset of this 
figure is in Figure 7. 
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Supplementary Figure 4. Expression of 10 chosen genes from the ‘Regulation of 
Complement Cascade’pathways with significance calculated with ANOVA. Each 
graph contains information on different genes, the x-axis contains information on the 
treatment of the organoids and the y-axis has the fold change of the control genes. All data 
were considered significantly different from the blank when P < alpha (0.05), and indicat-
ed with * (P < 0.05=*, P < 0.01=**, P < 0.001=***). 
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Abstract 
The mucosal immune system of the intestine balances its tolerance towards feed/food de-
rived antigens and commensal microbes and its response to suppress the activity of patho-
genic microbes. Changes in the diet are known to affect immune parameters like Immuno-
globin A and cytokine levels, both at the intestine and at the systemic level. These im-
mune parameters help shape the external immune phenotype of the organism. In order to 
investigate the effects of dietary changes on functional immunity parameters, we analysed 
and compared the gene expression profiles of intestinal mucosal tissues of mice fed with 
various different diets. Such a molecular profile may be regarded as an internal phenotype. 
In addition, we obtained information on 36 functional immunity parameters that are linked 
to the external immune phenotype based on Genome Wide Association Studies (GWAS) 
as deposited in the NCBI dbGaP database. Not less than 1354 genes associated with at 
least one of the 36 selected functional immunity parameters. These genes are indicated 
here as Functional Immunity Parameters Genes (FIPGs).  
Data from 9 different dietary intervention studies were analysed both at the gene and the 
pathway level to compare the intestinal mucosal transcriptomes of the experimental ani-
mals versus the control animals for each study. These results of these analyses were then 
linked to the selected functional immunity parameters via the FIPGs associated with them. 
Out of the 36 functional immunity parameters, 31 were found to be linked to changes in 
diet by either differentially expressed genes or differentially regulated pathways. With 
this, we discovered potential links between dietary interventions and functional immunity 
parameters.  
Keywords: Dietary intervention, Gene expression, Functional immunity parameter, Gas-
trointestinal tract, Immune system 
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Introduction 
The intestinal mucosal immune system maintains a delicate balance between immunogen-
icity against invading pathogens and tolerance against feed/food antigens and the com-
mensal microbiota. Changes in diets have been shown to affect mucosal as well as sys-
temic parameters of immunity, such as levels of Immunoglobin A antibodies and cyto-
kines like Interleukin 10 (Y.-S. Wu et al. 2016; Gomaa and El-Aziz 2017. Variations in 
this type of immunity parameters correlate with external immune-related phenotypes such 
as the inflammatory status of an organism (Ding et al. 2010; Munkonda et al. 2012 or its 
susceptibility to an infectious disease (Alex et al. 2009. Still, limited knowledge is availa-
ble on the relationships between dietary components, immunity parameters and external 
immune phenotypes.  
An improved understanding of these relationships may be obtained by studying the effect 
of diets or dietary components on so-called internal or intermediate phenotypes (Houle, 
Govindaraju, and Omholt 2010; Leuchter et al. 2014. Such internal phenotypes can be 
profiled in specific tissues or body fluids on different biological levels by the use of tran-
scriptomic, proteomic, metabolomic and/or metagenomic measurements. Measurements 
with these techniques quantify all the components of a particular type (mRNA, protein, 
metabolites, microbiota) in the tested sample. The activity and the interactions of several 
of these components, both intra- component-type as well as inter- component-type, may 
contribute to the establishment of external phenotypes which is based on the genotype 
interactions with the environment.  
Since complex external phenotypes, such as immunological resistance, are not always 
easy to quantify, it is common to identify quantifiable functional-related parameters that 
are known to be indicators of a particular external phenotype. Several of these indicators 
have been identified for external phenotypes, especially those associated with a diseased 
state, for example the insulin serum concentration as an indicator for diabetes. 
In a previous study, we have identified several immune related genes and pathways that 
are affected in intestinal mucosal tissues by dietary interventions in mice (Benis et al, in 
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preparation). It is not known yet to what extent these changes contribute to the expression 
of immunity parameters and to the establishment of immune related external phenotypes. 
Therefore, the aim of this study is to develop and build a concept of a quantitative model 
to predict the effects of dietary changes on the expression of a selected set of immunity 
parameters that are functional related to the immune phenotype (immune competence) of 
an organism.  
As a first step, we developed and built the concept of the model using microarray derived 
transcriptome data because this data is comparable between various mice experiments and 
because it covers the expression of whole genomes. Moreover, several dedicated data-
bases exist that store such gene expression data (Gene Expression Omnibus (Barrett et al. 
2013, Array Express (Kolesnikov et al. 2015) thereby enabling the integration of results 
arising from multiple independent experiments. To link gene expression data with func-
tional immunity parameters and immune related external phenotypes, we use databases 
with information on the linkage between genes and such immunity parameters. The data-
base of Genotypes and Phenotypes (dbGaP) (Tryka et al. 2014 and the National Human 
Genome Research Institute Genome Wide Association Studies Catalog (NHGRI GWAS 
Catalog) (Welter et al. 2014 contain results from studies on interactions between geno-
types and phenotypes, most often arising from Genome Wide Association Studies 
(GWAS) experiments. dbGaP and NHGRI GWAS Catalog contain information on genes 
associated to the functional immunity parameters. 
Datasets and Methods 
Microarray datasets 
We acquired microarray data from 9 mice studies where the diet of the animals was al-
tered and a section of the intestine was sampled for gene expression data with microarray 
technology. In three of these studies relative levels of dietary components were changed: 
three different levels of fat were tested with gene expression measured in three sections of 
the small intestine (de Wit et al. 2011; a high fat diet transcriptomics measured in two 
sections of the small intestine (Desmarchelier et al. 2012; and five different types of fibres 
with responses measured in the colon (Lange et al. 2015. The six other studies added sup-
plements / additives in the diet: dietary heme was added and the colon sampled for gene 
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expression (IJssennagger et al. 2012; quercetin was added and two sections of the small 
intestine and the colon were sampled (Mutch et al. 2006; a Ppar alpha agonist was given 
to the mice and the small intestine was sampled (Bünger et al. 2007; and a probiotic name-
ly, VSL#3, was administered to the mice and the small intestine and colon of two strains 
of mice were sampled for gene expression (Mariman et al. 2015. These nine studies com-
prise a total of 25 experimental conditions. Here an experimental condition is defined as a 
dietary change measured in a section of tissue in a strain of animal. Each study also con-
tained data corresponding to control conditions in the same tissue and strain of animal. 
More details on these 25 conditions are given in Supplementary Table 1 which also con-
tains the abbreviations used in this paper to denote these conditions. 
Differential gene expression analysis 
Gene expression was analysed by comparing each of the 25 experimental conditions to 
their respective controls using linear modelling for microarrays (LIMMA) (Smyth 2005. 
Significance of gene differential expression was evaluated with p-values after correcting 
for multiple testing with the Benjamini & Hochberg adjustment. Genes were considered 
differentially expressed when False Discovery Rate (FDR) less than 0.05 and log2 fold 
change more than 1.3 or less than -1.3 to only capture highly variant genes. 
Differential pathway analysis 
Using the topological pathway enrichment tool CePa (Z. Gu and Wang 2013 and path-
ways from Reactome version 51 (Croft et al. 2014; Fabregat et al. 2016 with a modified 
version of the GSA (Gene Set Analysis) function we analysed the data for each experi-
mental condition versus the control in each experiment as described in Benis et al 
(manuscript in preparation). Pathways with p-values less than 0.01 were considered signif-
icant for that comparison, p-values were not adjusted for multiple comparisons because 
the pathways are not independent of each other. 
Functional parameter to gene association 
We extracted genotype to phenotype associations from the interface Phenotype Genotype 
Integrator (PheGenI) (Ramos et al. 2014 which accesses data from dbGaP and NHGRI 
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GWAS Catalog. The information from dbGaP is based on over 800 GWAS studies sub-
mitted to NCBI and the NHGRI GWAS Catalog has information from over 2,000 GWAS 
publications. GWAS studies primarily investigate variations in genes that could be the 
cause of health or disease traits. These variations are generally studied in the form of Sin-
gle Nucleotide Polymorphisms (SNPs) that differ between experimental and control co-
horts. GWAS studies aim to identify a relation between the presence of a SNP and the 
occurrence or risk of a disease or another external phenotype, such as feed efficiency in 
livestock sciences. Generally, if the SNP is found on a gene or in an intergenic region, and 
this association passes a significance threshold, the disease or phenotype is attributed to 
these genes. Data can be retrieved from dbGaP with the browser PheGenI where it is pos-
sible to search for data pertaining a selected phenotype or trait. The terminology describ-
ing these traits is taken from the thesaurus Medical Subject Headings which has precise 
definitions for the terms and thus reduces ambiguity. In addition to the association be-
tween the trait and the gene where the SNP is located, PheGenI also returns provenance 
information related to study that identified the association.  
We hand-picked 36 immunity parameters such that the parameters are easily measured 
and are functionally related to immune relevant external phenotypes. These functional 
immunity parameters were queried in PheGenI and downloaded all the genes associated 
with these parameters. For simplicity, we refer to these genes as Functional Immunity 
Parameters Genes (FIPG). dbGaP was accessed with PheGenI in 4 different batches on 09
-Jan-2017.  
Pathways associated with functional parameters 
The functional parameters were associated to different pathways by using the Over Repre-
sentation Analysis (ORA) method in the pathway analysis tool CePa. All the genes associ-
ated with a functional immunity parameter (FIPGs) were used as a gene list and all the 
genes in the pathways were used as a background gene list. The ORA analysis was run 
five times with 5,000 random iterations each and the pathways with p-values less than 
0.01 in all the runs were considered to be significant. These significant pathways were 
assigned to each functional parameter.  
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Associations of diets and functional parameters 
The dietary conditions were linked to functional parameters using two different methods. 
In the first, the gene method, we use the differentially expressed genes from each dietary 
condition. A dietary condition and a functional immunity parameter were linked if the 
FIPGs associated to the parameter are seen to be differentially expressed in the diet expo-
sure.  
In the second approach, the pathway method, we first associated pathways to diets when-
ever the pathways were significantly enriched (p-value < 0.01) in the experimental condi-
tion versus the control. Pathways were then associated to functional immunity parameters 
if the pathway genes showed enrichment in each set of FIPGs. Finally, dietary conditions 
and functional immunity parameters were linked whenever they were associated to com-
mon pathways.  
Literature validation of Diet-Parameter associations 
In order to verify whether the observed associations between diets and functional immun-
ity parameter are already described in literature, we performed a literature search for co-
occurrence of dietary changes and functional parameters that are associated in either 
methods. We used the R package rentrez (Winter 2016 to perform the search on PubMed 
abstracts. We reduced the names of the dietary changes to more general search terms; all 
the ‘Fat’ conditions were converted to “High Fat”, all the ‘Fibre’ conditions were con-
verted to names of the fibres used, “Arabinoxylan”, “Oligofructose”, “Guar gum”, 
“Inulin” and “Resistant Starch”. The ‘Additive’ experimental conditions were searched as 
“Dietary heme”, “Quercetin”, “PPAR agonist” and “Probiotic” respectively. 
Results 
Concept of the model 
The developed model describes associations between dietary interventions and functional 
immunity parameters pertinent to external immune related phenotypes by the use of die-
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tary-induced genome-wide transcription data. We used two types of differential analysis 
on the gene expression data, one is based on the differential expression of individual 
genes and the other on the differential regulation of biological pathways. The differential 
expressed genes and pathways were subsequently linked to the functional immunity pa-
rameters (Figure 1). From the interface PheGenI, we obtained Genes associated with 
Functional Immunity Parameters, termed FIPGs for simplicity. The hypotheses behind 
these methods is that the dietary-induced differential expression of FIPGs, or the differen-
tial expression of gene sets that are functionally linked to FIPGs, affect the same function-
al immunity parameters as the genetic variation of the FIPG. 
Figure 1. Linking dietary changes to functional immunity parameters related to the external 
immune phenotype via transcriptome data. Scheme representing the model concept to link die-
tary conditions to immune functional parameters using transcriptome data from gut mucosal tissue. 
Model inputs and predictions are shown on the left and right, respectively. The middle part de-
scribes the two methods here presented, the gene method, based on differential expression of indi-
vidual genes, and the pathway method that uses significantly regulated pathways. The arrows con-
tain information on the analysis methods. FIPG denotes the genes associated with the functional 
immunity parameters as obtained from PheGenI. 
Gene to Functional Immunity Parameter associations from GWAS studies 
From the traits linked to genes in GWAS studies we chose 36 traits corresponding to easi-
ly measured parameters linked to immunity. Twelve of them are related to immune cell 
counts and behaviour, another twelve are cytokines or chemokines or their receptors, two 
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are immunoglobins, four are adhesion related proteins, three are proteins expressed on 
immune cells, one is a metabolite (Acylcarnitine) and one other is a physiological state 
(Inflammation). More details on these functional immunity parameters are given in Sup-
plementary Table 2. 
The chosen 36 functional immunity parameters were associated with 1354 Functional 
Immunity Parameter Genes (FIPGs) in the results from PheGenI. These trait-to-gene asso-
ciations arise from SNPs being assigned to a particular gene based on the location of the 
SNPs in relation to the chromosomal boundaries of that gene. The gene assignments are 
performed in the individual GWAS the results of which are submitted to dbGaP or ex-
tracted from literature in NHGRI GWAS Catalog. The basis for gene assignment is given 
as a functional code in the results of PheGenI. Among the 4001 results downloaded from 
dbGaP, half of the associations have the functional code ‘Intergenic’ which indicates that 
the SNP associated with the trait was found more than 2 kilo base-pairs up-stream and 
more than 500 base-pairs down-stream of the genes flanking this intergenic region. 
Among all the FIPGs, 86% have been associated with traits with SNPs that are found in 
intergenic regions. There are eight other functional codes among the results from dbGaP: 
Intron, Missense, NearGene-3, NearGene-5, UTR (untranslated region) -3, UTR-5, Cds 
(coding DNA sequence) synon and STOP-GAIN which are explained in Supplementary 
Table 3. 
There are four functional immunity parameters (Interleukin-10, Interleukin-1beta, Inter-
leukin-12, Complement C4 binding protein) with only one FIPG, whereas the parameter 
Erythrocytes has the largest number of FIPGs with 184. From the 36 functional immunity 
parameters selected, 28 were found to share FIPGs, as can be seen in Figure 2. The pa-
rameter Neutrophils shares FIPGs with 17 other parameters, with a maximum of 70 FIPGs 
with the parameter Lymphocytes. The number of genes shared among the functional im-
munity parameters is limited as shown in the insert of Figure 2; 102 of the 117 connec-
tions have a maximum of five shared FIPGs. The gene DARC is the most shared FIPG 
and is associated with 6 functional immunity parameters (Neutrophils, Monocyte Attract-
ant Protein -1, Leukocyte count, Chemokine CCL2, Immunoglobin E and Inflammation). 
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Figure 2. Connections between functional immunity parameters. The nodes in the network rep-
resent functional immunity parameters with the node size corresponding to the number of FIPGs 
associated with them in dbGaP. The edges represent shared FIPGs between the connected functional 
immunity parameters and are coloured according to the number of shared FIPGs. Edges that repre-
sent less than 5 FIPGs are coloured blue, shared FIPGs more than 5 and less than 10 are coloured 
purple, FIPGs with more than 10 genes are coloured pink. There is one edge coloured red which 
represents 70 shared FIPGs. The same colours are used in the inset which shows the distribution of 
shared FIPGs in the network. 
Differential analysis of dietary conditions on gene and pathway levels 
Each dietary condition in the nine studies was compared to the control in the correspond-
ing study (details given in Supplementary Table 1) and differential gene expression was 
computed. Out of the 25 dietary conditions there were 18 conditions that had significant 
differentially expressed genes, as is shown in Table 1. A total of 602 differentially ex-
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pressed genes were identified. The condition with the highest number of differentially 
expressed genes is Add.PparAgonist.SI with 199 significant genes.  
The differential gene expression analysis was also performed on a pathway level where 
the expression of the pathway nodes in each of the 25 dietary conditions was compared to 
the pathway expression in the control conditions. All the 25 conditions had significantly 
regulated pathways, Add.Heme.C has the highest number of significant regulated path-
ways (882) as is shown in Table 1. A total of 1289 Reactome pathways were found signif-
icant in at least one of the dietary conditions. 
Table 1: Differential expressed gene and pathway linked to functional immunity parameters. 
The first column has the names of the dietary conditions, the second has number of differentially 
expressed genes and the fourth column has the number of differentially regulated pathways. The 
third and fifth columns show the number of associations between the dietary condition and the func-
tional immunity parameter followed by the number of those associations validated in a literature 
search. Occasions where there were no literature results for uncovered diet-parameter associations 
are marked in red. 
Dietary conditions 
Number of 
Differential 
Expressed 
Genes 
Number of asso-
ciated functional 
immunity param-
eters in model / 
number found in 
literature (Gene 
Method) 
Number of 
Regulated 
Pathways 
Number of asso-
ciated functional 
immunity param-
eters in model / 
number found in 
literature 
(Pathway Meth-
od) 
Fat.20.D.SI 0 0 128 11 / 10 
Fat.30.D.SI 6 0 238 17 / 15 
Fat.45.D.SI 30 3 / 3 260 14 / 13 
Fat.20.M.SI 0 0 292 16 / 13 
Fat.30.M.SI 3 0 369 21 / 19 
Fat.45.M.SI 37 3 / 3 349 17 / 15 
Fat.20.P.SI 0 0 120 17 / 15 
Fat.30.P.SI 1 0 207 15 / 13 
Fat.45.P.SI 4 0 243 14 / 12 
Fat.60.D.SI 62 3 / 3 230 23 / 20 
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Diet-Gene-Parameter associations 
Out of the 18 dietary conditions that have significantly differentially expressed genes, ten 
of them are related to at least one functional parameter (Table 1). These associations are 
represented in Figure 3.A which is also used as a ranking method (from the top-right). The 
top three Diet – Parameter associations (ranked from the top right) from the gene method 
are, Add.Probio.C57BL6.SI, Add.PparAgonist.SI and Add.Heme.C. 
 
 
Fat.60.P.SI 33 1 / 1 438 21 / 19 
Fibre.AX.C 3 0 532 23 / 0 
Fibre.FOS.C 0 0 669 25 / 1 
Fibre.GG.C 2 0 669 26 / 0 
Fibre.IN.C 9 1 / 0 356 25 / 7 
Fibre.RS.C 4 0 528 23 / 2 
Add.Heme.C 118 7 / 3 882 26 / 3 
Add.Quercetin.C 0 0 199 15 / 7 
Add.Quercetin.I.SI 0 0 126 11 / 8 
Add.Quercetin.J.SI 0 0 131 14 / 8 
Add.PparAgonist.SI 199 10 / 4 344 20 / 6 
Add.Probio.BALBc.C 2 0 98 9 / 3 
Add.Probio.BALBc.SI 143 5 / 4 166 21 / 14 
Add.Probio.C57BL6.C 3 1 / 0 166 17 / 9 
Add.Probio.C57BL6.SI 170 9 / 8 68 10 / 8 
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Figure 3. Diet – Parameter Associations through Genes (A) and Pathways (B). Points on both 
graphs represent the 10 dietary conditions that have associations with functional immunity parame-
ters. In both graphs, the y-axis represents the number of functional immunity parameters that are 
associated with the dietary condition. In graph A, the x-axis has the number of differentially ex-
pressed genes in a dietary condition that form the associations with the functional immunity parame-
ters on the y-axis (different scales in graphs A and B). In graph B, the number of pathway that link 
the dietary condition to functional immunity parameters is given on the x-axis.  
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Diet-Pathway-Parameter linkage 
We linked all the Reactome pathways to the functional immunity parameters with the 
gene associations obtained from the dbGaP results. Each set of FIPGs is used for pathway 
enrichment analysis. For a p-value threshold of 0.01 in 5 iterations, there were a total of 
283 pathways linked to 29 functional immunity parameters. Each functional immunity 
parameter is significantly associated with an average of 13.7 pathways while the 283 path-
ways are linked to 1.4 parameters on average. A majority (71%) of the significant path-
ways are associated with only one functional immunity parameter. 
Subsequently, with these Pathway-Parameter associations, we link the dietary conditions 
to functional immunity parameters by seeking out the differentially regulated pathways in 
which the FIPGs are over represented. We discovered that 217 pathways were significant 
in both the differential analysis and in the over-representation analysis. These 217 path-
ways were linked to 25 dietary conditions and 29 functional immunity parameters, as is 
shown in Table 1. Based on the number of significant pathways and number of functional 
immunity parameters linked to those pathways (see Figure 3.B), we ranked the dietary 
conditions. The top three dietary conditions in this ranking are Add.Heme.C, Fibre.GG.C 
and Fibre.FOS.C, see Figure 3.B.  
Functional immunity parameters associated with dietary conditions 
Overall, combining the results of both methods, we observed associations between 25 
diets and 31 functional parameters. No links were observed for T-lymphocytes, CD8 posi-
tive T-lymphocytes, Interleukin-8 and Interleukin-12. Among the functional immunity 
parameters that are associated with dietary changes, there are three with only one FIPG 
(Interleukin-1, Interleukin-10 and Complement C4b-binding protein). The parameter In-
terleukin-1 is associated with 3 dietary conditions in the gene method alone. The parame-
ters Interleukin-10 and Complement C4b-binding protein are linked to 18 (through 1 sig-
nificantly over represented pathway) and 14 (through 11significantly over represented 
pathways) dietary conditions, respectively. The functional immunity parameter that is 
linked to the most dietary conditions is Immunoglobin E which has 17 FIPGs and is asso-
ciated with 23 dietary conditions. The functional immunity parameter Erythrocytes which 
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has the largest number of FIPGs is linked to 22 dietary conditions through the pathway 
method and 5 dietary conditions by the gene method. 
Screening literature for identified Diet-Parameter associations 
We performed an automated search for co-occurrence of associated diets and functional 
immunity parameters in PubMed abstracts. The dietary changes were converted into more 
general search terms, such as “High fat”, “Dietary Heme”, and the results are shown in 
Table 1. The results of the literature search (PubMed identifiers) are given in Supplemen-
tary File 1. All the ‘Fat’ to functional parameter associations found in the gene method are 
represented in literature. The one ‘Fibre’ association from the gene method does not have 
any results in literature, neither do two ‘Fibre’ associations from the pathway method even 
though there are several associations uncovered by the pathway method. The functional 
immunity parameters associated with the 'Fat' dietary conditions have the most literature 
results.  
Highest ranked dietary intervention 
In both the gene and the pathway method, the dietary condition Add.Heme.C is among the 
top three conditions. Table 2 shows all the connections that this dietary condition has with 
the functional parameters as found in this analysis. In the gene method Add.Heme.C is 
associated with six functional parameters and is ranked third, in the pathway method it is 
ranked highest with the highest number of pathway associations (882) and parameter asso-
ciations (26).  
Table 2. Functional parameters associated with the Add.Heme.C dietary condition. Each row 
contains information on the functional immunity parameters that are associated with the ‘Additive’ 
dietary condition. Columns three and four have the number of genes and pathways that link the 
functional immunity parameter to the dietary condition via the gene method and the pathway meth-
ods respectively. 
Broad func-
tionality 
Functional immunity param-
eter 
Number of linking 
genes in the Gene 
method 
Number of linking 
pathways in the 
Pathway method 
Immune Cell Basophils 0 3 
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Immune Cell Eosinophils 1 2 
Immune Cell Erythrocytes 2 9 
Immune Cell Leukocyte Count 1 7 
Immune Cell Lymphocyte Count 0 12 
Immune Cell Lymphocytes 0 2 
Immune Cell Monocytes 0 10 
Immune Cell Neutrophils 0 3 
Immune Cell Platelet Aggregation 0 6 
Cytokine CCL2 0 2 
Cytokine Interleukin 1 Receptor Antago-
nist Protein 
0 14 
Cytokine Interleukin-6 0 5 
Cytokine Interleukin-6 Receptors 0 11 
Cytokine Interleukin-10 0 8 
Cytokine Interleukin-18 0 11 
Cytokine Monocyte Chemoattractant 
Protein-1 
0 4 
Antibody Immunoglobulin A 0 10 
Antibody Immunoglobulin E 0 9 
Cell adhesion 
molecule 
Cell Adhesion Molecules 3 3 
Cell adhesion 
molecule 
E-Selectin 0 5 
Cell adhesion 
molecule 
P-Selectin 0 5 
Cell adhesion 
molecule 
Intercellular Adhesion Mole-
cule-1 
1 2 
Others CD40 Ligand 1 29 
Others Complement C4b-Binding 
Protein 
0 1 
Others Inflammation 2 11 
Others Tumour Necrosis Factor Type 
II Receptors 
0 6 
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Discussion 
In this study, we developed and built a concept of a model that links dietary changes to 
immunity parameters that are functionally linked to immune related external phenotypes. 
This is a first-generation model and it is based only on transcriptome data because it is 
readily available for reuse from online repositories like Gene Expression Omnibus. We 
used two methods, both of which rely on gene expression data obtained from gut mucosal 
tissues. Extension of the model by inclusion of other types of data is possible, provided 
that suitable new links to functional immunity parameters can be identified for the new 
data types. For example, it may be possible to directly link proteome data to the functional 
parameters using a similar method.  
Functional parameters from dbGaP 
We obtained genes associated with selected functional immunity parameters (FIPGs) from 
the interface PheGenI (Ramos et al. 2014. Genes were associated with these selected func-
tional immunity parameters with varying levels of significance gauged by a p-value. Since 
the data were derived from a variety of studies, we decided to use all the gene associations 
regardless of the p-value and the location of the variation (SNP) on the gene. In the 
GWAS results obtained from dbGaP there are several ways in which the genes are associ-
ated with a SNP and thus a trait. Most of the association were found in intergenic regions 
of the genome. There have been concerns about assigning traits to genes that are close to 
the SNPs when it is possible that the intergenic region regulates genes much further away. 
But we decided to work with the gene assignments as deposited in dbGaP without exclud-
ing any gene to trait associations based on SNP location. There have been several studies 
that integrate gene expression data with GWAS data using expression Quantitative Trait 
Loci’s. It has been described for several traits that SNP in DNA regions that regulate the 
expression of specific genes, significantly contribute to that trait (Nicolae et al. 2010. 
Hence in this study, we used transcriptomic data to associate experimental conditions to 
traits under the assumption that differential expression of a gene will impact the same 
functions that are attributed to variations in that gene. 
 
169 
Chapter 6 
 
6 
Diet-Parameter associations and literature validations 
We obtained fewer diet to functional immunity parameter associations through the differ-
entially expressed genes than associations through significantly different expressed path-
ways. This is in line with our expectation since the number of differentially expressed 
genes is lower than the number of significant pathways in each dietary condition as shown 
in Table 1. Gene set enrichment analysis is often recommended for gene expression analy-
sis with the aim to identify differences in biological pathways, as groups of genes are 
more likely to be responsible for a functionality than a single gene (Emmert-Streib and 
Glazko 2011. This is reflected not only in the number of connections between dietary con-
ditions and functional parameters, but also in the literature validation results as there are 
more literature results for the Diet-Parameter associations obtained via the pathway meth-
od. Literature results are highly dependent on the topics that are currently studied. Among 
the ‘Fat’ and ‘Fibre’ dietary conditions there are many more literature results for the Fat-
Parameter connections, indicating dedicated experiments to measure the effect of changes 
in the fat content on aspects of the immune system. For example, Hogan et al (Hogan et 
al. 2017 discovered changes in the levels of E-Selectin and Interleukin 6 in high fat fed 
mice. Several of these experiments were performed in order to understand the develop-
ment of obesity and the immune implications of the disease. Other dietary components, 
carbohydrates and proteins, have not been implicated in diseases, hence changes in the 
immune system are not the focus of these dietary intervention studies (Lange et al. 2015, 
which results on a lower recovery rate for the identified Fibre-Parameter connections. 
Among the ‘Additive’ dietary conditions, the probiotic conditions have the most literature 
validations as they have been extensively studied in the context of gut health benefits . 
Thus, literature validation of the observed associations resulting from our model, points to 
several gaps in knowledge in the effects of diets on the immune system. Several connec-
tions that we identified between dietary interventions and functional immunity parameters 
appear not to be investigated yet. As shown in this study dietary changes do bring about 
several changes in the immune system hence should be investigated in dietary intervention 
studies. Besides recording the changes induced by the dietary interventions in internal 
phenotypes, the changes induced in immune related parameters and external phenotypes 
must be recorded more often. 
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Increased Heme in the diet 
We specifically concentrated on the dietary intervention Add.Heme.C since this Diet-
Parameter connection ranked among the top three in both the gene and the pathway meth-
ods. In this intervention, dietary heme was added to the diet in order to simulate a human 
diet rich in red meat. We have identified several inflammation related parameters linked to 
this dietary perturbation: inflammatory cytokines Interleukin-6, Interleukin-18, the CD40 
ligand, and the Inflammation parameter itself (see Table 2). Also, several immune cell 
types appear associated with the dietary condition: Neutrophils, Basophils, Eosinophils 
and Monocytes. Among the associations between “heme addition to the diet” and func-
tional immune parameters, three correspond to connections that are already described in 
literature, the link to Erythrocytes, Inflammation and Interleukin-6. These literature results 
further validate the identified links between dietary heme and inflammation (Le Leu et al. 
2013). Heme addition to the diet has also been shown to damage the colonic mucosal lay-
er and increased proliferation of epithelial cells (IJssennagger et al. 2012). However, IJs-
sennagger et al report that they observed no changes in certain inflammatory marker 
genes, which are different from the FIPGs we found to be related to inflammation. 
Uses of a Diet-Parameter model 
With the associations between dietary components and immunity parameters functionally 
involved in immune-related phenotypes that we identified in this study, it is possible to 
generate new hypothesis on how changes in diets may affect the immune system and its 
ability to defend the host against challenges. This model integrates both experimental data 
and already existing information in databases and can be expanded to build a more com-
prehensive model. In order to achieve a higher level of prediction, there needs to be an 
iterative cycle of model driven experimentation, with in vivo experiments specifically 
designed to measure associations between functional immunity parameters and dietary 
interventions. 
Availability of an extensive enough data compendium will enable a statistical model 
which would treat the functionalities of the organism or gut as an unknown variable or a 
black box and only predict the changes in functional parameters given changes in diet. 
Although this model would serve the purpose of predicting immune functional changes, it 
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would not provide insights on the mechanisms in the gut that leads to changes. Our mod-
elling approach explicitly includes measurements of internal phenotypes (i.e. tran-
scriptomics or proteomics) to uncover associations between the environment (here the 
diet) and the external immune phenotype, therefore it also has the potential to unravel the 
mechanisms behind the functional changes in the immune system induced by dietary 
changes.  
Supplementary Files 
Supplementary Table 1. Description of the 25 conditions. This table describes the ab-
breviated names of experimental conditions as used in the paper and the control condi-
tions in each of the experiments.  
  
Names Description of Experimental 
conditions 
Description of the 
control condition 
F
a
t 
Fat.20.P.SI 20% of the energy in the diet 
comes from fat, proximal sec-
tion of the small intestine is 
sampled 
10% of the energy in 
the diet comes from 
fat, proximal section 
of the small intestine 
is sampled 
Fat.30.P.SI 30% of the energy in the diet 
comes from fat, proximal sec-
tion of the small intestine is 
sampled 
Fat.45.P.SI 45% of the energy in the diet 
comes from fat, proximal sec-
tion of the small intestine is 
sampled 
Fat.20.M.SI 20% of the energy in the diet 
comes from fat, middle section 
of the small intestine is sampled 
10% of the energy in 
the diet comes from 
fat, middle section of 
the small intestine is 
sampled 
Fat.30.M.SI 30% of the energy in the diet 
comes from fat, middle section 
of the small intestine is sampled 
Fat.45.M.SI 45% of the energy in the diet 
comes from fat, middle section 
of the small intestine is sampled 
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F
a
t 
Fat.20.D.SI 20% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
10% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
Fat.30.D.SI 30% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
Fat.45.D.SI 45% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
Fat.60.D.SI 60% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
11% of the energy in the 
diet comes from fat, dis-
tal section of the small 
intestine is sampled 
Fat.60.P.SI 60% of the energy in the 
diet comes from fat, 
proximal section of the 
small intestine is sam-
pled 
11% of the energy in the 
diet comes from fat, 
proximal section of the 
small intestine is sampled 
F
i
b
r
e 
Fibre.AX.C Control diet with 10% of 
corn starch substituted 
with Arabinoxylan, sam-
pled at the colon 
Standard semi-synthetic 
low fat diet with corn 
starch as carbohydrate 
source, sampled at the 
colon 
Fibre.FOS.C Control diet with 10% of 
corn starch substituted 
with Oligofructose, sam-
pled at the colon 
Fibre.GG.C Control diet with 10% of 
corn starch substituted 
with Guar gum, sampled 
at the colon 
Fibre.IN.C Control diet with 10% of 
corn starch substituted 
with Inulin, sampled at 
the colon 
Fibre.RS.C Control diet with 20% of 
corn starch substituted 
with Resistant starch 
sampled at the colon 
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A
d
d
i
t
i
v
e 
Add.Heme.C  Control diet supplement-
ed with 0.5 µmol/g heme, 
sampled at the colon 
Westernized control diet 
(40% fat (mainly palm 
oil) low calcium (30 
µmol/g)), sampled at the 
colon 
Add.Quercetin.C RM3 (E) 801710 Soya-
free powdered diet + 7mg 
quercetin, sampled at the 
colon 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled at the colon 
Add.Quercetin.I.SI RM3 (E) 801710 Soya-
free powdered diet + 7mg 
quercetin, sampled at the 
ileum 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled at the ileum 
Add.Quercetin.J.SI RM3 (E) 801710 Soya-
free powdered diet + 7mg 
quercetin, sampled at the 
jejunum 
 RM3 (E) 801710 Soya-
free powdered diet, sam-
pled at the jejunum 
Add.PparAgonist.SI Standard laboratory chow 
(RMH-B), sampled at the 
small intestine 
Standard laboratory 
chow (RMH-B), sampled 
at the small intestine 
Add.Probio.BALBc.C SSNIFF R/M-H feed pel-
let diet or 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain BALBc 
mice, sampled at the colon 
SSNIFF R/M-H feed 
pellet diet given oral 
gavage with PBS, strain 
BALBc mice, sampled at 
the colon 
Add.Probio.BALBc.SI SSNIFF R/M-H feed pel-
let diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain BALBc 
mice, sampled at the small 
intestine 
SSNIFF R/M-H feed 
pellet diet, oral gavage 
with PBS, strain BALBc 
mice, sampled at the 
small intestine 
Add.Probio.C57BL6.C SSNIFF R/M-H feed pel-
let diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain C57BL6 
mice, sampled at the colon 
SSNIFF R/M-H feed 
pellet diet, oral gavage 
with PBS, strain C57BL6 
mice, sampled at the 
colon 
Add.Probio.C57BL6.SI SSNIFF R/M-H feed pel-
let diet with 3 * 10^8 CFU 
VSL#3 suspended in 200 
mL PBS, strain C57BL6 
mice, sampled at the small 
intestine 
SSNIFF R/M-H feed 
pellet diet, oral gavage 
with PBS, strain C57BL6 
mice, sampled at the 
small intestine 
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Supplementary Table 2. Functionalities of immunity parameters. The names of the 
functional immunity parameters are in column one along with the most well-known func-
tions of those parameters in the immune system. The last column shows the number of 
genes associated with the functional immunity parameters in the results of GWAS studies 
from dbGaP and NHGRI. The functional immunity parameters in bold are not found to be 
associated with dietary changes in either the gene method or the pathway method. 
Broad functionality Functional 
immunity 
parameter 
Functional information Number of 
associated 
genes 
(FIPGs) 
Immune Cell Basophils Leukocyte, involved in phag-
ocytosis in inflammatory 
response 
117 
Immune Cell Blood Plate-
lets 
Anucleate cellular fragments, 
first responders to wound to 
begin clotting, also have 
TLR receptors 
2 
Immune Cell CD8-Positive 
T-
Lymphocytes 
T-cell that expresses CD8 on 
the surface, two sub-types; 
cytotoxic T-cells and sup-
pressor T-cells 
2 
Immune Cell Eosinophils Leukocyte, triggered by cy-
tokines, immunoglobins and 
complements, pro-
inflammatory. 
124 
Immune Cell Erythrocytes Most abundant cell type in 
the blood, participates in 
antigen-antibody interaction, 
coats pathogens to mark for 
phagocytosis 
184 
Immune Cell Leukocyte 
Count 
Number of white blood cells 
in venous blood, immune 
cells 
137 
Immune Cell Lymphocyte 
Count 
Number of lymphocytes in 
venous blood 
2 
Immune Cell Lymphocytes Immune cells occurring in 
the lymphatic system, sub-
types are natural killer cells, 
T-cells and B-cells 
124 
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Immune Cell Monocytes Leukocyte produced in the 
bone marrow, matures to be 
a macrophage that can phag-
ocytose pathogens 
121 
Immune Cell Neutrophils Leukocyte, highly motile 
and is among the first im-
mune cells at site of stimula-
tion 
182 
Immune Cell Platelet Aggregation Clumping of platelets acti-
vated by thrombin as a first 
step of blood clotting 
103 
Immune Cell T-Lymphocytes Lymphocyte produced by 
the thymus gland, two types 
of cells; cytotoxic T-cells 
that kill invaders and helper 
T-cells that activate other 
immune cells 
2 
Cytokine CCL2 Chemokine that attracts 
monocytes or macrophages 
from blood into tissues in 
response to inflammation 
7 
Cytokine CCL4 Chemokine of family CC, 
produced by monocytes and 
macrophages 
4 
Cytokine Chemokines Class of cytokines that are 
able to induce chemotaxis in 
responsive cells, classified 
into CXC, CC, CX3C and 
XC sub-families 
9 
Cytokine Interleukin-1beta Cytokine that is produced by 
activated macrophages, 
plays a role in inflammation, 
cell proliferation and differ-
entiation 
1 
Cytokine Interleukin 1 Recep-
tor Antagonist Pro-
tein 
Cytokine that dampens in-
flammatory response 
3 
Cytokine Interleukin-2 Recep-
tor alpha Subunit 
Pluripotent cytokine, control 
regulatory T cells 
3 
Cytokine Interleukin-6 Cytokine, pro-inflammatory 
action, produced at sites of 
inflammation 
41 
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Cytokine Interleukin-6 Re-
ceptors 
A complex essential for the activity 
of Interleukin-6 
3 
Cytokine Interleukin-8 Chemokine produced by tissues and 
blood, targets neutrophils 
2 
Cytokine Interleukin-10 Cytokine synthesis inhibitory factor, 
is anti-inflammatory by limiting 
immune response 
1 
Cytokine Interleukin-12 Cytokine produced by phagocytic 
cells, pro-inflammatory action by 
inducing cytokine production 
1 
Cytokine Interleukin-18 Cytokine, pro-inflammatory action, 
regulates innate and adaptive im-
munity 
4 
Cytokine Monocyte Chemo-
attractant Protein-1 
Chemokine that attracts monocytes 
or macrophages from blood into 
tissues in response to inflammation 
22 
Antibody Immunoglobulin A Antibody, secreted from intestinal 
epithelial cells to control the growth 
of bacteria at the luminal surface of 
the gut 
17 
Antibody Immunoglobulin E Antibody, important in cross talk 
between the innate and adaptive 
arms of immunity by coating para-
sites 
17 
Cell adhesion 
molecule 
Cell Adhesion 
Molecules 
Different molecules that help cell 
bind to other cells or to the extracel-
lular matrix, also involved in wound 
healing 
108 
Cell adhesion 
molecule 
E-Selectin A cellular adhesion molecule, re-
sponsible for leukocytes adhering to 
vascular walls 
81 
Cell adhesion 
molecule 
P-Selectin Cell adhesion molecule, stored in 
platelets and secreted by endothelial 
cells, facilitates binding of platelets 
to leukocytes and allows movement 
of leukocytes on vascular surface 
28 
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Supplementary Table 3. SNP function codes when assigned to genes. This table shows 
the possible ways in which SNPs are assigned to genes as used by the NCBI database 
dbSNP and is only limited to the results that we work with. These codes are also refer-
enced in the results of PheGenI when linking traits to genes. 
Cell adhesion 
molecule 
Intercellular Adhe-
sion Molecule-1 
Cellular adhesion molecule 
that is induced by cytokines, 
participates in T-cell mediat-
ed inflammatory responses 
43 
Others Acylcarnitine Intermediate metabolite, di-
agnostic marker for fatty acid 
oxidation diseases 
2 
Others CD40 Ligand Belongs to the TNF receptor 
family, is expressed on acti-
vated T and B lymphocytes 
50 
Others Complement C4b-
Binding Protein 
Serum protein, regulates the 
classical complement activa-
tion pathway 
1 
Others Inflammation Pathological process where 
cells or tissues are injured or 
destroyed, is an immune re-
sponse to stimulus 
73 
Others Tumour Necrosis 
Factor Type II 
Receptors 
Expressed on immune cells, 
is involved in cell prolifera-
tion and cell death 
43 
Function 
Codes 
Explanation 
cds-synon synonymous change. 
intron intron. 
E.g. rs249. 
nearGene-3 within 3' 0.5kb to a gene. 
E.g. rs3916027 is at NT_030737.9 pos7669796, within 500 bp of UTR 
nearGene-5 within 5' 2kb to a gene. 
E.g. rs7641128 is at NT_030737.9 pos7641128, with 2K bp of UTR starts 
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Supplementary File 1. Results of literature search. Two zipped files one for the gene 
method and one for the pathway method, contains several text files, one for each Diet – 
Immunity parameter connection found in literature. The text files contain PubMed identi-
fiers where the dietary condition and the immunity parameter co-occur in the abstract. 
This file can be found at http://semantics.systemsbiology.nl/index.php/data-sets-used-in-
pubblications/ 
 
 
 
 
 
 
 
intergenic variant between two genes, outside of 2Kb upstream and 500bp down-
stream of a gene. 
STOP-
GAIN 
changes to STOP codon. 
E.g. rs328, TCA->TGA, Ser to terminator. 
missense alters codon to make an altered amino acid in protein product.  
E.g. rs300, ACT->GCT, Thr->Ala. 
UTR-3 3 prime untranslated region.  
E.g. rs3289. 
UTR-5 5 prime untranslated region.  
E.g. rs1800590. 
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Background 
Health has been a major research interest for years, both related to humans and to animals 
of economic value, such as farm animals. Since the gastrointestinal tract (GIT) plays a 
major role in the health of organisms, it has been the subject of many in-depth investiga-
tions. However, even though there have been undertakings to define gut health (Kogut and 
Arsenault 2016; Bischoff 2011), the definition of precise parameters to quantify and de-
fine the concept of gut health has remained elusive. Knowledge is also lacking on the fac-
tors that influence health-related functionalities of the GIT and the underlying mecha-
nisms. This is due to difficulties in studying the complex system of the GIT with precise 
measurements to capture time and spatial dynamics and fluctuations under different envi-
ronmental conditions.  
Objectives and research approaches 
The functioning of the GIT results from the simultaneous fulfilment of different biological 
processes and their mutual interactions. The various processes are heavily influenced by 
external factors such as dietary components and the use of (oral) drugs. In order to better 
understand the various processes of the gut, how they are linked together and how they are 
affected by different external factors, a holistic research approach is required, so that the 
different processes and their relationships are analysed together. Systems biology advo-
cates for such an approach (Kitano 2002), as it aims at the holistic understanding of living 
systems. As a first step in obtaining a systems’ view on the pleiotropic functionalities of 
the gut, this thesis describes the development and application of several computational 
methods to get an improved understanding of the gut as a system. The approach I used 
aggregates high throughput quantifications of intermediate biological levels (mRNA, pro-
teins, metabolites, microbiota) connecting the genotype of the organism to the external 
phenotype. Throughout this thesis these intermediate levels are denoted as internal pheno-
types (Houle, Govindaraju, and Omholt 2010; Leuchter et al. 2014). Their quantifications 
have been collected from in-house experiments, from literature and by the extraction of 
relevant information from accessible databases. Subsequently, computational methods and 
strategies have been deployed in order to integrate the multiple datasets (Figure 1).  
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Figure 1. Overview of used research methodologies and data integration. This figure 
is a representation of the multiple measurements of internal phenotypes and the types of 
data integration as described in this thesis. The colours on the parallelograms indicate 
different types of internal phenotypes which are represented along the vertical axis. On 
these parallelograms, circles represent different components of that internal phenotype 
e.g., transcripts, proteins, and microbes and arrows indicate interactions between them 
discovered from analysis of individual data sets. Arrows between layers of different col-
ours represent interactions discovered by the use of vertical data integration methods. On 
the horizontal axis, internal phenotypes are indicated which are measured at different time 
points. Arrows between them represent interactions discovered using horizontal data inte-
gration methods. The third lateral axis represents the variation in the experimental condi-
tions or interventions. Layers along this axis represent measurements of the same internal 
phenotype under different experimental conditions and the arrows between them represent 
the interactions discovered by the use of lateral data integration methods.  
Two types of integration approaches have been used depending on whether the datasets to 
be integrated are related to the same internal phenotype (horizontal, also termed lateral, 
data integration) or they are related to different internal phenotypes (vertical data integra-
tion). These approaches are schematically indicated in Figure 1. The colours on the paral-
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lelograms represent different internal phenotypes and the interactions within their compo-
nents are determined by analysing individual data types. The connections between the 
internal phenotypes shown along the vertical axis are discovered with vertical data inte-
gration techniques used in Chapters 2 and 3. The parallelograms along the horizontal and 
lateral axes represent multiple measurements of the same internal phenotype. Along the 
horizontal axis are measurements across time, with the arrows indicating connections 
found by data integration techniques. This type of data integration across time was done in 
Chapter 2 using techniques that can simultaneously handle several time points. The 
measurements across the Interventions axis are integrated with lateral data integration 
techniques, which was performed in Chapters 5 and is the basis for the model in Chapter 
6. This lateral data integration was performed with a method that can handle several da-
tasets. For clarity, the spatial dimension has been left out in Figure 1. In this thesis, the 
spatial dimension corresponds to the different parts of the intestine, such as the small in-
testine and the colon, or may relate to local (GIT) or systemic internal phenotypes. Exam-
ples of such systemic internal phenotypes are metabolite and cytokine concentrations in 
bio fluids. The integration of local and systemic internal phenotypes represents an exam-
ple of vertical data integration. It should be emphasized here that the links I have identi-
fied relate to the healthy status of the tested system. The majority of the experimental con-
ditions or interventions used in this thesis research are dietary in nature which do not dete-
riorate health. It is my belief that many of these links might be affected in pathological 
conditions or disease states, which have not been explored here.  
Time-dependent dynamics of processes in the gut after an early life perturbation 
There are several specifics that need to be accounted for while studying the gut as a 
whole. An important aspect is the time-dependent dynamics of the diverse biological pro-
cesses in the GIT system since it is known that the functioning and morphology of the gut 
changes in time as does the composition and diversity of the luminal microbiota. In Chap-
ter 2, changes in the gut of growing animals were investigated after the gut system was 
perturbed early in life. With a two-dimensional analysis of time and treatment together, it 
was found that with an interval of about 6 months, the early life perturbation still had a 
significant effect on the mucosal gene expression in the GIT of the animals. By using this 
approach, several high-level regulatory genes (linked to the functions cell cycle, cell pro-
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liferation, immune processes and ubiquitination) were identified which are most likely 
drivers of long term changes in the gut. Such high-level regulators would not have been 
discovered by application of one-dimensional approaches, which is currently most com-
mon in gene expression analyses. Such high-level regulators may be important targets for 
the development of strategies to modulate GIT associated processes over the life of the 
animal.  
In Chapter 2, not only the dynamics of the gene expression of the small intestine was 
studied but also, the dynamics of the microbial community structures along the horizontal 
axis of Figure 1. Initially, two-dimensional analysis was performed on the gene expression 
and the microbiota separately. Subsequently, the two types of dynamic data were integrat-
ed with each other i.e. integration of the horizontal and vertical axes of Figure 1. This time 
dependent integration of two different types of internal phenotypes provided information 
on possible microbe-host interactions that sustain the changes induced by the early life 
perturbation. The results showed that there were a few bacterial groups that consistently 
highly correlated with gene profiles that exhibited long lasting changes in response to the 
early life perturbation. Some of these bacterial groups (Ruminococcus bromii, Faecalibac-
terium) are known to have beneficial effects on the host but they have not been studied 
over the course of time interacting with the host. Such bacterial groups could be interest-
ing targets for dietary prebiotics in order to modulate GIT homeostasis.  
A dynamic analysis is also possible with other types of data, provided that the measure-
ments are made at the same time points. In Chapter 2, only three time points with inter-
vals of 47 and 121 days were used. However, the mechanistic information that results 
from this type of multi-dimensional analyses would benefit from shorter time intervals 
between measurements and an increased sample size. Decreasing the time intervals be-
tween sampling may provide more information on the dynamic changes that can be in-
duced by other environment changes, for example seasonal and dietary changes or chang-
es due to fertility cycles or movements between different compartments of husbandry sys-
tems. In addition, with large sample sizes, the statistical significance of the dynamic inter-
actions can be gauged more accurately. However, acquiring such data from animal experi-
ments poses several practical limitations and ethical considerations. The data used in 
Chapter 2 comes from the small intestine which is almost impossible to sample without 
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sacrificing the animal, hence samples at different time points come from different animals 
undergoing the same treatment, introducing individual variation in the data. On the other 
hand, following the same animal over time is only possible with minimally invasive tech-
niques, e.g., sampling blood and stool, which negatively impacts the mechanistic insights 
into the gut. 
Interactions between internal phenotypes 
An important aspect that needs to be resolved for a holistic systems’ understanding, is the 
interaction between various internal phenotypes. In Chapter 2 a possible cross-talk be-
tween microbes and host cells was investigated through the identification of significant 
correlations between two internal phenotypes, the gene expression profiles and the micro-
biota profiles. These correlations were expected to occur, since the early life antibiotic 
treatment is known to affect the intestinal microbiota and the subsequent cross-talk be-
tween microbiota and host cells in the intestinal mucosa. The results of the data integra-
tion pinpointed several key microbial groups which are potentially involved in the ob-
served long term changes in the intestinal mucosa. In Chapter 3, similar methods were 
used to investigate the interactions between five different internal phenotypes as measured 
at a single time point. Of these five types of data, two were based on gut associated pa-
rameters and three were based on systemic measurements. The latter were expected to be 
connected to biological processes in the gut system. By using a newly developed analysis 
pipeline, it was indeed possible to identify several biological components (genes, proteins, 
metabolites and microbes) that are linked to components that belong to another internal 
phenotypic layer. Strikingly, components were found with connections to all other internal 
phenotypic layers. Such components were denoted “connectivity hubs” and they can be 
regarded as “super system regulators”.  
The presence of such regulators shows that some components play a bigger role in ex-
changing information between internal phenotypes. The results of Chapter 3 are based on 
correlations which only points to a possible interaction between components but does not 
give information on causality. However, further investigation into the role of these con-
nectivity hubs may reveal the types of interactions and the mechanisms behind their inter-
actions. Designing new experiments to further study these interactions is not a trivial task 
186 
Chapter 7 
 
7 
given the spatial differences in the measurements. In Chapter 3 we searched existing lit-
erature for the discovered connections between the components of the internal phenotypes. 
Several literature results showed that the addition of one of the identified components in-
deed affected the connected component. Such studies give an idea of the causality be-
tween the connected components which can be investigated further. Thus, the systems 
approach used in Chapter 3 successfully generated hypothesis for targeted research to 
identify causal relationships between the various biological scales. Expanding hypothesis 
driven studies by incorporating the dynamics of time dependent changes in the profiles of 
the various molecular and cellular components, will further reduce the knowledge gap on 
gut functionalities.  
There are several considerations before measurements of different internal phenotypes can 
be integrated. It is important that all the different data being integrated originate from the 
same organism, from the same time point. Furthermore, it is useful to measure parameter 
types that are expected to influence each other. In Chapter 2, we integrated gene expres-
sion profiles of the jejunum and the composition of bacterial groups as measured in the 
same location of the small intestine. This proximity lends credibility to the possible inter-
actions between the host and microbes that are selected up by a correlation analysis. In 
Chapter 3 we integrated five data-types, two were from the same location in the small 
intestine and the other three were systemic measurements in serum and urine. Due to the 
nature of the intervention, changes in protein sources, there is reason to believe that the 
changes in the systemic measurements are linked to the changes in the intestine, i.e. the 
concentrations of amine and acyl-carnitine metabolites in the urine and blood are linked to 
the digestive capabilities in the small intestine. The differential cytokine concentrations in 
the blood are also most probably linked to the mucosal immune system of the intestine 
which is in direct contact with the changed diet. 
The integration of five different datatypes in Chapter 3 allowed the combined analysis of 
local and systemic measurements of internal phenotypes which is demands vertical inte-
gration approaches. This multi-omics integration approach is valuable and can be extend-
ed to not only explore dietary interventions, as shown in my thesis, they can also be ap-
plied to explore the effect of systemic perturbations such as stress where the majority of 
changes are brought about by signalling from the nervous system (Braun et al. 2013).  
187 
Chapter 7 
 
7 
Functional plasticity of the gut 
In contrast to other organs like the heart and liver, the gut displays a very high level of 
functional plasticity. This is phenomenon is reflected in the ability of the gut to adapt to 
the changing environment to which it is exposed. Functional plasticity of the gut can best 
be investigated by comparing gut responses after a variety of challenges under the same 
experimental conditions. Such studies with multiple challenges have not been described in 
literature and/or the data are not available via public databases. Therefore, in Chapter 5 
the transcriptional response data of mucosal tissues of mice, derived from 14 different 
individual studies, were compared. The experimental perturbations varied from mild 
changes in diet to an infection by pathogens and we stratified the challenges into dietary, 
drug based and immune challenge classes. By integrating these transcriptional responses 
of the gut to a variety of challenges, several biological processes (pathways) were found 
to be regulated irrespective of the challenge category. The consistently regulated process-
es fall in different classes, several metabolic processes, some immune processes and some 
signalling cascades, among others. The diversity of these processes indicates the number 
of sub-systems that are involved in restoring the gut to homeostasis after a perturbation of 
any sort. 
Performing horizontal integration of intestinal responses to different challenges gives an 
overview of the processes that are common in the mucosal response towards different 
types of challenges and the processes that are uniquely modulated by a single type of chal-
lenge. With these results, it is possible to answer questions like “which dietary challenges 
regulate the same processes as the processes regulated by an infection of the intestine with 
a pathogenic organism?”. Identification of these common processes may form the 
knowledge base for the development of nutritional strategies that antagonize intestinal 
infections. In Chapter 5, datasets derived from drug-based and immune challenge studies 
were underrepresented as compared to the dietary challenges. Availability of larger num-
bers of datasets derived from drug-based and immune challenge studies may improve this 
knowledge-base.  
The horizontal high-level data integration in Chapter 5 was performed at a pathway level. 
Pathways are gene-sets that also have information on the interactions between the member 
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genes of a pathway. A pathway represents a biological process and is decided on by do-
main experts. The pathway information that was used in Chapter 5 is from Reactome 
(Fabregat et al. 2016), a regularly updated and manually curated database. This pathway 
information was retrieved using the tool developed in Chapter 4. It was decided to use 
pathways as a functional unit because pathway gene-sets are more likely to regulate bio-
logical processes than single genes. However, in Chapter 5 it was found that pathways 
are not uniformly regulated by experimental conditions that belong to different challenge 
categories. A majority of the pathways were up-regulated by the experimental conditions 
irrespective of the challenge categories. However, the expression patterns of the gene-
nodes in the pathways were found to be different between experimental conditions. This 
plasticity in the intra-pathway response to challenges calls for caution when interpreting 
the pathway results.  
Another way of analysing the results of the horizontal integration of data across perturba-
tions is to critically analyse, from a biologic perspective, the regulation of a particular 
processes under different conditions. This can lead to the generation of hypotheses that 
can be tested in subsequent wet lab experiments on animals or in vitro as was done in 
Chapter 5. On the basis of the computational results, experts in the field of mucosal im-
munity hypothesised that the reason behind the regulation of several common processes in 
the gut under such a variety of conditions was the induction of a low-grade inflammatory 
condition. The pathway ‘Regulation of Complement Cascade’ was observed to be part of 
the processes implicated in functional plasticity of the gut. This was surprising because the 
Complement Cascade process is not expected to be active in gut tissue. The hypothesis of 
the low-grade inflammation was tested on the pathway ‘Regulation of Complement Cas-
cade’ by designing an in vitro experiment that only exposed small intestinal cells to in-
flammatory conditions. Mice small intestinal organoids were stimulated with an inflam-
matory cytokine (TNF alpha), a PPARalpha agonist and flagellin to study the effects of 
these challenges on the local system. Among the three stimulations, the cytokine elicited 
the maximum response from genes in the ‘Regulation of Complement Cascade’ pathway. 
Besides proving that this pathway is indeed expressed in the intestinal tissue, this valida-
tion experiment showed that this ‘Regulation of Complement Cascade’ pathway is indeed 
regulated under low inflammatory conditions. Although experimental validation was not 
done, another pathway regulated by all the three categories of challenges, ‘Laminin Inter-
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actions’ is also known to be stimulated by inflammatory cytokines. Thus, by using the 
results of integrative computational approaches as a basis for the generation of hypotheses 
on biological processes, improved insights into the mechanisms underlying these process-
es in the gut may be obtained. This process is sometimes called a ‘wet-lab – dry-lab’ cycle 
in systems biology as described by Kitano (Kitano 2002) which is a data-driven design of 
an experiment.  
Immune modulation by dietary changes 
The results of the lateral data integration in Chapter 5 showed that dietary interventions 
have an impact on the activity of components that belong to the immune system. Although 
changes in the immune system have been observed for certain dietary changes like and 
increase in fat intake, most dietary intervention studies do not analyse the effects of the 
dietary change on the immune system. In Chapter 6 we aimed to find links between die-
tary changes and specific immune parameters functionally related to the immune system 
using experimental data from Chapter 5 and information that is present in publicly availa-
ble databases. With these combined resources, we developed a first-generation model rep-
resenting potential links between dietary changes and the expression of relevant immunity 
parameters. This model predicts the functional parameters that could be influenced by 
certain changes in the diet while it also provides insights into mechanisms causing these 
changes. With literature validations, it was proved that some of the predicted connections 
between dietary changes and the functional immunity parameters already have been de-
scribed in literature. This underscores the biological relevance of the computational output 
of the model. The model predicts that several changes in diets induce an unexpectedly 
high level of changes in the immune system.  
To improve the predictability of the model and to allow the use of more detailed infor-
mation on the dietary input side, this immunity parameter model needs to be validated 
with more data. Predictive and simulation models always need to go through a step of 
validation using data (Kohavi 1995; Sargent 2013). But the work in Chapter 6 did not 
have this validation step due to a lack of proper data. This validation is usually done with 
data from similar conditions as the data used to build the model. For example, the connec-
tions between the dietary condition where the fibre Arabinoxylan is added to the diet and 
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23 functional immunity parameters can be validated by using another dataset with a simi-
lar dietary change. The new dataset is subject to the same analysis to discover connections 
to the functional immunity parameters, and the overlapping connections will have higher 
confidence as predictions. But this type of validation could not be performed since there 
were a limited number of datasets that fit the selection criteria as mentioned in Chapter 6. 
Sometimes a few samples of the same dataset are left out of building the model in order to 
be used for validation. This was also not possible with the data that we had because of the 
small sample sizes in the experiments. Besides data validation, the model can also be vali-
dated with specifically designed experiments based on the ‘wet-lab – dry-lab’ cycle. New 
experiments on animals could be designed to test the connections found in the Diet-
Immunity model by introducing changes in the diet and measuring the internal phenotypes 
and the functional immunity parameters. The results of such experiments could prove or 
disprove the predicted connections between dietary changes and parameters of the im-
mune system. 
While building this model, we used the transcriptome internal phenotype to link it to func-
tional immunity parameters. This was done by using data that result from Genome Wide 
Association Studies (GWAS) that use Single Nucleotide Polymorphisms (SNPs) to link 
certain traits to genes. By linking dietarily perturbed genes or gene-sets to these trait-
associated SNPs and the location of the SNPs near genes, it was possible to link the diets 
to chosen traits. Due to the expected increase in knowledge on SNP variation and their 
relationships with trait characteristics it will be possible to further refine the model. Intro-
ducing a stricter threshold for SNP to gene associations from GWAS databases, could also 
increase the confidence of the connections between dietary changes and the functional 
immunity parameters.  
The Diet – Immunity parameter model was built with both gene and pathway information 
from transcriptomic data. In the horizontal integration as described in Chapter 5 we ob-
served a plasticity in the response of the pathway to stimulations. This plasticity can be 
used to further refine the model by using the pathway response pattern as an indicator of 
the changes in the functional immunity parameter. Even though the model was limited to 
only account for changes in functional parameters associated to immunity, the method 
developed can be expanded to encompass a wider range of external phenotypes.  
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The model developed in Chapter 6 was built to predict the effects of dietary changes on 
the immune system. An expanded and quantitatively validated version of this model may 
in future be used to find important modulators (genes, proteins or metabolites) of the im-
mune system. When the diet – immunity parameter model can predict, with reasonable 
accuracy, the effects of dietary changes on the immune system, it would be possible to 
take the model a step further. With enough data on dietary compositional changes, internal 
phenotypes and functional immunity parameters, this model could, theoretically, be used 
to predict the organism’s immune competence. This objective is not easy to reach since 
immune competence depends on a wide number of known and unknown factors, including 
individual genetic variation and early life programming. 
Computational methods 
During most of the work presented in this thesis, I was able to develop tailor made data 
analysis pipelines through combinations of already existing and tested methods. This was 
enabled by the existence of strict requirements regarding software interoperability and 
documentation. All the pipelines were developed in R, an open-source scripting language. 
On one occasion, I had to modify the inner workings of an algorithm (CePa (Z. Gu and 
Wang 2013)) so that it would suit the data and the analysis requirements. The software 
tool presented in Chapter 4 is a function that would retrieve full pathways, while ensuring 
inter-operability with the rest of the tools in the software package. All these pipelines were 
made possible because the code was accessible and it was possible to edit it to suit the 
specific research question at hand. This is due to open source initiatives that allow code to 
be publicly shared.  
I also used several freely accessible databases for gathering both data and knowledge. 
Some of the databases I used are Reactome, Gene Expression Omnibus (Barrett et al. 
2013), dbGaP (Tryka et al. 2014) and PubMed. Most of this information was retrieved 
automatically with packages from R that can interface directly with these databases. This 
access allows a user to make maximum use of all the information stored in databases of 
different types with a high-throughput data search. For example, in Chapters 3 and 6 we 
used the R package rentrez (Winter 2016) that can gather information from the NCBI ap-
plication programming interface and search through PubMed abstracts for co-occurrences 
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of specific search terms. With this method, it was possible to quickly ascertain the amount 
of literature on a subject and delve into specific publications as required, even if only the 
abstracts were publicly available. 
An important aspect of systems biology is to understand the interactions between different 
parts of the system. In this thesis, this was achieved with vertical data integration. I inte-
grated measurements of internal phenotypes to discover interactions between them. From 
a computational perspective, if the different data-types are being integrated, it is important 
that all of them undergo the same pre-processing steps. Only this will allow a proper com-
parison between the different measurements. The results of a differential analysis cannot 
be compared to that of a time-series analysis because the premise of the two methods is 
different. More than two types of data are not often integrated. However, with the ap-
proach described in Chapter 3, I showcase a flexible method that can be used on any type 
of data and is built upon existing methods integrating two data types at a time. Methods 
that can handle more than two non-specific datasets simultaneously, like MCIA (multiple 
co-inertia analysis) (Meng et al. 2014) compare several datasets rather than discover pos-
sible interactions between them. Other methods that can indeed integrate more than 2 data 
types simultaneously are specific to certain types of data and are sometimes cumulative, 
i.e. two datasets are integrated and a third dataset is integrated to the results of the first 
integration. 
The presented approaches for data integration most often rely on correlations. Correlation 
analysis is a technique often used in individual data analysis and in data integration and 
has often been used in this thesis for data integration. The results of correlation studies 
must be interpreted with caution as correlation and causation relationships are frequently 
confused. A major opposition to correlation analysis is that it might often lead to the iden-
tification of spurious associations due to indirect associations. The fact that one variable 
(e.g. gene) changes along with another variable (e.g. metabolite) does not necessarily 
mean that one controls the changes in the other. Sometimes there is an independent agent 
causing these changes in both the variables but is not captured due to the inability to meas-
ure it or due to time delays in the measurements.  
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The methods used in Chapters 2 and 5 to find significant correlations between the ana-
lysed datasets were specifically devised to diminish the possible impact of these spurious 
associations. In both chapters, sparse Partial Least Squares (sPLS) was chosen to mini-
mize the possible number of false positives in the data integration result. This method pe-
nalizes the inclusion of interactions, thereby effectively minimizing them. Disentangling 
causative effects following the approaches presented here could be done by using so-
called time delayed correlations, in which the correlations between both data types is done 
by introducing a shift to account for the different time points at which the measurement 
was taken. However, these methods can only be applied when time series data with suffi-
cient resolution is available, for example measurements made within hours of each other. 
Here the only chapter in which time data series data was used was Chapter 2 but these 
time points are too far apart, with intervals of several weeks, to allow for this type of anal-
ysis.  
In Chapter 5 the validity of the sPLS correlation approach on multi-layered integration 
was tested using a permutation test. A permutation test enables precise measurements of 
the power of an algorithm to detect a signal. The test compares the data from the biologi-
cal system (measurements of internal phenotypes) to permuted data that contains no infor-
mation. This is a powerful approach that also lies at the core of the selected method for 
pathway enrichment analysis when gauging the significance of the pathway score. There I 
permuted the gene expression values in the pathway nodes in order to remove biological 
information from the pathway before computing the pathway score. This randomised 
score is computed several times and the likelihood of the occurrence of the original score 
is calculated. This value is used to gauge significance of the pathway score. 
Data integration over different perturbations provided information on the functional plas-
ticity of the gut. With the horizontal integration performed in Chapter 5, changes in gene 
expression of the intestinal epithelial cells were detected that contribute to the functional 
plasticity of the gut. However, the transcriptional profile is only one aspect of the func-
tioning of the gut. The integration of other types of data, like microbial or protein compo-
sition, may contribute to a further understanding of the functional plasticity of this com-
plex system. 
194 
Chapter 7 
 
7 
Requirements to improve results of integrative research approaches  
During the computational research as described in this thesis, I have gathered knowledge 
on the current limitations in the performance of integrative research approaches. These 
limitations often boil down to lack of sufficient detail on the descriptions of experiments 
and most often they could be overcome by an improved annotation of information in data-
bases.  
1. Availability of experimental data 
Often animal experiments are not comparable because they have different measurements 
of biological parameters based on the research questions in that experiment. There are a 
few measurements that are almost always performed like weighing the animal and estimat-
ing food and water consumption. The data most often used in this thesis are derived from 
genome-wide transcription measurements using microarrays. The decrease in prices of the 
use of sequencing technologies and the ever-growing speed in sequence acquisition has 
provoked a sharp rise in datasets related to complete genome structures (Stephens et al. 
2015), gene expression patterns and information on the composition, diversity genetic po-
tential and activity of microbiomes. Mass spectrometry based techniques for proteomics 
and metabolomics are increasingly being used but the costs incurred by these measure-
ments limit the studies that perform them. The decrease in prices of sequencing techniques 
and the increased interest in the role of the microbiota have increased availability of micro-
biota measurements.  
Several repositories exist where datasets generated from experiments can be deposited 
such that they are freely available to the public. It is important that these repositories are 
stable to ensure that the data is available over a long period of time. In the case of sensitive 
data (e.g., patient information) there are several cyber security measures to only make 
parts of the data public. Some databases are specifically for one type of data, like Gene 
Expression Omnibus (GEO) and Array Express (Kolesnikov et al. 2015), which are for 
gene expression from either microarrays or RNA sequencing techniques. NCBI and EBI 
have several databases for different types of data, like protein sequences, but there are also 
repositories like Zenodo that can handle any type of data. These general purpose databases 
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are often used for metabolomics data since there are very few dedicated databases to store 
metabolomic data from experiments, e.g. Metabolights (Haug et al. 2013). 
2. Data description 
Repeatability of an analysis and reusability of shared data by an independent party re-
quires good data description. There are well-known standards that need to be followed 
while reporting an experiment or depositing the data from an experiment in a database. 
Reports on animal experiments in publications are required to follow the Animal Re-
searching: Reporting on In Vivo Experiments (ARRIVE) guidelines set by National Cen-
ter for the Replacement Refinement and Reduction of Animals in Research (Kilkenny et 
al. 2010). The meta-data in databases is required to adhere to a general set of guidelines 
for minimal information that should be provided for each experiment the – Minimum In-
formation for Biological and Biomedical Investigations (MIBBI) (C. F. Taylor et al. 
2008). These guidelines detail the information to be included such as information on ethi-
cal permissions, size of experimental and control groups, precise description of experi-
mental and surgical procedures and sample description, among others. 
Ambiguity of the experimental descriptions can be reduced by using the meta-data de-
scription terms from an ontology (agreed upon terms used in a particular field). Using 
ontologies also facilitates using meta-data terms as search terms to increase sensitivity and 
specificity when searching for data from specific experimental conditions. This issue with 
meta-data was especially apparent in the work done in Chapter 5 where several publicly 
available datasets were re-used for analysis from a different perspective. A few datasets 
were left out of the analysis due either to ambiguity or lack of detail in the metadata. The 
databases that store the experimental data should expand the minimal meta-data that is 
required before a data submission is accepted. Another practise that could be adopted by 
the databases is to use ontologies or thesauri like Medical SubHeadings (MeSH) for the 
keywords used in the description. 
Both issues enumerated above related to experimental data availability and data descrip-
tion, greatly limit re-usability of existing data. There are two major reasons for re-using 
data, to verify the results of the original study or to use the same data for a different re-
search question. Being able to verify results of a study is the idea behind publishing and 
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the cornerstone of research itself. Another frequent reason for re-using data is to perform 
an analysis similar to the integration performed in Chapter 5 of this thesis.  
Issues with data availability and meta-data can be addressed by making data Findable Ac-
cessible Interoperable and Reusable (FAIR) as detailed by Wilkinson et al (Wilkinson et 
al. 2016). Fulfilling the first two parts of FAIR, Findable and Accessible, requires that the 
data be publicly available so that a human user or machine can find it and use it with ap-
propriate permissions. Carrying out an integrative or meta-analysis is often restricted to 
specific experimental conditions which can only be identified with distinctive search 
terms and extensive meta-data. Once the data has been obtained, most often, it needs to be 
pre-processed. For example, there could be an identifier (id) mapping step where the ids 
used in each experiment are mapped to each other. The Interoperable part of the FAIR 
principle pushes data harmonisation steps from the end user to the data generator. Besides 
this id mapping requirement, interoperable data must be ready not only for human under-
standing but also for machine access. Satisfying the first three conditions (F, A, I) helps 
with the last principle of making data Re-usable but also requires very detailed experi-
mental information.  
The responsibility for making data FAIR falls partly on researchers who must take the 
initiative to properly document their data. But the power to enforce the recommendations 
(FAIR, ARRIVE, MIBBI) for data descriptions resides partly with the journals that pub-
lish the results of the experiments and databases that host the data from the experiments. 
This drive for proper data stewardship is currently gaining momentum among large fund-
ing agencies which have the most power to enforce these guidelines. 
3. Annotation of data 
Another important issue when dealing with biological data is the annotation of biological 
entities with functions that they are observed to perform. In the transcriptomics data that 
were used in this thesis, there are several gene sequences on the microarray that lack func-
tional annotation. Such un-annotated entities cannot be used for further analysis, for exam-
ple, when converting the animal gene ids (mice or pigs) to human ids. This id conversion 
step to human ids is essential since there are several databases (or knowledgebases) that 
have most information on human data. The functional annotation of microbial rRNA se-
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quences is limited by the lack of information on the roles of microbes in a habitat, e.g. the 
gut. 
The research described in Chapters 5 and 6 is based heavily on pathway information 
which was obtained from the Reactome database. Interactions between nodes in a pathway 
are assigned based on information in existing literature. This means that there could be 
several annotations for an interaction between nodes since these interactions are some-
times studied under various conditions. There is also the issue that there are several defini-
tions of pathways depending on the database and there is no consensus on what constitutes 
a pathway. It would be easier for end users if there were mappings between the different 
pathway databases to connect pathways with similar information. 
The datasets used in this thesis represent so-called internal phenotypes. For the model in 
Chapter 6, the transcriptional internal phenotype was used. There is, however, an ambi-
guity surrounding the terms external phenotype and trait, which are often used in the same 
context, but some researchers define a phenotype as a measurable trait (Beck et al. 2012). 
In several cases the traits or phenotypes in databases are linked to pathological states. 
There are databases that link genes to traits or external phenotypes which are specific to 
domains or organisms. The database used in Chapter 6 is dbGaP which is specific for 
human data and links genes to traits (from MeSH terms) based on results of GWAS stud-
ies. The database Mouse Genome Informatics has plenty of information on linking genes 
to traits (from the Mammalian Phenotype Ontology (C. L. Smith and Eppig 2009)) based 
on mice studies. Traits of production animals are documented in the Animal Trait Ontolo-
gy for Livestock (Golik et al. 2012) and has information on the species where the trait is 
present or absent. It is possible to map these ontologies to obtain maximum information 
from them. Such attempts can be found in the ontology repository BioPortal using the 
automatic matching tool LOOM. These automatic mappings definitely need manual cura-
tion especially since there is ambiguity around the words trait and phenotypes. In this the-
sis, the information in dbGaP was used since it contained traits that can be measured to 
gauge the functionality of the immune system. Also, the results of GWAS studies have 
been linked to the expression of the trait-associated genes, which lends credence to linking 
gene expression changes to GWAS results. 
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Final remarks 
Most of the research as described in this thesis was performed on already existing data 
with available methods and extensions of existing methods. This research demonstrated 
that the re-use of existing data and their analysis from a systems wide perspective, pro-
vides unique insights into the functioning of the system. It indicates that hidden infor-
mation is present in currently available databases and datasets, that can be extracted with 
methodologies that arise from the objective to understand the functioning of systems as a 
whole. Although we are far from a model that represents a “virtual gut” the research in 
this thesis demonstrates computational methods can be developed and applied to get im-
proved insight into time-dependent dynamics of a gut systems, to obtain information on 
key links between internal phenotypic of different biological levels, to understand the 
functional plasticity of the gut mucosal tissue, and to develop a concept of a model that 
allows to make links between internal phenotypes and to immunity parameters functional-
ly related to external immune-based phenotypes. 
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The gastrointestinal tract is subject of much research for its role in an organism’s health 
owing to its role as gatekeeper. A major function of the gut is to act as a barrier to chal-
lenges from the external environment. The tissue must keep out harmful substances like 
pathogens and toxins while absorbing nutrients that arise from the digestion of dietary 
components in in the lumen. There is a large population of microbiota that plays an im-
portant role in the functioning of the gut, digestion and homeostasis of the immune sys-
tem. All these sub-systems of the gastrointestinal tract contribute to the normal function-
ing of the gut. Due to its various functionalities, the gut is able to respond to different 
types of stimuli and bring the system back to homeostasis after perturbations. This ability 
is called the functional plasticity of the gut. Chapter 1 provides more information on the 
morphology and functionality of the gut. The techniques for the measurements of various 
internal phenotypes (measurements of transcripts, proteins and metabolites, among others) 
are described. It describes the various methods traditionally used to study the gut and the 
novel methods used in this thesis to study the gut from a more holistic perspective. It also 
introduces the two types of data integration methods used in the thesis, vertical and hori-
zontal integration. Vertical integration finds connections between different types of data 
and horizontal data integration combines several datasets of the same type of data. These 
data integration methods were used in the following five chapters to gain insights into the 
dynamics of a perturbed gut system over several time points, to find connections between 
different types of biological measurements (gene expressions, proteins, metabolites and 
microbes), to improve our understanding of the functional plasticity of the gut under vari-
ous types of challenges and to link changes in the diet to changes in the local and systemic 
immune system. 
The work in Chapter 2 aimed to improve our understanding of the dynamics of the gut 
functionality that contributes to long lasting changes in the intestinal mucosal tissue. The 
data were obtained from a pig experiment where an antibiotic was administered at a very 
early age, along with stress that would be common in a farm environment. The small in-
testines of these animals were then sampled at three time points over the next six months 
to obtain the measurements of two internal phenotypes; gene expression of the intestinal 
mucosal tissue and microbial community data from the luminal content at the same loca-
tion in the gut. The data analysis in this chapter involves both horizontal data integration 
(across time) and vertical data integration (integration of gene expression with microbio-
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ta). The integration across time was performed along two dimensions by taking into ac-
count the time dynamics and the treatment effects simultaneously. This was done using a 
regression-based method on both the gene expression and microbiota data. Subsequently 
the results of the time dynamics and treatment effects were integrated with each other. 
This vertical integration was performed based on correlations to discover potential cross-
talk between the host and microbiota that are affected both by treatment and time. The 
results show that there are several genes with consistent long term changes in their gene 
expression. These genes could be important regulators of gut functionalities. These regula-
tors seem to cause the persistent changes in the tissue gene expression. The vertical data 
integration revealed the important roles of a few bacterial groups in maintaining the long-
term changes in the gene expression. These results provide insights into the dynamic inter-
actions between the host and its microbes.  
Interactions between internal phenotypes were further studied in Chapter 3, where five 
measurements of internal phenotypes were obtained from dietary interventions in mice. 
The mice were given diets with different protein sources and several different internal 
phenotype measurements were made in the intestine, serum and urine. From the same lo-
cation of the small intestine, scrapings were used to obtain gene expression profiles of the 
mucosal tissue and the content was used to acquire data on microbial community struc-
tures. Cytokine levels in the serum were measured along with metabolomic profiles. 
Metabolomic data was also obtained from urine. Pairwise correlation analysis was per-
formed ten times to integrate each dataset to the other four and these results were com-
bined to obtain an integrated network with elements from all the five datasets. The corre-
lations from the pairwise integration were verified using a permutation approach that 
checks whether the observed correlations are based on biological information in the data. 
The connections between internal phenotypes were validated with a literature search for 
co-occurrence of the connected components. The results of this literature search revealed 
that several connections uncovered in this Chapter have been found previously in other 
studies. The integrated network was found to contain several components that were linked 
to all other four types of data. These components were denoted “connectivity hubs”. The 
presence of such hubs indicates that there are some components of the internal phenotypes 
that are more involved in the interactions between internal phenotypes than others. The 
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hypotheses generated in this study can be used to design wet-lab experiments to validate 
uncovered connections between the internal phenotypes. 
Pathways are groups of functionally related genes with information on the interactions 
between the genes that fulfil a biological function. When integrating several transcriptom-
ics datasets together (horizontal integration) the analysis is more comparable between ex-
periments and platforms when analysed with pathway expression rather than gene expres-
sion. Pathway data from several databases is available in a Resource Description Frame-
work format called BioPAX (Biological Pathway eXchange) which is not easy to work 
with for transcriptomic analysis. In order to use this information in the R environment, an 
open source programming language and software environment for statistical computing 
and graphics, the package rBiopaxParser converts the BioPAX object into one that can be 
utilised in R. One important function in this package is pathway2RegulatoryGraph which 
converts the information in a pathway to a graph of the regulatory components in the path-
way. Chapter 4 is a description of a new function pathway2Graph that can use all infor-
mation in the pathway to build a graph of the entire pathway. This function has been in-
corporated into the package rBiopaxParser distribution. 
The gut is exposed to a variety of challenges and its response to them is of utmost im-
portance since the gut is a critical barrier to the external environment. The functional plas-
ticity displayed by the gut allows an appropriate response of the gut towards a variety of 
challenges, perturbations and/or stimulations. In order to study the mechanisms behind 
functional plasticity, in Chapter 5 a horizontal integration of intestinal mucosal gene ex-
pression profiles was performed after exposure to three categories of challenges: dietary, 
drug-based or immune challenges. These transcriptomics datasets, derived from 14 inde-
pendent experiments in mice, were obtained from an online database in order to study the 
gut under different challenging conditions. The gene expression analysis was performed 
on a pathway level and combined with information present in the Reactome database ob-
tained with the pathway2Graph function developed in Chapter 4. A high-level data inte-
gration was performed where the datasets are analysed separately and only the results are 
integrated. The results of the high-level data integration demonstrated that there is a con-
siderable overlap in the significantly regulated pathways induced by the three categories 
of challenges. We concluded that these common processes contribute to the functional 
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plasticity of the gut. One of the processes common to the three challenge categories is 
‘Regulation of Complement Cascade’, which is an immune process that is regulated in 
several of the dietary challenge experiments. Since the regulation of this process is not 
expected in the gut tissue, a validation experiment was designed using mice intestinal or-
ganoids to understand the conditions that lead to the regulation of this pathway. The re-
sults suggest that an inflammatory condition could be the reason behind the regulation of 
this pathway. Thus, by performing targeted experiments, based on the results of computa-
tional analyses, helps to better understand the mechanisms behind the functional plasticity 
of the gut. The high-level data integration on different types of challenges, as described in 
Chapter 5, showed that the dietary changes induced changes in immune-related process-
es. Therefore, in Chapter 6, a model was built to find connections between dietary chang-
es and functional immunity parameters. The data from 9 dietary challenge studies was 
analysed for differentially expressed genes and differentially regulated pathways. In order 
to obtain links between genes and functional immunity parameters, information from Ge-
nome Wide Association Studies (GWAS) were used that are deposited in the NCBI data-
base Genotype and Phenotype. GWAS links traits to Single Nucleotide Polymorphisms 
(SNP) that are subsequently linked to genes based on the proximity of SNP’s to genes. We 
retrieved this trait to gene associations for selected functional immunity parameters that 
can be measured and linked to the immune status of organisms. We formed associations 
between dietary changes and functional immunity parameters through the genes and path-
ways. These connections were validated through a literature search which established that 
there have been studies linking some dietary changes to the changes in the functional im-
munity parameters predicted by the model.  
Chapter 7 is a general discussion of all the five research chapters. The ways in which the 
research objectives were achieved are enumerated along with details of the methods used. 
Work that can be performed on the current results to improve the understand of the gut is 
also detailed. I discuss current bottlenecks and possible ways to increase our understand-
ing of gut function. It is concluded that the re-use of existing data and their analysis from a 
systems wide perspective, provides unique insights into the functioning of biological sys-
tem. It is also concluded that hidden information, which is present in currently available 
databases and datasets, can be extracted with methodologies that arise from the objective 
to understand the functioning of systems as a whole. Finally, it is concluded that the re-
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search in this thesis demonstrates that computational methods can be developed and ap-
plied to get improved insights into the time-dependent dynamics of a gut systems, to ob-
tain information on key links between internal phenotypes of different biological levels, to 
better understand the functional plasticity of the gut mucosal tissue, and to develop models 
that allows to make links between internal phenotypes and to immunity parameters func-
tionally related to external immune-based phenotypes. 
 
 
 
  
 
 
References 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
209 
References 
 
Abell, Guy C J, Caroline M Cooke, Corinna N Bennett, Michael A Conlon, and Alexandra L 
McOrist. 2008. “Phylotypes Related to Ruminococcus Bromii Are Abundant in the Large 
Bowel of Humans and Increase in Response to a Diet High in Resistant Starch.” FEMS 
Microbiology Ecology 66 (3). The Oxford University Press: 505–15. 
Adourian, Aram, Ezra Jennings, Raji Balasubramanian, Wade M Hines, Doris Damian, Thomas N 
Plasterer, Clary B Clish, et al. 2008. “Correlation Network Analysis for Data Integration and 
Biomarker Selection.” Molecular BioSystems 4 (3). The Royal Society of Chemistry: 249–59. 
doi:10.1039/B708489G. 
Ahmad, R, R Chaturvedi, D Olivares-Villagomez, T Habib, M Asim, P Shivesh, D B Polk, et al. 
2014. “Targeted Colonic Claudin-2 Expression Renders Resistance to Epithelial Injury, 
Induces Immune Suppression, and Protects from Colitis.” Mucosal Immunol 7 (6). Society for 
Mucosal Immunology: 1340–53. http://dx.doi.org/10.1038/mi.2014.21. 
Ahmed, Rafi, and David Gray. 1996. “Immunological Memory and Protective Immunity: 
Understanding Their Relation.” Science 272 (5258). American Association for the 
Advancement of Science: 54–60. 
Akavia, Uri David, Oren Litvin, Jessica Kim, Felix Sanchez-Garcia, Dylan Kotliar, Helen C. 
Causton, Panisa Pochanard, Eyal Mozes, Levi A. Garraway, and Dana Pe&apos;Er. 2010. 
“An Integrated Approach to Uncover Drivers of Cancer.” Cell 143 (6): 1005–17. 
doi:10.1016/j.cell.2010.11.013. 
Akira, Shizuo, and Kiyoshi Takeda. 2004. “Toll-like Receptor Signalling.” Nat Rev Immunol 4 (7): 
499–511. http://dx.doi.org/10.1038/nri1391. 
Albert, Reka, Hawoong Jeong, and Albert-Laszlo Barabasi. 2000. “Error and Attack Tolerance of 
Complex Networks.” Nature 406 (6794): 378–82. http://dx.doi.org/10.1038/35019019. 
Alex, Philip, Nicholas C Zachos, Thuan Nguyen, Liberty Gonzales, Tian E Chen, Laurie S Conklin, 
Michael Centola, and Xuhang Li. 2009. “Distinct Cytokine Patterns Identified from 
Multiplex Profiles of Murine DSS and TNBS-Induced Colitis.” Inflammatory Bowel Diseases 
15 (3): 341–52. doi:10.1002/ibd.20753. 
Alexa, Adrian, and Jörg Rahnenführer. 2009. “Gene Set Enrichment Analysis with topGO.” 
Available. 
Antezana, Erick, Martin Kuiper, and Vladimir Mironov. 2009. “Biological Knowledge 
Management: The Emerging Role of the Semantic Web Technologies.” Briefings in 
Bioinformatics 10 (4). England: 392–407. doi:10.1093/bib/bbp024. 
Antonopoulos, Dionysios A, Susan M Huse, Hilary G Morrison, Thomas M Schmidt, Mitchell L 
Sogin, and Vincent B Young. 2009. “Reproducible Community Dynamics of the 
Gastrointestinal Microbiota Following Antibiotic Perturbation.” Infection and Immunity 77 
(6): 2367–75. doi:10.1128/IAI.01520-08. 
210 
References 
 Arrieta, Marie-Claire, and Barton Brett Finlay. 2012. “The Commensal Microbiota Drives Immune 
Homeostasis.” Frontiers in Immunology 3. Frontiers Media SA. 
Arrieta, Marie-Claire, Leah T Stiemsma, Nelly Amenyogbe, Eric M Brown, and Brett Finlay. 2014. 
“The Intestinal Microbiome in Early Life: Health and Disease.” Frontiers in Immunology 5. 
Frontiers Media SA. 
Artis, David. 2008. “Epithelial-Cell Recognition of Commensal Bacteria and Maintenance of Im-
mune Homeostasis in the Gut.” Nat Rev Immunol 8 (6). Nature Publishing Group: 411–20. 
http://dx.doi.org/10.1038/nri2316. 
Ashburner, Michael, Catherine A Ball, Judith A Blake, David Botstein, Heather Butler, J Michael 
Cherry, Allan P Davis, et al. 2000. “Gene Ontology: Tool for the Unification of Biology.” 
Nat Genet 25 (1). Nature America Inc.: 25–29. http://dx.doi.org/10.1038/75556. 
Assenov, Yassen, Fidel Ramírez, Sven-Eric Schelhorn, Thomas Lengauer, and Mario Albrecht. 
2008. “Computing Topological Parameters of Biological Networks.” Bioinformatics 24 (2): 
282–84. http://bioinformatics.oxfordjournals.org/content/24/2/282.abstract. 
Avalle, Lidia, Sara Pensa, Gabriella Regis, Francesco Novelli, and Valeria Poli. 2012. “STAT1 and 
STAT3 in Tumorigenesis: A Matter of Balance.” JAK-STAT. doi:10.4161/jkst.20045. 
Barabasi, Albert-Laszlo, and Zoltan N Oltvai. 2004. “Network Biology: Understanding the Cell’s 
Functional Organization.” Nat Rev Genet 5 (2): 101–13. http://dx.doi.org/10.1038/nrg1272. 
Barrett, Tanya, Stephen E Wilhite, Pierre Ledoux, Carlos Evangelista, Irene F Kim, Maxim To-
mashevsky, Kimberly A Marshall, et al. 2013. “NCBI GEO: Archive for Functional Ge-
nomics Data Sets—update.” Nucleic Acids Research 41 (D1): D991–95. doi:10.1093/nar/
gks1193. 
Bayerlová, Michaela, Klaus Jung, Frank Kramer, Florian Klemm, Annalen Bleckmann, and Tim 
Beißbarth. 2015. “Comparative Study on Gene Set and Pathway Topology-Based Enrichment 
Methods.” BMC Bioinformatics 16 (1): 334. doi:10.1186/s12859-015-0751-5. 
Beck, Tim, Robert C Free, Gudmundur A Thorisson, and Anthony J Brookes. 2012. “Semantically 
Enabling a Genome-Wide Association Study Database.” Journal of Biomedical Semantics 3 
(1). BioMed Central: 9. doi:10.1186/2041-1480-3-9. 
Belkaid, Yasmine, and Timothy W Hand. 2014. “Role of the Microbiota in Immunity and Inflam-
mation.” Cell 157 (1): 121–41. doi:10.1016/j.cell.2014.03.011. 
Benchaoui, H A, M Nowakowski, J Sherington, T G Rowan, and S J Sunderland. 2004. 
“Pharmacokinetics and Lung Tissue Concentrations of Tulathromycin in Swine.” Journal of 
Veterinary Pharmacology and Therapeutics 27 (4). Blackwell Science Ltd: 203–10. 
doi:10.1111/j.1365-2885.2004.00586.x. 
211 
References 
 Benis, Nirupama, Dirkjan Schokker, Frank Kramer, Mari A. Smits, Maria Suarez-Diez, Nirupama 
Benis, Dirkjan Schokker, Frank Kramer, Mari A. Smits, and Maria Suarez-Diez. 2016. 
“Building Pathway Graphs from BioPAX Data in R.” F1000Research 5 (December): 2414. 
doi:10.12688/f1000research.9582.2. 
Benis, Nirupama, Dirkjan Schokker, Maria Suarez-Diez, Vitor A P Martins Dos Santos, Hauke 
Smidt, and Mari A Smits. 2015. “Network Analysis of Temporal Functionalities of the Gut 
Induced by Perturbations in New-Born Piglets.” BMC Genomics 16 (1). BioMed Central Ltd: 
556. doi:10.1186/s12864-015-1733-8. 
Benjamini, Yoav, and Yosef Hochberg. 1995. “Controlling the False Discovery Rate: A Practical 
and Powerful Approach to Multiple Testing.” Journal of the Royal Statistical Society. Series 
B (Methodological) 57 (1). [Royal Statistical Society, Wiley]: 289–300. http://www.jstor.org/
stable/2346101. 
Berthoud, Hans-Rudolf. 2008. “The Vagus Nerve, Food Intake and Obesity.” Regulatory Peptides 
149 (1–3): 15–25. doi:10.1016/j.regpep.2007.08.024. 
Bhatia, Vikram, and Tandon. 2005. “Stress and the Gastrointestinal Tract.” Journal of Gastroenter-
ology and Hepatology 20 (3). Blackwell Science Pty: 332–39. doi:10.1111/j.1440-
1746.2004.03508.x. 
Bischoff, Stephan C. 2011. “‘Gut Health’: a New Objective in Medicine?” BMC Medicine 9 (1): 24. 
doi:10.1186/1741-7015-9-24. 
Bischoff, Stephan C, Giovanni Barbara, Wim Buurman, Theo Ockhuizen, Jorg-Dieter Schulzke, 
Matteo Serino, Herbert Tilg, Alastair Watson, and Jerry M Wells. 2014. “Intestinal Permea-
bility--a New Target for Disease Prevention and Therapy.” BMC Gastroenterology 14 
(November). England: 189. doi:10.1186/s12876-014-0189-7. 
Biswas, Amlan, Jeanette Wilmanski, Huamei Forsman, Tomas Hrncir, Liming Hao, Helena Tlaska-
lova-Hogenova, and Koichi S. Kobayashi. 2011. “Negative Regulation of Toll-like Receptor 
Signaling Plays an Essential Role in Homeostasis of the Intestine.” European Journal of Im-
munology 41 (1): 182–94. doi:10.1002/eji.201040479. 
Blikslager, A. T., A. J. Moeser, J. L. Gookin, S. L. Jones, and J. Odle. 2007. “Restoration of Barrier 
Function in Injured Intestinal Mucosa.” Physiological Reviews 87 (2): 545–64. doi:10.1152/
physrev.00012.2006. 
Borate, Bhavesh R, Elissa J Chesler, Michael A Langston, Arnold M Saxton, and Brynn H Voy. 
2009. “Comparison of Threshold Selection Methods for Microarray Gene Co-Expression 
Matrices.” BMC Research Notes 2 (1). BioMed Central Ltd: 240. 
Braun, Thorsten, John R Challis, John. P Newnham, and Deborah M Sloboda. 2013. “Early-Life 
Glucocorticoid Exposure: The Hypothalamic-Pituitary-Adrenal Axis, Placental Function, and 
212 
References 
 Long-Term Disease Risk.” Endocrine Reviews 34 (6). The Endocrine Society: 885–916. 
doi:10.1210/er.2013-1012. 
Brazma, Alvis, Helen Parkinson, Ugis Sarkans, Mohammadreza Shojatalab, Jaak Vilo, Niran 
Abeygunawardena, Ele Holloway, Misha Kapushesky, Patrick Kemmeren, and Gonzalo Gar-
cia Lara. 2003. “ArrayExpress—a Public Repository for Microarray Gene Expression Data at 
the EBI.” Nucleic Acids Research 31 (1). Oxford Univ Press: 68–71. 
Brown, Lisa, Bernard Rosner, Walter W Willett, and Frank M Sacks. 1999. “Cholesterol-Lowering 
Effects of Dietary Fiber: A Meta-Analysis.” Am J Clin Nutr 69 (1): 30–42. http://
ajcn.nutrition.org/cgi/content/long/69/1/30. 
Bruggeman, Frank J, Jorrit J Hornberg, Fred C Boogerd, and Hans V Westerhoff. 2007. 
“Introduction to Systems Biology.” EXS 97. Switzerland: 1–19. 
Bünger, Meike, Heleen M van den Bosch, Jolanda van der Meijde, Sander Kersten, Guido J E J 
Hooiveld, and Michael Müller. 2007. “Genome-Wide Analysis of PPARα Activation in Mu-
rine Small Intestine.” Physiological Genomics 30 (2): 192 LP-204. http://
physiolgenomics.physiology.org/content/30/2/192.abstract. 
Burger-van Paassen, Nanda, Audrey Vincent, Patrycja J. Puiman, Maria van der Sluis, Janneke 
Bouma, Günther Boehm, Johannes B. van Goudoever, Isabelle van Seuningen, and Ingrid B. 
Renes. 2009. “The Regulation of Intestinal Mucin MUC2 Expression by Short-Chain Fatty 
Acids: Implications for Epithelial Protection.” Biochemical Journal 420 (2): 211–19. 
doi:10.1042/BJ20082222. 
Camacho, Diogo, Alberto De La Fuente, and Pedro Mendes. 2005. “The Origin of Correlations in 
Metabolomics Data.” Metabolomics 1 (1). Springer: 53–63. 
Cani, Patrice D, Rodrigo Bibiloni, Claude Knauf, Aurélie Waget, Audrey M Neyrinck, Nathalie M 
Delzenne, and Rémy Burcelin. 2008. “Changes in Gut Microbiota Control Metabolic Endo-
toxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice.” 
Diabetes 57 (6): 1470–81. http://diabetes.diabetesjournals.org/content/57/6/1470.abstract. 
Carvalho, F A, I Nalbantoglu, J D Aitken, R Uchiyama, Y Su, G H Doho, M Vijay-Kumar, and A T 
Gewirtz. 2012. “Cytosolic Flagellin Receptor NLRC4 Protects Mice against Mucosal and 
Systemic Challenges.” Mucosal Immunol 5 (3). Society for Mucosal Immunology: 288–98. 
http://dx.doi.org/10.1038/mi.2012.8. 
Castro-Sánchez, Patricia, and José M Martín-Villa. 2013. “Gut Immune System and Oral Toler-
ance.” British Journal of Nutrition 109 (S2). Cambridge, UK: Cambridge University Press: 
S3–11. doi:10.1017/S0007114512005223. 
Cera, K R, D C Mahan, R F Cross, G A Reinhart, and R E Whitmoyer. 1988. “Effect of Age, Wean-
ing and Postweaning Diet on Small Intestinal Growth and Jejunal Morphology in Young 
213 
References 
 Swine.” Journal of Animal Science 66 (2). The American Society of Animal Science: 574–84. 
Chassaing, Benoit, and Andrew T Gewirtz. 2014. “Gut Microbiota, Low-Grade Inflammation, and 
Metabolic Syndrome.” Toxicologic Pathology 42 (1). United States: 49–53. 
doi:10.1177/0192623313508481. 
Cho, Clara E, and Mikael Norman. 2013. “Cesarean Section and Development of the Immune Sys-
tem in the Offspring.” American Journal of Obstetrics and Gynecology 208 (4): 249–54. 
doi:http://dx.doi.org/10.1016/j.ajog.2012.08.009. 
Cho, Ilseung, Shingo Yamanishi, Laura Cox, Barbara A Methe, Jiri Zavadil, Kelvin Li, Zhan Gao, 
et al. 2012. “Antibiotics in Early Life Alter the Murine Colonic Microbiome and Adiposity.” 
Nature 488 (7413). Nature Publishing Group, a division of Macmillan Publishers Limited. 
All Rights Reserved.: 621–26. http://dx.doi.org/10.1038/nature11400. 
Cicha, Iwona, and Katharina Urschel. 2015. “TNF-α in the Cardiovascular System: From Physiolo-
gy to Therapy.” International Journal of Interferon, Cytokine and Mediator Research 7 
(July). Dove Medical Press Ltd: 9. doi:10.2147/IJICMR.S64894. 
Civelek, Mete, and Aldons J Lusis. 2014. “Systems Genetics Approaches to Understand Complex 
Traits.” Nature Reviews. Genetics 15 (1): 34–48. doi:10.1038/nrg3575. 
Collins, Stephen M., and Premsyl Bercik. 2009. “The Relationship Between Intestinal Microbiota 
and the Central Nervous System in Normal Gastrointestinal Function and Disease.” Gastro-
enterology 136: 2003–14. doi:10.1053/j.gastro.2009.01.075. 
Conesa, Ana, María José Nueda, Alberto Ferrer, and Manuel Talón. 2006. “maSigPro: A Method to 
Identify Significantly Differential Expression Profiles in Time-Course Microarray Experi-
ments.” Bioinformatics 22 (9). Oxford Univ Press: 1096–1102. 
Corring, T. 1980. “The Adaptation of Digestive Enzymes to the Diet : Its Physiological Signifi-
cance.” Reprod. Nutr. Dévelop. 20 (4B): 1217–35. http://dx.doi.org/10.1051/rnd:19800713. 
Couto, Narciso, Jennifer Wood, and Jill Barber. 2016. “The Role of Glutathione Reductase and 
Related Enzymes on Cellular Redox Homeostasis Network.” Free Radical Biology and Medi-
cine 95 (February). Elsevier Inc.: 27–42. doi:10.1016/j.freeradbiomed.2016.02.028. 
Cox, Laura M., Shingo Yamanishi, Jiho Sohn, Alexander V. Alekseyenko, Jacqueline M. Leung, 
Ilseung Cho, Sungheon G. Kim, et al. 2015. “Altering the Intestinal Microbiota during a Crit-
ical Developmental Window Has Lasting Metabolic Consequences.” Cell 158 (4). Elsevier: 
705–21. doi:10.1016/j.cell.2014.05.052. 
Creamer, B., R. G. Shorter, and J. Bamforth. 1961. “The Turnover and Shedding of Epithelial Cells: 
Part I The Turnover in the Gastro-Intestinal Tract.” Gut 2 (2): 110–16. doi:10.1136/
gut.2.2.110. 
214 
References 
 Croft, David. 2013. “Building Models Using Reactome Pathways as Templates.” In In Silico Sys-
tems Biology SE - 14, edited by Maria Victoria Schneider, 1021:273–83. Methods in Molecu-
lar Biology. Humana Press. doi:10.1007/978-1-62703-450-0_14. 
Croft, David, Antonio Fabregat Mundo, Robin Haw, Marija Milacic, Joel Weiser, Guanming Wu, 
Michael Caudy, et al. 2014. “The Reactome Pathway Knowledgebase.” Nucleic Acids Re-
search 42 (Database issue). England: D472-7. doi:10.1093/nar/gkt1102. 
Crosas, M. 2011. “The Dataverse Network: An Open-Source Application for Sharing, Discovering 
and Preserving Data.” D-Lib Magazine 17 (1/2). doi:doi: 10.1045/january2011-crosas. 
Csardi, Gabor, and Tamas Nepusz. 2006. “The Igraph Software Package for Complex Network 
Research.” InterJournal, Complex Systems 1695 (5): 1–9. 
Cummings, J H, J M Antoine, F Azpiroz, R Bourdet-Sicard, P Brandtzaeg, P C Calder, G R Gibson, 
et al. 2004. “PASSCLAIM: Gut Health and Immunity.” Eur J Nutr 43. 
Cummings, John H, Jean-Michel Antoine, Fernando Azpiroz, Raphaelle Bourdet-Sicard, Per 
Brandtzaeg, Philip C Calder, Glenn R Gibson, Francisco Guarner, Erika Isolauri, and Daphne 
Pannemans. 2004. “PASSCLAIM1—Gut Health and Immunity.” European Journal of Nutri-
tion 43 (2). Springer: ii118-ii173. 
Das, Siddhartha, David S Reiner, John Zenian, Daniel L Hogan, Michael A Koss, Chi-Sun Wang, 
and Frances D Gillin. 1988. “Killing of Giardia Lamblia Trophozoites by Human Intestinal 
Fluid in Vitro.” Journal of Infectious Diseases 157 (6): 1257–60. doi:10.1093/
infdis/157.6.1257. 
Davis, Sean, and Paul S Meltzer. 2007. “GEOquery: A Bridge between the Gene Expression Omni-
bus (GEO) and BioConductor.” Bioinformatics (Oxford, England) 23 (14). England: 1846–
47. doi:10.1093/bioinformatics/btm254. 
De Bie, Tijl, Léon Charles Tranchevent, Liesbeth M M van Oeffelen, and Yves Moreau. 2007. 
“Kernel-Based Data Fusion for Gene Prioritization.” In Bioinformatics. Vol. 23. doi:10.1093/
bioinformatics/btm187. 
de Wit, Nicole J W, Mark V Boekschoten, Eva-Maria Bachmair, Guido J E J Hooiveld, Philip J de 
Groot, Isabel Rubio-Aliaga, Hannelore Daniel, and Michael Müller. 2011. “Dose-Dependent 
Effects of Dietary Fat on Development of Obesity in Relation to Intestinal Differential Gene 
Expression in C57BL/6J Mice.” PLoS ONE 6 (4). Public Library of Science: e19145. http://
dx.doi.org/10.1371%2Fjournal.pone.0019145. 
Dejean, Sebastien, Ignacio Gonzalez, Kim-Anh Lê Cao, and Pierre Monget. 2011. “mixOmics: Om-
ics Data Integration Project.” R Package Version, 2–9. 
Dekkers, Johanna F, Caroline L Wiegerinck, Hugo R de Jonge, Inez Bronsveld, Hettie M Janssens, 
215 
References 
 Karin M de Winter-de Groot, Arianne M Brandsma, et al. 2013. “A Functional CFTR Assay Using 
Primary Cystic Fibrosis Intestinal Organoids.” Nat Med 19 (7): 939–45. http://
dx.doi.org/10.1038/nm.3201. 
Demir, Emek, Michael P Cary, Suzanne Paley, Ken Fukuda, Christian Lemer, Imre Vastrik, Guan-
ming Wu, Peter D’Eustachio, Carl Schaefer, and Joanne Luciano. 2010. “The BioPAX Com-
munity Standard for Pathway Data Sharing.” Nature Biotechnology 28 (9). Nature Publishing 
Group: 935–42. 
den Besten, Gijs, Karen van Eunen, Albert K Groen, Koen Venema, Dirk-Jan Reijngoud, and 
Barbara M Bakker. 2013. “The Role of Short-Chain Fatty Acids in the Interplay between 
Diet, Gut Microbiota, and Host Energy Metabolism.” Journal of Lipid Research 54 (9): 2325
–40. doi:10.1194/jlr.R036012. 
DeSantis, T Z, P Hugenholtz, N Larsen, M Rojas, E L Brodie, K Keller, T Huber, D Dalevi, P Hu, 
and G L Andersen. 2006. “Greengenes, a Chimera-Checked 16S rRNA Gene Database and 
Workbench Compatible with ARB.” Applied and Environmental Microbiology 72 (7): 5069–
72. doi:10.1128/AEM.03006-05. 
Deschodt-Lanckman, M., P. Robberecht, J. Camus, and J. Christophe. 1971. “Short-Term Adapta-
tion of Pancreatic Hydrolases to Nutritional and Physiological Stimuli in Adult Rats.” Bio-
chimie 53 (6). Elsevier Masson: 789–96. doi:10.1016/S0300-9084(71)80120-7. 
Desmarchelier, Charles, Christoph Dahlhoff, Sylvia Keller, Manuela Sailer, Gerhard Jahreis, and 
Hannelore Daniel. 2012. “C57Bl/6 N Mice on a Western Diet Display Reduced Intestinal and 
Hepatic Cholesterol Levels despite a Plasma Hypercholesterolemia.” BMC Genomics 13 
(March). BioMed Central: 84. doi:10.1186/1471-2164-13-84. 
Diaz-Vivancos, Pedro, Ambra de Simone, Guy Kiddle, and Christine H Foyer. 2015. “Glutathione - 
Linking Cell Proliferation to Oxidative Stress.” Free Radical Biology & Medicine 89 
(December). Elsevier Inc.: 1154–64. doi:10.1016/j.freeradbiomed.2015.09.023. 
Ding, Shengli, Michael M Chi, Brooks P Scull, Rachael Rigby, Nicole M J Schwerbrock, Scott 
Magness, Christian Jobin, and Pauline K Lund. 2010. “High-Fat Diet: Bacteria Interactions 
Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin 
Resistance in Mouse.” PLOS ONE 5 (8). Public Library of Science: e12191. http://
dx.doi.org/10.1371%2Fjournal.pone.0012191. 
Domogatskaya, Anna, Sergey Rodin, and Karl Tryggvason. 2012. “Functional Diversity of Lam-
inins.” Annual Review of Cell and Developmental Biology 28 (1). Annual Reviews: 523–53. 
doi:10.1146/annurev-cellbio-101011-155750. 
Donaldson, Gregory P, S Melanie Lee, and Sarkis K Mazmanian. 2016. “Gut Biogeography of the 
Bacterial Microbiota.” Nat Rev Micro 14 (1). Nature Publishing Group, a division of Macmil-
lan Publishers Limited. All Rights Reserved.: 20–32. http://dx.doi.org/10.1038/nrmicro3552. 
216 
References 
 Dopazo, Joaquin. 2006. “Functional Interpretation of Microarray Experiments.” Omics: A Journal 
of Integrative Biology 10 (3). Mary Ann Liebert, Inc. 2 Madison Avenue Larchmont, NY 
10538 USA: 398–410. 
Edgar, Ron, Michael Domrachev, and Alex E Lash. 2002. “Gene Expression Omnibus: NCBI Gene 
Expression and Hybridization Array Data Repository.” Nucleic Acids Research 30 (1): 207–
10. doi:10.1093/nar/30.1.207. 
Eguíluz, Victor M, Dante R Chialvo, Guillermo A Cecchi, Marwan Baliki, and A Vania Apkarian. 
2005. “Scale-Free Brain Functional Networks.” Physical Review Letters 94 (1). American 
Physical Society: 18102. http://link.aps.org/doi/10.1103/PhysRevLett.94.018102. 
Ekman, Diana, Sara Light, Åsa K Björklund, and Arne Elofsson. 2006. “What Properties Character-
ize the Hub Proteins of the Protein-Protein Interaction Network of Saccharomyces Cere-
visiae?” Genome Biology 7 (6). BioMed Central Ltd: R45. 
Elahi, Shokrollah, James M Ertelt, Jeremy M Kinder, Tony T Jiang, Xuzhe Zhang, Lijun Xin, Van-
dana Chaturvedi, et al. 2013. “Immunosuppressive CD71+ Erythroid Cells Compromise Neo-
natal Host Defence against Infection.” Nature 504 (7478). Nature Publishing Group, a divi-
sion of Macmillan Publishers Limited. All Rights Reserved.: 158–62. http://
dx.doi.org/10.1038/nature12675. 
“EMEA: Tulathromycin.” 2004. 
Emmert-Streib, Frank, and Galina V Glazko. 2011. “Pathway Analysis of Expression Data: Deci-
phering Functional Building Blocks of Complex Diseases.” PLoS Comput Biol 7 (5). Public 
Library of Science: e1002053. http://dx.doi.org/10.1371%2Fjournal.pcbi.1002053. 
Evans, Christian C, Kathy J LePard, Jeff W Kwak, Mary C Stancukas, Samantha Laskowski, Joseph 
Dougherty, Laura Moulton, et al. 2014. “Exercise Prevents Weight Gain and Alters the Gut 
Microbiota in a Mouse Model of High Fat Diet-Induced Obesity.” PLoS ONE 9 (3). Public 
Library of Science: e92193. http://dx.doi.org/10.1371%2Fjournal.pone.0092193. 
Fabregat, Antonio, Konstantinos Sidiropoulos, Phani Garapati, Marc Gillespie, Kerstin Hausmann, 
Robin Haw, Bijay Jassal, et al. 2016. “The Reactome Pathway Knowledgebase.” Nucleic 
Acids Research 44 (D1). England: D481-7. doi:10.1093/nar/gkv1351. 
Fagerberg, Linn, Björn M Hallström, Per Oksvold, Caroline Kampf, Dijana Djureinovic, Jacob 
Odeberg, Masato Habuka, et al. 2014. “Analysis of the Human Tissue-Specific Expression by 
Genome-Wide Integration of Transcriptomics and Antibody-Based Proteomics.” Molecular 
& Cellular Proteomics 13 (2): 397–406. doi:10.1074/mcp.M113.035600. 
Fatehullah, Aliya, Si Hui Tan, and Nick Barker. 2016. “Organoids as an in Vitro Model of Human 
Development and Disease.” Nature Cell Biology 18 (3). Nature Research: 246–54. 
doi:10.1038/ncb3312. 
217 
References 
 Foliaki, Sunia, Neil Pearce, Bengt Björkstén, Javier Mallol, Stephen Montefort, and Erika von Muti-
us. 2009. “Antibiotic Use in Infancy and Symptoms of Asthma, Rhinoconjunctivitis, and 
Eczema in Children 6 and 7 Years Old: International Study of Asthma and Allergies in Child-
hood Phase III.” Journal of Allergy and Clinical Immunology 124 (5): 982–89. doi:http://
dx.doi.org/10.1016/j.jaci.2009.08.017. 
Fontanesi, Luca. 2016. “Metabolomics and Livestock Genomics: Insights into a Phenotyping Fron-
tier and Its Applications in Animal Breeding.” Animal Frontiers 6. Madison, WI: American 
Society of Animal Science. doi:10.2527/af.2016-0011. 
Frantz, Christian, Kathleen M Stewart, and Valerie M Weaver. 2010. “The Extracellular Matrix at a 
Glance.” Journal of Cell Science 123 (Pt 24). Company of Biologists: 4195–4200. 
doi:10.1242/jcs.023820. 
Fryknäs, Mårten, Sumeer Dhar, Fredrik Öberg, Linda Rickardson, Maria Rydåker, Hanna Görans-
son, Mats Gustafsson, et al. 2007. “STAT1 Signaling Is Associated with Acquired Crossre-
sistance to Doxorubicin and Radiation in Myeloma Cell Lines.” International Journal of 
Cancer 120 (1). Wiley Subscription Services, Inc., A Wiley Company: 189–95. doi:10.1002/
ijc.22291. 
Gentleman, Robert, Vincent J Carey, Wolfgang Huber, Rafael A Irizarry, and Sandrine Dudoit. 
2005. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Vol. 
746718470. Springer. 
Gentry, J G, J J McGlone, M F Miller, and J R Blanton. 2004. “Environmental Effects on Pig Per-
formance, Meat Quality, and Muscle characteristics1.” Journal of Animal Science 82. Madi-
son, WI: American Society of Animal Science: 209–17. doi:/2004.821209x. 
Göke, M, A Zuk, and D K Podolsky. 1996. “Regulation and Function of Extracellular Matrix Intes-
tinal Epithelial Restitution in Vitro.” The American Journal of Physiology 271 (5 Pt 1): G729
-40. http://www.ncbi.nlm.nih.gov/pubmed/8944685. 
Golik, Wiktoria, Olivier Dameron, Jérôme Bugeon, Alice Fatet, Isabelle Hue, Catherine Hurtaud, 
Matthieu Reichstadt, et al. 2012. “ATOL: The Multi-Species Livestock Trait Ontology.” In , 
289–300. Springer, Berlin, Heidelberg. doi:10.1007/978-3-642-35233-1_28. 
Gomaa, Asmaa M S, and Ebtihal A Abd El-Aziz. 2017. “Vitamin D Reduces High-Fat Diet Induced 
Weight Gain and C-Reactive Protein, Increases Interleukin-10, and Reduces CD86 and 
Caspase-3.” Pathophysiology : The Official Journal of the International Society for Patho-
physiology 24 (1). Netherlands: 31–37. doi:10.1016/j.pathophys.2017.01.003. 
González, Ignacio, Kim-Anh Lê Cao, Melissa J Davis, and Sébastien Déjean. 2012. “Visualising 
Associations between Paired ‘Omics’ Data Sets.” BioData Mining 5 (1): 19. 
doi:10.1186/1756-0381-5-19. 
218 
References 
 Gremel, Gabriela, Alkwin Wanders, Jonathan Cedernaes, Linn Fagerberg, Björn Hallström, Karoli-
na Edlund, Evelina Sjöstedt, Mathias Uhlén, and Fredrik Pontén. 2015. “The Human Gastro-
intestinal Tract-Specific Transcriptome and Proteome as Defined by RNA Sequencing and 
Antibody-Based Profiling.” Journal of Gastroenterology 50 (1): 46–57. doi:10.1007/s00535-
014-0958-7. 
Gu, Xianhong, Defa Li, and Ruiping She. 2002. “Effect of Weaning on Small Intestinal Structure 
and Function in the Piglet.” Archives of Animal Nutrition 56 (4). Taylor & Francis: 275–86. 
Gu, Zuguang, and Jin Wang. 2013. “CePa: An R Package for Finding Significant Pathways 
Weighted by Multiple Network Centralities.” Bioinformatics (Oxford, England) 29 (5). Eng-
land: 658–60. doi:10.1093/bioinformatics/btt008. 
Habuka, Masato, Linn Fagerberg, Björn M Hallström, Caroline Kampf, Karolina Edlund, Åsa 
Sivertsson, Tadashi Yamamoto, Fredrik Pontén, Mathias Uhlén, and Jacob Odeberg. 2014. 
“The Kidney Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based 
Profiling.” Edited by Harald Mischak. PLoS ONE 9 (12). San Francisco, USA: Public Library 
of Science: e116125. doi:10.1371/journal.pone.0116125. 
Haenen, Daniëlle, Carol Souza da Silva, Jing Zhang, Sietse Jan Koopmans, Guido Bosch, Jacques 
Vervoort, Walter J.J. Gerrits, et al. 2013. “Dietary Resistant Starch Improves Mucosal Gene 
Expression Profile and Luminal Microbiota Composition in Porcine Colon.” Wageningen 
University. https://www.researchgate.net/profile/Carol_Silva2/
publication/258386844_Fermentation_in_the_gut_to_prolong_satiety__Exploring_mechanis
ms_by_which_dietary_fibres_affect_satiety_in_pigs/
links/53df79f30cf27a7b8306792b.pdf#page=121. 
Haenen, Daniëlle, Jing Zhang, Carol Souza da Silva, Guido Bosch, Ingrid M van der Meer, Jeroen 
van Arkel, Joost J G C van den Borne, et al. 2013. “A Diet High in Resistant Starch Modu-
lates Microbiota Composition, SCFA Concentrations, and Gene Expression in Pig Intestine.” 
The Journal of Nutrition 143: 274–83. doi:10.3945/jn.112.169672. 
Harris, J Kirk, Karim C El Kasmi, Aimee L Anderson, Michael W Devereaux, Sophie A Fillon, 
Charles E Robertson, Brandie D Wagner, Mark J Stevens, Norman R Pace, and Ronald J 
Sokol. 2014. “Specific Microbiome Changes in a Mouse Model of Parenteral Nutrition Asso-
ciated Liver Injury and Intestinal Inflammation.” Edited by Stefan Bereswill. PLoS ONE 9 
(10). San Francisco, USA: Public Library of Science: e110396. doi:10.1371/
journal.pone.0110396. 
Haug, K., R. M. Salek, P. Conesa, J. Hastings, P. de Matos, M. Rijnbeek, T. Mahendraker, et al. 
2013. “MetaboLights--an Open-Access General-Purpose Repository for Metabolomics Stud-
ies and Associated Meta-Data.” Nucleic Acids Research 41 (D1). Oxford University Press: 
D781–86. doi:10.1093/nar/gks1004. 
219 
References 
 Heinritz, Sonja N, Rainer Mosenthin, and Eva Weiss. 2013. “Use of Pigs as a Potential Model for 
Research into Dietary Modulation of the Human Gut Microbiota.” Nutrition Research Re-
views 26: 191–209. doi:10.1017/S0954422413000152. 
Henderson, Paul, Johan E van Limbergen, Jürgen Schwarze, and David C Wilson. 2011. “Function 
of the Intestinal Epithelium and Its Dysregulation in Inflammatory Bowel Disease.” Inflam-
matory Bowel Diseases 17 (1): 382–95. doi:10.1002/ibd.21379. 
Hogan, Meghan F, Amy W Liu, Michael J Peters, Joshua R Willard, Zaheen Rabbani, Erik C Bar-
tholomew, Adam Ottley, and Rebecca L Hull. 2017. “Markers of Islet Endothelial Dysfunc-
tion Occur in Male B6.BKS(D)-Leprdb/J Mice and May Contribute to Reduced Insulin Re-
lease.” Endocrinology 158 (2): 293–303. http://dx.doi.org/10.1210/en.2016-1393. 
Hooper, L. V., D. R. Littman, and A. J. Macpherson. 2012. “Interactions Between the Microbiota 
and the Immune System.” Science. doi:10.1126/science.1223490. 
Hooper, Lora V. 2004. “Bacterial Contributions to Mammalian Gut Development.” Trends in Mi-
crobiology. doi:10.1016/j.tim.2004.01.001. 
Hörmann, Nives, Inês Brandão, Sven Jäckel, Nelli Ens, Maren Lillich, Ulrich Walter, and Christoph 
Reinhardt. 2014. “Gut Microbial Colonization Orchestrates TLR2 Expression, Signaling and 
Epithelial Proliferation in the Small Intestinal Mucosa.” Edited by Antonio Moschetta. PLoS 
ONE 9 (11). Public Library of Science: e113080. doi:10.1371/journal.pone.0113080. 
Hoskin-Parr, Lauren, Alison Teyhan, Ariel Blocker, and A J W Henderson. 2013. “Antibiotic Expo-
sure in the First Two Years of Life and Development of Asthma and Other Allergic Diseases 
by 7.5 Yr: A Dose-Dependent Relationship.” Pediatric Allergy and Immunology 24 (8): 762–
71. doi:10.1111/pai.12153. 
Houle, David, Diddahally R Govindaraju, and Stig Omholt. 2010. “Phenomics: The next Chal-
lenge.” Nat Rev Genet 11 (12). Nature Publishing Group, a division of Macmillan Publishers 
Limited. All Rights Reserved.: 855–66. http://dx.doi.org/10.1038/nrg2897. 
Iantomasi, T, F Favilli, P Marraccini, T Magaldi, P Bruni, and M T Vincenzini. 1997. “Glutathione 
Transport System in Human Small Intestine Epithelial Cells.” Biochimica et Biophysica Acta 
1330 (2). NETHERLANDS: 274–83. 
Ihle, James N. 2001. “The Stat Family in Cytokine Signaling.” Current Opinion in Cell Biology 13 
(2): 211–17. doi:http://dx.doi.org/10.1016/S0955-0674(00)00199-X. 
IJssennagger, Noortje, Muriel Derrien, Gerdien M van Doorn, Anneke Rijnierse, Bartholomeus van 
den Bogert, Michael Müller, Jan Dekker, Michiel Kleerebezem, and Roelof van der Meer. 
2012. “Dietary Heme Alters Microbiota and Mucosa of Mouse Colon without Functional 
Changes in Host-Microbe Cross-Talk.” PLoS ONE 7 (12). Public Library of Science: e49868. 
http://dx.doi.org/10.1371%2Fjournal.pone.0049868. 
220 
References 
 Inman, C F, K Haverson, S R Konstantinov, P H Jones, C Harris, H Smidt, B Miller, M Bailey, and 
C Stokes. 2010. “Rearing Environment Affects Development of the Immune System in Neo-
nates.” Clinical & Experimental Immunology 160 (3). Blackwell Publishing Ltd: 431–39. 
doi:10.1111/j.1365-2249.2010.04090.x. 
Inoue, Ryo, Takamitsu Tsukahara, Nobuo Nakanishi, and Kazunari Ushida. 2005. “Development of 
the Intestinal Microbiota in the Piglet.” The Journal of General and Applied Microbiology 51 
(4). 財団法人 応用微生物学研究奨励会: 257–65. 
Iorio, Valentina, Lee D Troughton, and Kevin J Hamill. 2015. “Laminins: Roles and Utility in 
Wound Repair.” Advances in Wound Care 4 (4). 140 Huguenot Street, 3rd FloorNew Ro-
chelle, NY 10801USA: Mary Ann Liebert, Inc.: 250–63. doi:10.1089/wound.2014.0533. 
Jacobson, L., and R. Sapolsky. 1991. “The Role of the Hippocampus in Feedback Regulation of the 
Hypothalamic-Pituitary-Adrenocortical Axis.” Endocrine Reviews. doi:10.1210/edrv-12-2-
118. 
Jakobsson, Hedvig E, Ana M Rodríguez-Piñeiro, André Schütte, Anna Ermund, Preben Boysen, 
Mats Bemark, Felix Sommer, Fredrik Bäckhed, Gunnar C Hansson, and Malin E V Johans-
son. 2015. “The Composition of the Gut Microbiota Shapes the Colon Mucus Barrier.” EM-
BO Reports 16 (2): 164–77. doi:10.15252/embr.201439263. 
Jarillo-Luna, Adriana, Víctor Rivera-Aguilar, Humberto Reyna Garfias, Eleazar Lara-Padilla, Alex-
ander Kormanovsky, and Rafael Campos-Rodríguez. 2007. “Effect of Repeated Restraint 
Stress on the Levels of Intestinal IgA in Mice.” Psychoneuroendocrinology 32 (6): 681–92. 
doi:http://dx.doi.org/10.1016/j.psyneuen.2007.04.009. 
Jeong, H, S P Mason, A.-L. Barabasi, and Z N Oltvai. 2001. “Lethality and Centrality in Protein 
Networks.” Nature 411 (6833): 41–42. http://dx.doi.org/10.1038/35075138. 
Jernberg, Cecilia, Sonja Löfmark, Charlotta Edlund, and Janet K Jansson. 2010. “Long-Term Im-
pacts of Antibiotic Exposure on the Human Intestinal Microbiota.” Microbiology 156 (11): 
3216–23. doi:10.1099/mic.0.040618-0. 
Ju, Feng, and Tong Zhang. 2015. “16S rRNA Gene High-Throughput Sequencing Data Mining of 
Microbial Diversity and Interactions.” Applied Microbiology and Biotechnology 99 (10). 
Springer Berlin Heidelberg: 4119–29. doi:10.1007/s00253-015-6536-y. 
Kabat, Agnieszka M, Naren Srinivasan, and Kevin J Maloy. 2014. “Modulation of Immune Devel-
opment and Function by Intestinal Microbiota.” Trends in Immunology 35 (11). Elsevier: 507
–17. 
Kampf, Caroline, Adil Mardinoglu, Linn Fagerberg, Björn M Hallström, Karolina Edlund, Emma 
Lundberg, Fredrik Pontén, Jens Nielsen, and Mathias Uhlen. 2014. “The Human Liver-
221 
References 
 Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling.” The FASEB Journal 
28 (7): 2901–14. doi:10.1096/fj.14-250555. 
Kanehisa, M, and S Goto. 2000. “KEGG: Kyoto Encyclopedia of Genes and Genomes.” Nucleic 
Acids Research 28 (1). England: 27–30. 
Kar, Soumya K, Alfons J M Jansman, Nirupama Benis, Javier Ramiro-Garcia, Dirkjan Schokker, 
Leo Kruijt, Anja J J Taverne-Thiele, Jerry M Wells, and Mari A Smits. 2016. “Soybean Meal 
in Mouse Feed Reduces Expression of mTOR Signalling Pathways and Strongly Increases 
Abundance of Bacteroidales Family S24-7.” Submitted. 
Kelly, Caleb J., Leon Zheng, Eric L. Campbell, Bejan Saeedi, Carsten C. Scholz, Amanda J. Bay-
less, Kelly E. Wilson, et al. 2015. “Crosstalk between Microbiota-Derived Short-Chain Fatty 
Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.” Cell Host & Microbe 
17 (5). Elsevier: 662–71. doi:10.1016/j.chom.2015.03.005. 
Kelly, D, and A G Coutts. 2000. “Early Nutrition and the Development of Immune Function in the 
Neonate.” Proceedings of the Nutrition Society 59: 177–85. http://eutils.ncbi.nlm.nih.gov/
entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10946785&retmode=ref&cmd=prlinks%
5Cnpapers3://publication/doi/10.1017/S0029665100000197. 
Kelly, D, J A Smyth, and K J McCracken. 1991. “Digestive Development of the Early-Weaned Pig. 
2. Effect of Level of Food Intake on Digestive Enzyme Activity during the Immediate Post-
Weaning Period.” The British Journal of Nutrition 65 (2): 181–88. 
Kernbauer, Elisabeth, Verena Maier, Dagmar Stoiber, Birgit Strobl, Christine Schneckenleithner, 
Veronika Sexl, Ursula Reichart, et al. 2012. “Conditional Stat1 Ablation Reveals the Im-
portance of Interferon Signaling for Immunity to Listeria Monocytogenes Infection.” PLoS 
Pathog 8 (6). Public Library of Science: e1002763. http://dx.doi.org/10.1371%
2Fjournal.ppat.1002763. 
Khalfaoui, Taoufik, Jean-François Groulx, Georges Sabra, Amel GuezGuez, Nuria Basora, Patrick 
Vermette, and Jean-François Beaulieu. 2013. “Laminin Receptor 37/67LR Regulates Adhe-
sion and Proliferation of Normal Human Intestinal Epithelial Cells.” Edited by Michelina 
Plateroti. PLoS ONE 8 (8). Wiley-VCH Verlag: e74337. doi:10.1371/journal.pone.0074337. 
Kilkenny, Carol, William J. Browne, Innes C. Cuthill, Michael Emerson, and Douglas G. Altman. 
2010. “Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting 
Animal Research.” PLoS Biology 8 (6). Elsevier: e1000412. doi:10.1371/
journal.pbio.1000412. 
Kitano, Hiroaki. 2002. “Systems Biology: A Brief Overview.” Science 295 (5560): 1662 LP-1664. 
http://science.sciencemag.org/content/295/5560/1662.abstract. 
Kogut, Michael H, and Ryan J Arsenault. 2016. “Editorial: Gut Health: The New Paradigm in Food 
222 
References 
 Animal Production.” Frontiers in Veterinary Science 3 (August). Frontiers Media S.A.: 71. 
doi:10.3389/fvets.2016.00071. 
Kohavi, Ron. 1995. “A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Mod-
el Selection.” http://robotics.stanford.edu/~ronnyk. 
Kolesnikov, Nikolay, Emma Hastings, Maria Keays, Olga Melnichuk, Y Amy Tang, Eleanor Wil-
liams, Miroslaw Dylag, et al. 2015. “ArrayExpress Update--Simplifying Data Submissions.” 
Nucleic Acids Research 43 (Database issue). England: D1113-6. doi:10.1093/nar/gku1057. 
Konstantinov, Sergey R., Christine F. Favier, Wei Yun Zhu, Barbara A. Williams, Jeannette Kluess, 
Wolfgang-Bernhard Souffrant, Willem M. de Vos, Antoon D.L. Akkermans, and Hauke 
Smidt. 2004. “Microbial Diversity Studies of the Porcine Gastrointestinal Ecosystem during 
Weaning Transition.” Animal Research 53 (4): 317–24. doi:10.1051/animres:2004019. 
Konstantinov, Sergey R, Ajay A Awati, Barbara A Williams, Bevis G Miller, Philip Jones, Christo-
pher R Stokes, Antoon D L Akkermans, Hauke Smidt, and Willem M de Vos. 2006. “Post-
Natal Development of the Porcine Microbiota Composition and Activities.” Environmental 
Microbiology 8 (7). England: 1191–99. doi:10.1111/j.1462-2920.2006.01009.x. 
Konturek, Peter C, T Brzozowski, and S J Konturek. 2011. “Stress and the Gut: Pathophysiology, 
Clinical Consequences, Diagnostic Approach and Treatment Options.” Journal of Physiology 
and Pharmacology : An Official Journal of the Polish Physiological Society 62: 591–99. 
http://www.ncbi.nlm.nih.gov/pubmed/22314561. 
Kramer, Frank, Michaela Bayerlová, and Tim Beißbarth. 2014. “R-Based Software for the Integra-
tion of Pathway Data into Bioinformatic Algorithms.” Biology 3 (1): 85–100. doi:10.3390/
biology3010085. 
Kramer, Frank, Michaela Bayerlová, Florian Klemm, Annalen Bleckmann, and Tim Beißbarth. 
2013. “RBiopaxParser-an R Package to Parse, Modify and Visualize BioPAX Data.” Bioin-
formatics 29 (4): 520–22. doi:10.1093/bioinformatics/bts710. 
Lad, Sonya P, Elaine Y Fukuda, Jiali Li, M Luis, and Erguang Li. 2005. “Up-Regulation of the 
JAK/STAT1 Signal Pathway during Chlamydia Trachomatis Infection.” The Journal of Im-
munology 174 (11). Am Assoc Immnol: 7186–93. 
Lallès, Jean-Paul, Paolo Bosi, Hauke Smidt, and Chris R. Stokes. 2007. “Weaning — A Challenge 
to Gut Physiologists.” Livestock Science 108 (1–3): 82–93. doi:10.1016/j.livsci.2007.01.091. 
Lange, Katja, Floor Hugenholtz, Melliana C Jonathan, Henk A Schols, Michiel Kleerebezem, 
Hauke Smidt, Michael Müller, and Guido J E J Hooiveld. 2015. “Comparison of the Effects 
of Five Dietary Fibers on Mucosal Transcriptional Profiles, and Luminal Microbiota Compo-
sition and SCFA Concentrations in Murine Colon.” Molecular Nutrition & Food Research 59 
(8). Wiley Online Library: 1590–1602. doi:10.1002/mnfr.201400597. 
223 
References 
 Langrish, Claire L, Brent S McKenzie, Nicholas J Wilson, Rene de Waal Malefyt, Robert A Kaste-
lein, and Daniel J Cua. 2004. “IL‐12 and IL‐23: Master Regulators of Innate and Adaptive 
Immunity.” Immunological Reviews 202 (1). Wiley Online Library: 96–105. 
Le Bon, Agnes, and David F Tough. 2002. “Links between Innate and Adaptive Immunity via Type 
I Interferon.” Current Opinion in Immunology 14 (4): 432–36. doi:10.1016/S0952-7915(02)
00354-0. 
Lê Cao, Kim-Anh, Ignacio González, and Sébastien Déjean. 2009. “integrOmics: An R Package to 
Unravel Relationships between Two Omics Datasets.” Bioinformatics 25 (21). Oxford Univ 
Press: 2855–56. 
Le Leu, Richard K, Graeme P Young, Ying Hu, Jean Winter, and Michael A Conlon. 2013. “Dietary 
Red Meat Aggravates Dextran Sulfate Sodium-Induced Colitis in Mice Whereas Resistant 
Starch Attenuates Inflammation.” Digestive Diseases and Sciences 58 (12): 3475–82. 
doi:10.1007/s10620-013-2844-1. 
Leuchter, Andrew F, Aimee M Hunter, David E Krantz, and Ian A Cook. 2014. “Intermediate Phe-
notypes and Biomarkers of Treatment Outcome in Major Depressive Disorder.” Dialogues in 
Clinical Neuroscience 16 (4). France: Les Laboratoires Servier: 525–37. http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4336921/. 
Levy, David E, and J E Darnell. 2002. “STATs: Transcriptional Control and Biological Impact.” 
Nat Rev Mol Cell Biol 3 (9). Nature Publishing Group: 651–62. http://dx.doi.org/10.1038/
nrm909. 
Levy, David E, and Chien-kuo Lee. 2002. “What Does Stat3 Do?” The Journal of Clinical Investi-
gation 109 (9). The American Society for Clinical Investigation: 1143–48. doi:10.1172/
JCI15650. 
Li, Xuejuan, Fangrui Ding, Xiaoyan Zhang, Baihong Li, and Jie Ding. 2016. “The Expression Pro-
file of Complement Components in Podocytes.” International Journal of Molecular Sciences 
17 (4): 471. doi:10.3390/ijms17040471. 
Lindskog, Cecilia, Jerker Linné, Linn Fagerberg, Björn M Hallström, Carl Johan Sundberg, Malene 
Lindholm, Mikael Huss, et al. 2015. “The Human Cardiac and Skeletal Muscle Proteomes 
Defined by Transcriptomics and Antibody-Based Profiling.” BMC Genomics 16 (1): 475. 
doi:10.1186/s12864-015-1686-y. 
Liu, Xingyin, Rong Lu, Yinglin Xia, and Jun Sun. 2010. “Global Analysis of the Eukaryotic Path-
ways and Networks Regulated by Salmonella Typhimurium in Mouse Intestinal Infection in 
Vivo.” BMC Genomics 11 (1): 722. doi:10.1186/1471-2164-11-722. 
Lodish, Harvey, Arnold Berk, S Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James 
Darnell. 2000. “Transport across Epithelia.” In Molecular Cell Biology. 4th Edition, Section 
224 
References 
 15.7. New York: WH Freeman. https://www.ncbi.nlm.nih.gov/books/NBK21502/. 
Lozupone, Catherine A, Jesse I Stombaugh, Jeffrey I Gordon, Janet K Jansson, and Rob Knight. 
2012. “Diversity, Stability and Resilience of the Human Gut Microbiota.” Nature 489 (7415). 
Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.: 
220–30. http://dx.doi.org/10.1038/nature11550. 
Lu, Kun, Ryan Phillip Abo, Katherine Ann Schlieper, Michelle E. Graffam, Stuart Levine, John S. 
Wishnok, James A. Swenberg, Steven R. Tannenbaum, and James G. Fox. 2014. “Arsenic 
Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Met-
agenomics and Metabolomics Analysis.” Environmental Health Perspectives 122 (3): 284–
91. doi:10.1289/ehp.1307429. 
Macfarlane, G T, and S Macfarlane. 1997. “Human Colonic Microbiota: Ecology, Physiology and 
Metabolic Potential of Intestinal Bacteria.” Scand J Gastroenterol Suppl 222. 
Mamane, Yael, Chi Chung Chan, Genevieve Lavallee, Nicolas Morin, Li-Jing Xu, JingQi Huang, 
Robert Gordon, et al. 2009. “The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin 
Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activa-
tion.” Diabetes 58 (9). United States: 2006–17. doi:10.2337/db09-0323. 
Mantis, N J, N Rol, and B Corthesy. 2011. “Secretory IgA’s Complex Roles in Immunity and Mu-
cosal Homeostasis in the Gut.” Mucosal Immunol 4 (6). Society for Mucosal Immunology: 
603–11. http://dx.doi.org/10.1038/mi.2011.41. 
Mariman, Rob, Frans Tielen, Frits Koning, and Lex Nagelkerken. 2015. “The Probiotic Mixture 
VSL#3 Has Differential Effects on Intestinal Immune Parameters in Healthy Female BALB/c 
and C57BL/6 Mice.” The Journal of Nutrition 145 (6): 1354–61. doi:10.3945/jn.114.199729. 
Mayer, E A. 2000. “The Neurobiology of Stress and Gastrointestinal Disease.” Gut 47 (6): 861–69. 
http://gut.bmj.com/content/47/6/861.short. 
Mayer, Emeran A, Tor Savidge, and Robert J Shulman. 2014. “Brain-Gut Microbiome Interactions 
and Functional Bowel Disorders.” Gastroenterology 146 (6): 1500–1512. doi:10.1053/
j.gastro.2014.02.037. 
McCarthy, D. J., Y. Chen, and G. K. Smyth. 2012. “Differential Expression Analysis of Multifactor 
RNA-Seq Experiments with Respect to Biological Variation.” Nucleic Acids Research 40 
(10): 4288–97. doi:10.1093/nar/gks042. 
Mei, Yongguo, Vida Abedi, Adria Carbo, Xiaoying Zhang, Pinyi Lu, Casandra Philipson, Raquel 
Hontecillas, Stefan Hoops, Nathan Liles, and Josep Bassaganya-Riera. 2015. “Multiscale 
Modeling of Mucosal Immune Responses.” BMC Bioinformatics 16 Suppl 1. England: S2. 
doi:10.1186/1471-2105-16-S12-S2. 
225 
References 
 Meng, Chen, Bernhard Kuster, Aedín C Culhane, and Amin Moghaddas Gholami. 2014. “A Multi-
variate Approach to the Integration of Multi-Omics Datasets.” BMC Bioinformatics 15 (1): 
162. doi:10.1186/1471-2105-15-162. 
Merle, Nicolas S., Sarah Elizabeth Church, Veronique Fremeaux-Bacchi, and Lubka T. Roumenina. 
2015. “Complement System Part I - Molecular Mechanisms of Activation and Regulation.” 
Frontiers in Immunology 6 (June): 262. doi:10.3389/fimmu.2015.00262. 
Milacic, Marija, Robin Haw, Karen Rothfels, Guanming Wu, David Croft, Henning Hermjakob, 
Peter D’Eustachio, and Lincoln Stein. 2012. “Annotating Cancer Variants and Anti-Cancer 
Therapeutics in Reactome.” Cancers 4 (4). Multidisciplinary Digital Publishing Institute: 
1180–1211. 
Mitrea, Cristina, Zeinab Taghavi, Behzad Bokanizad, Samer Hanoudi, Rebecca Tagett, Michele 
Donato, Călin Voichiţa, and Sorin Drăghici. 2013. “Methods and Approaches in the Topolo-
gy-Based Analysis of Biological Pathways.” Frontiers in Physiology 4 (October). Frontiers 
Media S.A.: 278. doi:10.3389/fphys.2013.00278. 
Montiel-Castro, Augusto J, Rina M González-Cervantes, Gabriela Bravo-Ruiseco, and Gustavo 
Pacheco-López. 2013. “The Microbiota-Gut-Brain Axis: Neurobehavioral Correlates, Health 
and Sociality.” Frontiers in Integrative Neuroscience. Centro Darwin de Pensamiento Evolu-
cionista and Philosophy Department, Social Sciences and Humanities Division, Universidad 
Autonoma Metropolitana Iztapalapa Mexico City, Mexico. doi:10.3389/fnint.2013.00070. 
Mootha, Vamsi K, Cecilia M Lindgren, Karl-Fredrik Eriksson, Aravind Subramanian, Smita Sihag, 
Joseph Lehar, Pere Puigserver, et al. 2003. “PGC-1[alpha]-Responsive Genes Involved in 
Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes.” Nat Genet 
34 (3): 267–73. http://dx.doi.org/10.1038/ng1180. 
Moss, Paul, and Mark Drayson. 2015. “Normal Lymphocytes and Non-Neoplastic Lymphocyte 
Disorders.” In Postgraduate Haematology, 278–302. John Wiley & Sons, Ltd. 
doi:10.1002/9781118853771.ch16. 
Mowat, Allan M, and William W Agace. 2014. “Regional Specialization within the Intestinal Im-
mune System.” Nat Rev Immunol 14 (10). Nature Publishing Group, a division of Macmillan 
Publishers Limited. All Rights Reserved.: 667–85. http://dx.doi.org/10.1038/nri3738. 
Munakata, Kaori, Kiyoe Takashima, Mitsue Nishiyama, Naoko Asano, Akihito Mase, Kyoji Hioki, 
Yasuyuki Ohnishi, Masahiro Yamamoto, and Kenji Watanabe. 2012. “Microarray Analysis 
on Germfree Mice Elucidates the Primary Target of a Traditional Japanese Medicine Juzen-
taihoto: Acceleration of IFN-$α$ Response via Affecting the ISGF3-IRF7 Signaling Cas-
cade.” BMC Genomics 13 (1): 30. doi:10.1186/1471-2164-13-30. 
Munkonda, Mercedes Nancy, Marc Lapointe, Pierre Miegueu, Christian Roy, Danny Gauvreau, 
Denis Richard, and Katherine Cianflone. 2012. “Recombinant Acylation Stimulating Protein 
226 
References 
 Administration to C3-/- Mice Increases Insulin Resistance via Adipocyte Inflammatory Mecha-
nisms.” PloS One 7 (10). United States: e46883. doi:10.1371/journal.pone.0046883. 
Muñoz-Garcia, Agustí, Christopher P. Thomas, Diane S. Keeney, Yuxiang Zheng, and Alan R. 
Brash. 2014. “The Importance of the Lipoxygenase-Hepoxilin Pathway in the Mammalian 
Epidermal Barrier.” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of 
Lipids 1841 (3): 401–8. doi:10.1016/j.bbalip.2013.08.020. 
Mutch, David M, Vanessa Crespy, Jennifer Clough, Colin J Henderson, Sofiane Lariani, Robert 
Mansourian, Julie Moulin, C Roland Wolf, and Gary Williamson. 2006. “Hepatic Cyto-
chrome P-450 Reductase-Null Mice Show Reduced Transcriptional Response to Quercetin 
and Reveal Physiological Homeostasis between Jejunum and Liver.” American Journal of 
Physiology - Gastrointestinal and Liver Physiology 291 (1): G63 LP-G72. http://
ajpgi.physiology.org/content/291/1/G63.abstract. 
Newburg, David S, and W Allan Walker. 2007. “Protection of the Neonate by the Innate Immune 
System of Developing Gut and of Human Milk.” Pediatr Res 61 (1). International Pediatrics 
Research Foundation, Inc.: 2–8. http://dx.doi.org/10.1203/01.pdr.0000250274.68571.18. 
Newman, Mark E J. 2006. “Modularity and Community Structure in Networks.” Proceedings of the 
National Academy of Sciences 103 (23). National Acad Sciences: 8577–82. 
Nicholson, Jeremy K, Elaine Holmes, James Kinross, Remy Burcelin, Glenn Gibson, Wei Jia, and 
Sven Pettersson. 2012. “Host-Gut Microbiota Metabolic Interactions.” Science 336 (6086). 
American Association for the Advancement of Science: 1262–67. 
Nicolae, Dan L, Eric Gamazon, Wei Zhang, Shiwei Duan, M Eileen Dolan, and Nancy J Cox. 2010. 
“Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery 
from GWAS.” PLOS Genetics 6 (4). Public Library of Science: e1000888. http://
dx.doi.org/10.1371%2Fjournal.pgen.1000888. 
Nie, Fachuan, Dong Su, Ying Shi, Jinmei Chen, Haihui Wang, Wanxiang Qin, Yaohua Chen, Suxia 
Wang, and Lei Li. 2015. “A Preliminary Study on the Role of the Complement Regulatory 
Protein, Cluster of Differentiation 55, in Mice with Diabetic Neuropathic Pain.” Molecular 
Medicine Reports 11 (3): 2076–82. doi:10.3892/mmr.2014.2896. 
Niewold, T A. 2007. “The Nonantibiotic Anti-Inflammatory Effect of Antimicrobial Growth Pro-
moters, the Real Mode of Action? A Hypothesis.” Poultry Science 86 (4): 605–9. http://
ps.oxfordjournals.org/content/86/4/605.abstract. 
Nylund, Lotta, Reetta Satokari, Seppo Salminen, and Willem M de Vos. 2014. “Intestinal Microbio-
ta during Early Life - Impact on Health and Disease.” The Proceedings of the Nutrition Socie-
ty, 1–13. doi:10.1017/S0029665114000627. 
O’Hara, Ann M, and Fergus Shanahan. 2006. “The Gut Flora as a Forgotten Organ.” EMBO Reports 
227 
References 
 7 (7): 655–746. doi:10.1038/sj.embor.7400731. 
O’Mahony, Siobhain M, Julian R Marchesi, Paul Scully, Caroline Codling, Anne-Marie Ceolho, 
Eamonn M M Quigley, John F Cryan, and Timothy G Dinan. 2009. “Early Life Stress Alters 
Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and 
Psychiatric Illnesses.” Biological Psychiatry 65 (3): 263–67. doi:http://dx.doi.org/10.1016/
j.biopsych.2008.06.026. 
Odamaki, Toshitaka, Kumiko Kato, Hirosuke Sugahara, Nanami Hashikura, Sachiko Takahashi, Jin
-zhong Xiao, Fumiaki Abe, and Ro Osawa. 2016. “Age-Related Changes in Gut Microbiota 
Composition from Newborn to Centenarian: A Cross-Sectional Study.” BMC Microbiology 
16 (May). London: BioMed Central: 90. doi:10.1186/s12866-016-0708-5. 
Olszak, Torsten, Dingding An, Sebastian Zeissig, MP Miguel Pinilla Vera, Julia Richter, Andre 
Franke, Jonathan N Glickman, et al. 2012. “Microbial Exposure during Early Life Has Persis-
tent Effects on Natural Killer T Cell Function.” Science 336: 489–93. doi:10.1126/
science.1219328.Microbial. 
Ono, K, T Muetze, G Kolishovski, P Shannon, and B Demchak. 2015. “CyREST: Turbocharging 
Cytoscape Access for External Tools via a RESTful API [Version 1; Referees: 2 Approved].” 
F1000Research 4 (478). doi:10.12688/f1000research.6767.1. 
Ormerod, Kate L, David L A Wood, Nancy Lachner, Shaan L Gellatly, Joshua N Daly, Jeremy D 
Parsons, Cristiana G O Dal’Molin, et al. 2016. “Genomic Characterization of the Uncultured 
Bacteroidales Family S24-7 Inhabiting the Guts of Homeothermic Animals.” Microbiome 4 
(1): 1–17. doi:10.1186/s40168-016-0181-2. 
Orth, Jeffrey D, Ines Thiele, and Bernhard Ø Palsson. 2010. “What Is Flux Balance Analysis?” Na-
ture Biotechnology 28 (3). Nature Research: 245–48. doi:10.1038/nbt.1614. 
Ottman, Noora, Hauke Smidt, Willem M de Vos, and Clara Belzer. 2012. “The Function of Our 
Microbiota: Who Is out There and What Do They Do?” Frontiers in Cellular and Infection 
Microbiology 2 (August). Frontiers Media S.A.: 104. doi:10.3389/fcimb.2012.00104. 
Pabst, O, and A M Mowat. 2012. “Oral Tolerance to Food Protein.” Mucosal Immunol 5 (3). Socie-
ty for Mucosal Immunology: 232–39. http://dx.doi.org/10.1038/mi.2012.4. 
Paglialunga, Sabina, Patrick Schrauwen, Christian Roy, Esther Moonen-Kornips, Huiling Lu, Mat-
thijs K C Hesselink, Yves Deshaies, Denis Richard, and Katherine Cianflone. 2007. 
“Reduced Adipose Tissue Triglyceride Synthesis and Increased Muscle Fatty Acid Oxidation 
in C5L2 Knockout Mice.” The Journal of Endocrinology 194 (2). England: 293–304. 
doi:10.1677/JOE-07-0205. 
Palmer, Chana, Elisabeth M Bik, Daniel B DiGiulio, David A Relman, and Patrick O Brown. 2007. 
“Development of the Human Infant Intestinal Microbiota.” PLoS Biol 5 (7). Public Library of 
228 
References 
 Science: e177. http://dx.doi.org/10.1371/journal.pbio.0050177. 
Pérez Gutiérrez, O. 2010. Unraveling Piglet Gut Microbiota Dynamics in Response to Feed Addi-
tives. [Sl: sn]. 
Pérez Gutiérrez, O, B van den Bogert, M Derrien, S Koopmans, D Molenaar, W M de Vos, and H 
Smidt. 2010. “Design of a High-Throughput Diagnostic Microarray for the Characterization 
of Pig Gastrointestinal Tract Microbiota (Chapter 3).” Unraveling Piglet Gut Microbiota 
Dynamics in Response to Feed Additives [Dissertation]. Wageningen: Wageningen Universi-
ty, 40–67. 
Peterson, Lance W, and David Artis. 2014. “Intestinal Epithelial Cells: Regulators of Barrier Func-
tion and Immune Homeostasis.” Nat Rev Immunol 14 (3). Nature Publishing Group, a divi-
sion of Macmillan Publishers Limited. All Rights Reserved.: 141–53. http://
dx.doi.org/10.1038/nri3608. 
Phipson, Belinda, Stanley Lee, Ian J. Majewski, Warren S. Alexander, and Gordon K. Smyth. 2016. 
“Robust Hyperparameter Estimation Protects against Hypervariable Genes and Improves 
Power to Detect Differential Expression.” Applications; Genomics. The Annals of Applied 
Statistics 10 (2): 946–63. doi:10.1214/16-AOAS920. 
Pluske, John R, Jean Le Dividich, and Martin W A Verstegen. 2003. Weaning the Pig: Concepts 
and Consequences. Wageningen Academic Pub. 
Poe, S L, M Arora, T B Oriss, M Yarlagadda, K Isse, A Khare, D E Levy, et al. 2013. “STAT1-
Regulated Lung MDSC-like Cells Produce IL-10 and Efferocytose Apoptotic Neutrophils 
with Relevance in Resolution of Bacterial Pneumonia.” Mucosal Immunol 6 (1). Society for 
Mucosal Immunology: 189–99. http://dx.doi.org/10.1038/mi.2012.62. 
Qing, Yulan, and George R Stark. 2004. “Alternative Activation of STAT1 and STAT3 in Response 
to Interferon-Gamma.” The Journal of Biological Chemistry 279 (40): 41679–85. 
doi:10.1074/jbc.M406413200. 
Rajasundaram, Dhivyaa, Jean-Luc Runavot, Xiaoyuan Guo, William G T Willats, Frank 
Meulewaeter, and Joachim Selbig. 2014. “Understanding the Relationship between Cotton 
Fiber Properties and Non-Cellulosic Cell Wall Polysaccharides.” PLoS ONE 9 (11). Public 
Library of Science: e112168. http://dx.doi.org/10.1371%2Fjournal.pone.0112168. 
Rajilić-Stojanović, Mirjana, Hans G H J Heilig, Douwe Molenaar, Kajsa Kajander, Anu Surakka, 
Hauke Smidt, and Willem M De Vos. 2009. “Development and Application of the Human 
Intestinal Tract Chip, a Phylogenetic Microarray: Analysis of Universally Conserved Phylo-
types in the Abundant Microbiota of Young and Elderly Adults.” Environmental Microbiolo-
gy 11 (7). Blackwell Publishing Ltd: 1736–51. doi:10.1111/j.1462-2920.2009.01900.x. 
Ramos, Erin M, Douglas Hoffman, Heather A Junkins, Donna Maglott, Lon Phan, Stephen T Sher-
229 
References 
 ry, Mike Feolo, and Lucia A Hindorff. 2014. “Phenotype–Genotype Integrator (PheGenI): Synthe-
sizing Genome-Wide Association Study (GWAS) Data with Existing Genomic Resources.” 
European Journal of Human Genetics 22 (1). Nature Publishing Group: 144–47. doi:10.1038/
ejhg.2013.96. 
Rayan, Paran, Deborah Stenzel, and Pauline Ann McDonnell. 2005. “The Effects of Saturated Fatty 
Acids on Giardia Duodenalis Trophozoites in Vitro.” Parasitology Research 97 (3). Germa-
ny: 191–200. doi:10.1007/s00436-005-1432-5. 
Reikvam, Dag Henrik, Muriel Derrien, Rejoanoul Islam, Alexander Erofeev, Vedrana Grcic, Anders 
Sandvik, Peter Gaustad, et al. 2012. “Epithelial-Microbial Crosstalk in Polymeric Ig Receptor 
Deficient Mice.” European Journal of Immunology 42 (11): 2959–70. doi:10.1002/
eji.201242543. 
Reikvam, Dag Henrik, Alexander Erofeev, Anders Sandvik, Vedrana Grcic, Frode Lars Jahnsen, 
Peter Gaustad, Kathy D McCoy, Andrew J Macpherson, Leonardo A Meza-Zepeda, and Finn
-Eirik Johansen. 2011. “Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa 
and Epithelial Gene Expression.” PLoS ONE 6 (3). Public Library of Science: e17996. http://
dx.doi.org/10.1371%252Fjournal.pone.0017996. 
Relman, David A. 2012. “The Human Microbiome: Ecosystem Resilience and Health.” Nutrition 
Reviews 70. Blackwell Publishing Inc: S2–9. doi:10.1111/j.1753-4887.2012.00489.x. 
Ricklin, Daniel, George Hajishengallis, Kun Yang, and John D Lambris. 2010. “Complement: A 
Key System for Immune Surveillance and Homeostasis.” Nature Immunology 11 (9): 785–97. 
doi:10.1038/ni.1923. 
Rooks, Michelle G, Patrick Veiga, Leslie H Wardwell-Scott, Timothy Tickle, Nicola Segata, Monia 
Michaud, Carey Ann Gallini, et al. 2014. “Gut Microbiome Composition and Function in 
Experimental Colitis during Active Disease and Treatment-Induced Remission.” ISME J 8 
(7). International Society for Microbial Ecology: 1403–17. http://dx.doi.org/10.1038/
ismej.2014.3. 
Rossi, Oriana, Peter van Baarlen, and Jerry M Wells. 2011. “Host-Recognition of Pathogens and 
Commensals in the Mammalian Intestine.” In Between Pathogenicity and Commensalism, 
291–321. Springer. 
Rotenberg, Samuel, and Jens Oluf Andersen. 1982. “The Effect of Antibiotics on Some Lipid Me-
tabolism Parameters in Rats Receiving Corn Starch, Potato Flour or Pectin in the Diet.” Acta 
Agriculturae Scandinavica 32 (3). Taylor & Francis: 321–40. 
Saccenti, Edoardo, Maria Suarez-Diez, Claudio Luchinat, Claudio Santucci, and Leonardo Tenori. 
2014. “Probabilistic Networks of Blood Metabolites in Healthy Subjects as Indicators of La-
tent Cardiovascular Risk.” Journal of Proteome Research 14 (2). ACS Publications: 1101–
11. 
230 
References 
 Sahoo, Swagatika, and Ines Thiele. 2013. “Predicting the Impact of Diet and Enzymopathies on 
Human Small Intestinal Epithelial Cells.” Human Molecular Genetics 22 (13). England: 2705
–22. doi:10.1093/hmg/ddt119. 
Sanden, Suzy Van, Dan Lin, and Tomasz Burzykowski. 2008. “Performance of Gene Selection and 
Classification Methods in a Microarray Setting: A Simulation Study.” Communications in 
Statistics - Simulation and Computation 37 (2). Taylor & Francis Group : 409–24. 
doi:10.1080/03610910701792554. 
Sargent, R G. 2013. “Verification and Validation of Simulation Models.” Journal of Simulation 7 
(1). Palgrave Macmillan UK: 12–24. doi:10.1057/jos.2012.20. 
Sato, Hirokazu, Linda S. Zhang, Kristina Martinez, Eugene B. Chang, Qing Yang, Fei Wang, Philip 
N. Howles, Ryota Hokari, Soichiro Miura, and Patrick Tso. 2016. “Antibiotics Suppress Acti-
vation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-
Dawley Rats.” Gastroenterology 151 (5): 923–32. doi:10.1053/j.gastro.2016.07.009. 
Sato, Toshiro, Daniel E Stange, Marc Ferrante, Robert G J Vries, Johan H Van Es, Stieneke Van 
den Brink, Winan J Van Houdt, et al. 2011. “Long-Term Expansion of Epithelial Organoids 
from Human Colon, Adenoma, Adenocarcinoma, and Barrett’s Epithelium.” Gastroenterolo-
gy 141 (5). United States: 1762–72. doi:10.1053/j.gastro.2011.07.050. 
Sato, Toshiro, Robert G Vries, Hugo J Snippert, Marc van de Wetering, Nick Barker, Daniel E 
Stange, Johan H van Es, et al. 2009. “Single Lgr5 Stem Cells Build Crypt–villus Structures in 
Vitro without a Mesenchymal Niche.” Nature 459 (7244). Macmillan Publishers Limited. All 
rights reserved: 262–65. http://dx.doi.org/10.1038/nature07935. 
Schäfer, Juliane, and Korbinian Strimmer. 2005. “A Shrinkage Approach to Large-Scale Covariance 
Matrix Estimation and Implications for Functional Genomics.” Statistical Applications in 
Genetics and Molecular Biology 4 (1). 
Schmittgen, Thomas D, and Kenneth J Livak. 2008. “Analyzing Real-Time PCR Data by the Com-
parative CT Method.” Nature Protocols 3 (6). Nature Publishing Group: 1101–8. 
doi:10.1038/nprot.2008.73. 
Schokker, Dirkjan. 2014. “Pig Experiment Sterksel Early Antibiotics/stress.” Gene Expression Om-
nibus. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53170. 
Schokker, Dirkjan, Jing Zhang, Stéphanie A Vastenhouw, H G Heilig, Hauke Smidt, J M Rebel, and 
Mari A Smits. 2015. “Long-Lasting Effects of Early-Life Antibiotic Treatment and Routine 
Animal Handling on Gut Microbiota Composition and Immune System in Pigs.” PloS One 10 
(2). Public Library of Science. 
Schokker, Dirkjan, Jing Zhang, Ling-li Zhang, Stéphanie A Vastenhouw, Hans G H J Heilig, Hauke 
Smidt, Johanna M J Rebel, and Mari A Smits. 2014. “Early-Life Environmental Variation 
231 
References 
 Affects Intestinal Microbiota and Immune Development in New-Born Piglets.” PLoS ONE 9 (6). 
Public Library of Science: e100040. http://dx.doi.org/10.1371%2Fjournal.pone.0100040. 
Scholtens, Petra A M J, Raish Oozeer, Rocio Martin, Kaouther Ben Amor, and Jan Knol. 2012. 
“The Early Settlers: Intestinal Microbiology in Early Life.” Annual Review of Food Science 
and Technology 3 (1). Annual Reviews: 425–47. doi:10.1146/annurev-food-022811-101120. 
Schumann, Alexandra, Sophie Nutten, Dominique Donnicola, Elena M Comelli, Robert Mansouri-
an, Christine Cherbut, Irène Corthesy-Theulaz, and Clara Garcia-Rodenas. 2005. “Neonatal 
Antibiotic Treatment Alters Gastrointestinal Tract Developmental Gene Expression and In-
testinal Barrier Transcriptome.” Physiological Genomics 23: 235–45. doi:10.1152/
physiolgenomics.00057.2005. 
Schwartz, Scott, Iddo Friedberg, Ivan V Ivanov, Laurie A Davidson, Jennifer S Goldsby, David B 
Dahl, Damir Herman, Mei Wang, Sharon M Donovan, and Robert S Chapkin. 2012. “A Met-
agenomic Study of Diet-Dependent Interaction between Gut Microbiota and Host in Infants 
Reveals Differences in Immune Response.” Genome Biology 13 (4): 1–16. doi:10.1186/gb-
2012-13-4-r32. 
Segain, J P, D Raingeard de la Blétière, A Bourreille, V Leray, N Gervois, C Rosales, L Ferrier, C 
Bonnet, H M Blottière, and J P Galmiche. 2000. “Butyrate Inhibits Inflammatory Responses 
through NFkappaB Inhibition: Implications for Crohn’s Disease.” Gut 47 (3): 397–403. 
http://www.ncbi.nlm.nih.gov/pubmed/10940278. 
Sender, Ron, Shai Fuchs, and Ron Milo. 2016. “Revised Estimates for the Number of Human and 
Bacteria Cells in the Body.” PLoS Biology 14 (8). Public Library of Science: e1002533. 
doi:10.1371/journal.pbio.1002533. 
Serino, Matteo, Elodie Luche, Sandra Gres, Audrey Baylac, Mathieu Bergé, Claire Cenac, Aurelie 
Waget, et al. 2012. “Metabolic Adaptation to a High-Fat Diet Is Associated with a Change in 
the Gut Microbiota.” Gut 61 (4): 543–53. doi:10.1136/gutjnl-2011-301012. 
Sham, Ho Pan, Emily Yi Shan Yu, Muhammet F. Gulen, Ganive Bhinder, Martin Stahl, Justin M. 
Chan, Lara Brewster, et al. 2013. “SIGIRR, a Negative Regulator of TLR/IL-1R Signalling 
Promotes Microbiota Dependent Resistance to Colonization by Enteric Bacterial Pathogens.” 
Edited by Dana J. Philpott. PLoS Pathogens 9 (8). Public Library of Science: e1003539. 
doi:10.1371/journal.ppat.1003539. 
Shannon, Paul, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, 
Nada Amin, Benno Schwikowski, and Trey Ideker. 2003. “Cytoscape: A Software Environ-
ment for Integrated Models of Biomolecular Interaction Networks.” Genome Research 13 
(11): 2498–2504. doi:10.1101/gr.1239303. 
Sharma, R, C Young, and J Neu. 2010. “Molecular Modulation of Intestinal Epithelial Barrier: Con-
tribution of Microbiota.” J Biomed Biotechnol 2010. 
232 
References 
 Sherwood L, Gorbach. 1996. “Microbiology of the Gastrointestinal Tract.” In Medical Microbiolo-
gy, edited by Samuel Baron, 4thed. The University of Texas Medical Branch at Galveston. 
https://www.ncbi.nlm.nih.gov/books/NBK7670/. 
Smith, Cynthia L, and Janan T Eppig. 2009. “The Mammalian Phenotype Ontology: Enabling Ro-
bust Annotation and Comparative Analysis.” Wiley Interdisciplinary Reviews. Systems Biolo-
gy and Medicine 1 (3). NIH Public Access: 390–99. doi:10.1002/wsbm.44. 
Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glick-
man, and W. S. Garrett. 2013. “The Microbial Metabolites, Short-Chain Fatty Acids, Regu-
late Colonic Treg Cell Homeostasis.” Science 341 (6145): 569–73. doi:10.1126/
science.1241165. 
Smyth, G K. 2005. “Limma: Linear Models for Microarray Data.” In Bioinformatics and Computa-
tional Biology Solutions Using R and Bioconductor SE - 23, edited by Robert Gentleman, 
VincentJ. Carey, Wolfgang Huber, RafaelA. Irizarry, and Sandrine Dudoit, 397–420. Statis-
tics for Biology and Health. Springer New York. doi:10.1007/0-387-29362-0_23. 
Söderholm, J D, and M H Perdue. 2001. “Stress and the Gastrointestinal Tract II. Stress and Intesti-
nal Barrier Function.” American Journal of Physiology - Gastrointestinal and Liver Physiolo-
gy 280 (1 43-1): G7–13. http://www.scopus.com/inward/record.url?eid=2-s2.0-
0342960436&partnerID=40&md5=7e28463f6b40250d05c609af96d47695. 
Steegenga, Wilma T, Mona Mischke, Carolien Lute, Mark V Boekschoten, Agnes Lendvai, Maurien 
G M Pruis, Henkjan J Verkade, et al. 2016. “Maternal Exposure to a Western-Style Diet 
Causes Differences in Intestinal Microbiota Composition and Gene Expression of Suckling 
Mouse Pups.” Molecular Nutrition & Food Research. doi:10.1002/mnfr.201600141. 
Steinway, Steven N, Matthew B Biggs, Thomas P Loughran Jr, Jason A Papin, and Reka Albert. 
2015. “Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.” 
PLOS Computational Biology 11 (6). Public Library of Science: e1004338. http://
dx.doi.org/10.1371%2Fjournal.pcbi.1004338. 
Stephens, Zachary D., Skylar Y. Lee, Faraz Faghri, Roy H. Campbell, Chengxiang Zhai, Miles J. 
Efron, Ravishankar Iyer, Michael C. Schatz, Saurabh Sinha, and Gene E. Robinson. 2015. 
“Big Data: Astronomical or Genomical?” PLOS Biology 13 (7). Public Library of Science: 
e1002195. doi:10.1371/journal.pbio.1002195. 
Suh, M, M Belosevic, and M T Clandinin. 2004. “Dietary Lipids Containing Gangliosides Reduce 
Giardia Muris Infection in Vivo and Survival of Giardia Lamblia Trophozoites in Vitro.” 
Parasitology 128 (Pt 6). England: 595–602. 
Taché, Y, V Martinez, M Million, and L Wang. 2001. “Stress and the Gastrointestinal Tract III. 
Stress-Related Alterations of Gut Motor Function: Role of Brain Corticotropin-Releasing 
Factor Receptors.” American Journal of Physiology - Gastrointestinal and Liver Physiology 
233 
References 
 280 (2 43-2): G173–77. http://www.scopus.com/inward/record.url?eid=2-s2.0-
0035008662&partnerID=40&md5=ea12c3f385aa1e64224f90de8be4b3d7. 
Tako, Ernest A, Maryam F Hassimi, Erqiu Li, and Steven M Singer. 2013. “Transcriptomic Analy-
sis of the Host Response to Giardia Duodenalis Infection Reveals Redundant Mechanisms for 
Parasite Control.” mBio 4 (6): e00660-13. doi:10.1128/mBio.00660-13. 
Tanaka, Shigemitsu, Takako Kobayashi, Prapa Songjinda, Atsushi Tateyama, Mina Tsubouchi, 
Chikako Kiyohara, Taro Shirakawa, Kenji Sonomoto, and Jiro Nakayama. 2009. “Influence 
of Antibiotic Exposure in the Early Postnatal Period on the Development of Intestinal Micro-
biota.” FEMS Immunology & Medical Microbiology 56 (1). Blackwell Publishing Ltd: 80–
87. doi:10.1111/j.1574-695X.2009.00553.x. 
Taylor, Chris F, Dawn Field, Susanna-Assunta Sansone, Jan Aerts, Rolf Apweiler, Michael Ash-
burner, Catherine A Ball, et al. 2008. “Promoting Coherent Minimum Reporting Guidelines 
for Biological and Biomedical Investigations: The MIBBI Project.” Nat Biotech 26 (8). Na-
ture Publishing Group: 889–96. http://dx.doi.org/10.1038/nbt.1411. 
Taylor, Ian W, Rune Linding, David Warde-Farley, Yongmei Liu, Catia Pesquita, Daniel Faria, 
Shelley Bull, Tony Pawson, Quaid Morris, and Jeffrey L Wrana. 2009. “Dynamic Modularity 
in Protein Interaction Networks Predicts Breast Cancer Outcome.” Nat Biotech 27 (2). Nature 
Publishing Group: 199–204. http://dx.doi.org/10.1038/nbt.1522. 
Teran, V, P Luna Pizarro, M F Zacarias, G Vinderola, R Medina, and C Van Nieuwenhove. 2015. 
“Production of Conjugated Dienoic and Trienoic Fatty Acids by Lactic Acid Bacteria and 
Bifidobacteria.” JOURNAL OF FUNCTIONAL FOODS 19 (A): 417–25. doi:10.1016/
j.jff.2015.09.046. 
Tibshirani, Robert. 2011. “Regression Shrinkage and Selection via the Lasso: A Retrospective.” 
Journal of the Royal Statistical Society: Series B (Statistical Methodology) 73 (3). Wiley 
Online Library: 273–82. 
Topping, David L, and Peter M Clifton. 2001. “Short-Chain Fatty Acids and Human Colonic Func-
tion: Roles of Resistant Starch and Nonstarch Polysaccharides.” Physiological Reviews 81 
(3): 1031 LP-1064. http://physrev.physiology.org/content/81/3/1031.abstract. 
Tremaroli, Valentina, and Fredrik Backhed. 2012. “Functional Interactions between the Gut Micro-
biota and Host Metabolism.” Nature 489 (7415). Nature Publishing Group, a division of 
Macmillan Publishers Limited. All Rights Reserved.: 242–49. http://dx.doi.org/10.1038/
nature11552. 
Tryka, Kimberly A, Luning Hao, Anne Sturcke, Yumi Jin, Zhen Y Wang, Lora Ziyabari, Moira Lee, 
et al. 2014. “NCBI’s Database of Genotypes and Phenotypes: dbGaP.” Nucleic Acids Re-
search 42 (D1): D975–79. http://dx.doi.org/10.1093/nar/gkt1211. 
234 
References 
 
Tseng, George C, Debashis Ghosh, and Eleanor Feingold. 2012. “Comprehensive Literature Review 
and Statistical Considerations for Microarray Meta-Analysis.” Nucleic Acids Research 40 (9). 
Oxford University Press: 3785–99. doi:10.1093/nar/gkr1265. 
Tsurugizawa, Tomokazu, Akira Uematsu, Eiji Nakamura, Mai Hasumura, Mariko Hirota, Takashi 
Kondoh, Hisayuki Uneyama, and Kunio Torii. 2009. “Mechanisms of Neural Response to 
Gastrointestinal Nutritive Stimuli: The Gut-Brain Axis.” Gastroenterology 137 (1). Elsevier: 
262–73. doi:10.1053/j.gastro.2009.02.057. 
Uhlén, Mathias, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardi-
noglu, Åsa Sivertsson, et al. 2015. “Tissue-Based Map of the Human Proteome.” Science 347 
(6220). http://science.sciencemag.org/content/347/6220/1260419.abstract. 
Ulmius, Matilda, Anna Johansson, and Gunilla Önning. 2009. “The Influence of Dietary Fibre 
Source and Gender on the Postprandial Glucose and Lipid Response in Healthy Subjects.” 
European Journal of Nutrition 48 (7): 395. doi:10.1007/s00394-009-0026-x. 
Van den Abbeele, Pieter, Philippe Gérard, Sylvie Rabot, Aurélia Bruneau, Sahar El Aidy, Muriel 
Derrien, Michiel Kleerebezem, et al. 2011. “Arabinoxylans and Inulin Differentially Modu-
late the Mucosal and Luminal Gut Microbiota and Mucin-Degradation in Humanized Rats.” 
Environmental Microbiology 13 (10). Blackwell Publishing Ltd: 2667–80. doi:10.1111/
j.1462-2920.2011.02533.x. 
van der Flier, Laurens G, and Hans Clevers. 2009. “Stem Cells, Self-Renewal, and Differentiation in 
the Intestinal Epithelium.” Annual Review of Physiology 71 (1). Annual Reviews: 241–60. 
doi:10.1146/annurev.physiol.010908.163145. 
Wang, Bo, Aziz M Mezlini, Feyyaz Demir, Marc Fiume, Zhuowen Tu, Michael Brudno, Benjamin 
Haibe-Kains, and Anna Goldenberg. 2014. “Similarity Network Fusion for Aggregating Data 
Types on a Genomic Scale.” Nat Meth 11 (3). Nature Publishing Group, a division of Mac-
millan Publishers Limited. All Rights Reserved.: 333–37. http://dx.doi.org/10.1038/
nmeth.2810. 
Wang, X, Y F Tao, L L Huang, D M Chen, S Z Yin, A Ihsan, W Zhou, et al. 2012. 
“Pharmacokinetics of Tulathromycin and Its Metabolite in Swine Administered with an Intra-
venous Bolus Injection and a Single Gavage.” Journal of Veterinary Pharmacology and 
Therapeutics 35 (3). Blackwell Publishing Ltd: 282–89. doi:10.1111/j.1365-
2885.2011.01322.x. 
Wells, Jerry M, Robert J Brummer, Muriel Derrien, Thomas T MacDonald, Freddy Troost, Patrice 
D Cani, Vassilia Theodorou, et al. 2017. “Homeostasis of the Gut Barrier and Potential Bi-
omarkers.” American Journal of Physiology. Gastrointestinal and Liver Physiology 312 (3). 
United States: G171–93. doi:10.1152/ajpgi.00048.2015. 
Wells, Jerry M, Linda M P Loonen, and Jurgen M Karczewski. 2010. “The Role of Innate Signaling 
in the Homeostasis of Tolerance and Immunity in the Intestine.” International Journal of 
235 
References 
 Medical Microbiology : IJMM 300 (1). Germany: 41–48. doi:10.1016/j.ijmm.2009.08.008. 
Wells, Jerry M, Oriana Rossi, Marjolein Meijerink, and Peter van Baarlen. 2011. “Epithelial Cross-
talk at the Microbiota-Mucosal Interface.” Proceedings of the National Academy of Sciences 
of the United States of America, no. Supplement 1 (March). National Academy of Sciences: 
4607–14. doi:10.1073/pnas.1000092107. 
Welter, Danielle, Jacqueline MacArthur, Joannella Morales, Tony Burdett, Peggy Hall, Heather 
Junkins, Alan Klemm, et al. 2014. “The NHGRI GWAS Catalog, a Curated Resource of SNP
-Trait Associations.” Nucleic Acids Research 42 (Database issue). Oxford University Press: 
D1001–6. doi:10.1093/nar/gkt1229. 
Weng, M, and W A Walker. 2013. “The Role of Gut Microbiota in Programming the Immune Phe-
notype.” Journal of Developmental Origins of Health and Disease 4: 203–14. doi:10.1017/
S2040174412000712. 
Wilkinson, Mark D, Michel Dumontier, I Jsbrand Jan Aalbersberg, Gabrielle Appleton, Myles Ax-
ton, Arie Baak, Niklas Blomberg, et al. 2016. “The FAIR Guiding Principles for Scientific 
Data Management and Stewardship.” Scientific Data 3 (March). England: 160018. 
doi:10.1038/sdata.2016.18. 
Willing, Benjamin P, Navkiran Gill, and B Brett Finlay. 2010. “The Role of the Immune System in 
Regulating the Microbiota.” Gutmicrobes 1 (4). Landes Bioscience Inc.: 213–23. http://
www.landesbioscience.com/journals/gutmicrobes/article/12520/. 
Willing, Benjamin P, Shannon L Russell, and B Brett Finlay. 2011. “Shifting the Balance: Antibi-
otic Effects on Host-Microbiota Mutualism.” Nature Reviews. Microbiology 9: 233–43. 
doi:10.1038/nrmicro2536. 
Winter, David. 2016. “Rentrez: Entrez in R.” https://cran.r-project.org. https://cran.r-project.org/
web/packages/rentrez/rentrez.pdf. 
Wu, Guanming, Xin Feng, and Lincoln Stein. 2010. “Research a Human Functional Protein Interac-
tion Network and Its Application to Cancer Data Analysis.” Genome Biol 11: R53. 
Wu, Yu-Sheng, Shu-Ying Ho, Fan-Hua Nan, and Shiu-Nan Chen. 2016. “Ganoderma Lucidum Beta 
1,3/1,6 Glucan as an Immunomodulator in Inflammation Induced by a High-Cholesterol Di-
et.” BMC Complementary and Alternative Medicine 16 (1). England: 500. doi:10.1186/
s12906-016-1476-3. 
Xia, Jianguo, Christopher D Fjell, Matthew L Mayer, Olga M Pena, David S Wishart, and Robert E 
W Hancock. 2013. “INMEX--a Web-Based Tool for Integrative Meta-Analysis of Expression 
Data.” Nucleic Acids Research 41 (Web Server issue). Oxford University Press: W63-70. 
doi:10.1093/nar/gkt338. 
236 
References 
 Yichoy, M, T T Duarte, A De Chatterjee, T L Mendez, K Y Aguilera, D Roy, S Roychowdhury, S B 
Aley, and S Das. 2011. “Lipid Metabolism in Giardia: A Post-Genomic Perspective.” Para-
sitology 138 (3): 267–78. doi:10.1017/S0031182010001277. 
Yu, Jeffrey J, and Sarah L Gaffen. 2008. “Interleukin-17: A Novel Inflammatory Cytokine That 
Bridges Innate and Adaptive Immunity.” Frontiers in Bioscience : A Journal and Virtual 
Library. Department of Microbiology and Immunology, University at Buffalo School of 
Medicine and Biomedical Sciences, Buffalo, NY, USA. doi:10.2741/2667. 
Ze, Xiaolei, Sylvia H Duncan, Petra Louis, and Harry J Flint. 2012. “Ruminococcus Bromii Is a 
Keystone Species for the Degradation of Resistant Starch in the Human Colon.” ISME J 6 
(8). International Society for Microbial Ecology: 1535–43. http://dx.doi.org/10.1038/
ismej.2012.4. 
Zheng, G, H Yampara Iquise, J E Jones, and C Andrew Carson. 2009. “Development of Faecalibac-
terium 16S rRNA Gene Marker for Identification of Human Faeces.” Journal of Applied 
Microbiology 106 (2). Wiley Online Library: 634–41. 
Zhu, Yuelin, Sean Davis, Robert Stephens, Paul S Meltzer, and Yidong Chen. 2008. “GEOmetadb: 
Powerful Alternative Search Engine for the Gene Expression Omnibus.” Bioinformatics 24 
(23): 2798–2800. doi:10.1093/bioinformatics/btn520. 
Zoetendal, Erwin G, Jeroen Raes, Bartholomeus van den Bogert, Manimozhiyan Arumugam, Carien 
C G M Booijink, Freddy J Troost, Peer Bork, Michiel Wels, Willem M de Vos, and Michiel 
Kleerebezem. 2012. “The Human Small Intestinal Microbiota Is Driven by Rapid Uptake and 
Conversion of Simple Carbohydrates.” ISME J 6 (7). International Society for Microbial 
Ecology: 1415–26. http://dx.doi.org/10.1038/ismej.2011.212. 
  
 
 
Acknowledgements 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
239 
Acknowledgements 
 
I have several people to thank for the successful completion of my PhD starting from my 
patient supervisory team to my loving family and wonderful friends. I thank all of them 
for making my four years filled with laughter and joy (I know it sounds cliché but if you 
were there, you know this is absolutely true). 
From the very first meeting Prof. Mari Smits has been very supportive and understanding.  
The confidence he placed in my abilities allowed me to develop them more and I am eter-
nally grateful for that. Dirkjan Schokker, one of my daily supervisors was always very 
involved in my work with hours of discussion/poking holes in my theories, that tended to 
stray away from scientific topics several times. As his first PhD student, I would ‘strongly 
recommend’ him as a supervisor to my friends. Without Maria Suarez-Diez, my dry-lab 
supervisor, I might have given up on my PhD in the first year. From helping me turn on a 
computer (in my defence, it was a mac, they hide the power button), she has helped me 
every step of the way with quick solutions and encouraging words. Constructive criticism 
(or scepticism) from Prof. Vitor Martins dos Santos has always kept me on my toes. My 
discussions with Prof. Jerry Wells have helped me understand the biology behind my re-
sults and achieve the wet-lab – dry-lab – wet-lab cycle. 
Even starting my PhD would be inconceivable without the love and support of my hus-
band Rajaram Kaliyaperumal. From drying my tears in the first year to cooking all the 
meals in the last few months of my PhD, he was truly my rock. I would need a lifetime to 
thank him adequately. My mother Asumtha Mary, my father Philip Benis and my sister 
Anupama Philip bore with me very patiently as I kept forgetting to call them. Although 
doing a masters is not very common where I come from, and committing to a PhD even 
more rare, my family supported me through it all just to see me happy. This came with 
several sacrifices from their part for which I will always be grateful. My mother always 
knew the right yogasana to do for a particular ailment and never tired of helping me keep 
my health intact. My father's absolute confidence in me to basically do anything and my 
sister's kind encouragement were absolutely essential for my mental health.  
All my colleagues at both HMI (Host Microbe Interactomics) and SSB (Systems and Syn-
thetic Biology) are the best co-workers one could ask for. I had very lively officemates in 
both departments. Soumya Kar aka. Sam, was the first colleague I met, incidentally in a 
240 
Acknowledgements 
 
deep dark forest that looked like a serial killer's hideout. He helped me with my orienta-
tion, where the grocery store was, how to get to Wageningen from Ede, how to pronounce 
Ede and so many, many things. He also did not stop directing me until the third year of 
my PhD, but well, if you know Sam you know this is completely normal. All of HMI 
made me feel included and at home and I am privileged to call them my friends. Even 
though several HMIers were not used to a dry-lab person before, most of them gave me 
the benefit of the doubt and assumed I was in fact working and not just on Facebook all 
the time. Aga helped me with the outsider's view into the Netherlands while also allowing 
me to vent out my frustrations. I had a great time with Nuning and Berdien, I just hope I 
did not scare them too much on what was to come with my final year stress sessions. Loes 
is the heart of HMI, she is always willing to lend a ear and make you feel special. Anja 
and Nico are the most generous people I have ever met, they have, at some point, helped 
every single HMIer with a kind word, a shoulder to cry on or apple pie. Although Marcela 
and Edoardo took a lot of time to master my name (I only gave you 4 letters by the way), 
we did have a lot of non-fruitful conversations, which are the best kind anyway. Linda, 
Rogier, Ellen and Marjolein initiated me into the Dutch way with a lot of frankness that I 
was too nervous to understand in the first 6 months of my studies, but I must confess, I am 
far too comfortable with it now. Nadya, here is one whole sentence dedicated only to you, 
partly devoid of content, but seriously, I admire your wry sense of humour partly because 
you say things out loud as I am filtering them out of my thoughts. Raka, Jonna, Simon, 
Jori, Bart, Jurgen, Peter and Michiel (sorry we took your office) have all made my stay at 
HMI pleasant and eventful and I am very thankful for that.  
As Maarten once said, SSB used to be a group full of nerdy guys, they had things called 
LAN parties, I was hurt at not even being invited for this party until I learned what it was. 
Maarten, o where do I start, he did not interrupt anyone during work hours and balanced 
that by not staying quiet even for a minute during the breaks. Ruben 'white-knighted' me 
fending off many of Maarten's barbs, but Ruben's goal might have been to contradict him 
rather than protect me. During the ruckus Bart was very patient or he had very good head-
phones, but he never refused to help any way he could, even if that meant teaching me 
some very basic things. Dorett, the one person I could relate to in SSB initially, is a great 
listener and gave me permission to not write the whole acknowledgement section on her 
alone, for which I am very grateful, and I am not just saying this because she has embar-
241 
Acknowledgements 
 
rassing photos of me. Her wit and coffee after lunch kept me quite entertained, yes, some-
one else drinking coffee benefited me, its a long story. Bastian initiated our breaks, coffee 
and lunch, and did not take no for an answer, sometimes resorting to physical means to 
take people out of the office or make them stay at the break room. Benoit saved my laptop 
when it was 'too hot to handle', yes overheating problems, and has since helped me with 
shell scripts while making sure I feel thoroughly inadequate. My new office mates Linde 
and Nhung regaled me with their impressions of pressure which took me back to my first 
year. These wonderful officemates, initiated by Ruben, also kept a countdown of the days 
before my submission deadline, although I did not appreciate having it right in front of my 
face. Kalyanasundaram aka Kal, helped me pour out my 'challenges' in Tamil so that not 
everyone necessarily knew what I was talking about. Coffee and lunch breaks were al-
ways 'eventful' especially if Bastian, Maarten, Benoit, Robert and Nikolaos were all in-
volved, unless one migrated to the 'other' break group of Jasper, Jesse and Niels who were 
a little more PG-13. But now with more of a female presence with Emma, Erika, Linde 
and Nhung, we can finally talk about more than games I have never heard of or Maarten's 
VR system. My time in SSB was made more enjoyable by my colleagues Mark, Michel, 
Milad, Edoardo Saccenti, Peter Schaap, Tjerko, Sudarshan and Alex. 
All my collaborators on the IPOP Systems Biology project helped me bounce ideas off 
them as we were locked away in the most remote place organizers could find. I am espe-
cially grateful to the IPOP Virtual Gut team, Bastian, Balaji and Neeraj and their supervi-
sors for helping me along the way. 
My PhD experience was enhanced by the wonderful people I met and the amazing people 
who supported me. I apologise if I have missed anyone, it was not intentional. I hope to be 
able to carry on these friendships as I embark on my career in the 'real world'. 
 
 
 
  
 
 
 
 
Training and Supervision Plan 
 
245 
Training and Supervision Plan 
 Conferences and Symposiums (10 credits) 
ECCB2016, European Conference on Computation Biology, 2016  
(Poster presentation) 
BioSB2016, Dutch Bioinformatics and Systems Biology Conference, 2016  
(Poster presentation) 
BioSB2015 Dutch Bioinformatics and Systems Biology Conference, 2015  
(Poster presentation) 
SB@NL 2014 Systems Biology Symposium, Maastricht, 2014  
(Poster presentation) 
Symposium Systems Biology for Food, Feed, and Health, 2013,  
(Oral presentation) 
SB@NL 2013 Systems Biology Symposium, 2013  
(Poster presentation) 
NBIC2014 Netherlands Bioinformatics Conference, 2014  
(Poster presentation) 
 
246 
Training and Supervision Plan 
 In-depth Courses (12 credits) 
Parameter Estimation Tutorial, 2013 
Elementary Calculus in Systems Biology, 2014 
Algorithms for Biological Networks, 2014 
The Intestinal Microbiome and Diet in Human and Animal Health, 2014 
Pattern recognition, 2015 
Managing and Integrating Life Science Information, 2015 
Other courses (3) 
The Essentials of Scientific Writing and Presenting, 2015 
Mobilising your scientific network, 2015 
Information Literacy including EndNote Introduction, 2013 
Research skills training (6 credits) 
Preparing own PhD research proposal 
Management skills training (2 credits) 
WIAS Science Day organizing committee 
  
 
 
 
List of Publications 
 
249 
Curriculum Vitae 
  
Benis N, Schokker D, Suarez-Diez M, Martins dos Santos V, Smidt H, Smits M A, Net-
work Analysis of temporal functionalities of the gut induced by perturbations in new-born 
piglets, BMC Genomics, http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-
015-1733-8. 
 
Benis N, Schokker D, Kramer F, Smits M A, Suarez-Diez M, Building pathway graphs 
from BioPAX data in R, [version 2; referees: 3 approved, 1 approved with reservations]. 
F1000Research 2016, 5:2414 (doi: 10.12688/f1000research.9582.2).  
 
Benis N, Kar S K., Martins dos Santos V A. P., Smits M A., Schokker D, Suarez-Diez M, 
Multi-Level Integration of Environmentally Perturbed Internal Phenotypes Reveals Key 
Points of Connectivity between Them, Frontiers in Physiology  (https://doi.org/10.3389/
fphys.2017.00388) 
 
 
 The research described in this thesis was financially supported by the Systems Biology 
Investment Programme of Wageningen University. Financial support from the Wa-
geningen Institute of Animals Sciences for printing this thesis is gratefully acknowledged. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cover design by  Nirupama Benis 
Printed by Proefschriftmaken on FSC-certified paper  
 
